<!DOCTYPE html>

<html lang="en">


<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
      
        <link rel="prev" href="../Immunology/">
      
      
      
      <link rel="icon" href="../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.5.3, mkdocs-material-9.5.12">
    
    
<title>Literature Survey (VPE)</title>

    
      <link rel="stylesheet" href="../assets/stylesheets/main.7e359304.min.css">
      
        
        <link rel="stylesheet" href="../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
  <!-- Add scripts that need to run before here -->
  <!-- Add jquery script -->
  <script src="https://code.jquery.com/jquery-3.7.1.js"></script>
  <!-- Add data table libraries -->
  <script src="https://cdn.datatables.net/2.0.1/js/dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/2.0.1/css/dataTables.dataTables.css">
  <!-- Load plotly.js into the DOM -->
	<script src='https://cdn.plot.ly/plotly-2.29.1.min.js'></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/buttons/3.0.1/css/buttons.dataTables.css">
  <!-- fixedColumns -->
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/dataTables.fixedColumns.js"></script>
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/fixedColumns.dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/fixedcolumns/5.0.0/css/fixedColumns.dataTables.css">
  <!-- Already specified in mkdocs.yml -->
  <!-- <link rel="stylesheet" href="../docs/custom.css"> -->
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/dataTables.buttons.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.dataTables.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/jszip/3.10.1/jszip.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/pdfmake.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/vfs_fonts.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.html5.min.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.print.min.js"></script>
  <!-- Google fonts -->
  <link rel="stylesheet" href="https://fonts.googleapis.com/icon?family=Material+Icons">
  <!-- Intro.js -->
  <script src="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/intro.min.js"></script>
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/minified/introjs.min.css">


  <!-- 
      
     -->
  <!-- Add scripts that need to run afterwards here -->

    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../assets/_mkdocstrings.css">
    
      <link rel="stylesheet" href="../custom.css">
    
    <script>__md_scope=new URL("..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

<header class="md-header" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href=".." title="Literature Survey for Swathi" class="md-header__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Literature Survey for Swathi
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Oncology
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
      <div class="md-header__source">
        <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
            
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-grid">
    <ul class="md-tabs__list">
      
        
  
  
  
    <li class="md-tabs__item">
      <a href=".." class="md-tabs__link">
        
  
    
  
  Home

      </a>
    </li>
  

      
        
  
  
  
    <li class="md-tabs__item">
      <a href="../Immunology/" class="md-tabs__link">
        
  
    
  
  Immunology

      </a>
    </li>
  

      
        
  
  
    
  
  
    <li class="md-tabs__item md-tabs__item--active">
      <a href="./" class="md-tabs__link">
        
  
    
  
  Oncology

      </a>
    </li>
  

      
    </ul>
  </div>
</nav>
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
                
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" hidden>
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href=".." title="Literature Survey for Swathi" class="md-nav__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    Literature Survey for Swathi
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href=".." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Home
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../Immunology/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Immunology
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
      
      <a href="./" class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    Oncology
  </span>
  

      </a>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
                
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              <article class="md-content__inner md-typeset">
                
                  

  
  


  <h1>Oncology</h1>

<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
</head>

<body>
  <p>
  <i class="footer">This page was last updated on 2025-11-24 09:17:37 UTC</i>
  </p>

  <div class="note info" onclick="startIntro()">
    <p>
      <button type="button" class="buttons">
        <div style="display: flex; align-items: center;">
        Click here for a quick intro of the page! <i class="material-icons">help</i>
        </div>
      </button>
    </p>
  </div>

  <!--
  <div data-intro='Table of contents'>
    <p>
    <h3>Table of Contents</h3>
      <a href="#plot1">1. Citations over time on Oncology</a><br>
      <a href="#manually_curated_articles">2. Manually curated articles on Oncology</a><br>
      <a href="#recommended_articles">3. Recommended articles on Oncology</a><br>
    <p>
  </div>

  <div data-intro='Plot displaying number of citations over time 
                  on the given topic based on recommended articles'>
    <p>
    <h3 id="plot1">1. Citations over time on Oncology</h3>
      <div id='myDiv1'>
      </div>
    </p>
  </div>
  -->

  <div data-intro='Manually curated articles on the given topic'>
    <p>
    <h3 id="manually_curated_articles">Manually curated articles on <i>Oncology</i></h3>
    <table id="table1" class="display" style="width:100%">
    <thead>
      <tr>
          <th data-intro='Click to view the abstract (if available)'>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th data-intro='Highest h-index among the authors'>Highest h-index</th>
          <th data-intro='Recommended articles extracted by considering
                          only the given article'>
              View recommendations
              </th>
      </tr>
    </thead>
    <tbody>

        <tr id="Sustained smouldering, or low-grade activation, of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis1. Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells2. However, how these metabolic features act to perpetuate inflammation of the central nervous system is unclear. Here, using a multiomics approach, we identify a molecular signature that sustains the activation of microglia through mitochondrial complex I activity driving reverse electron transport and the production of reactive oxygen species. Mechanistically, blocking complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in an animal disease model in vivo. Complex I activity in microglia is a potential therapeutic target to foster neuroprotection in chronic inflammatory disorders of the central nervous system3. Blocking mitochondrial complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in vivo in an animal disease model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf" target='_blank'>
                Mitochondrial complex I activity in microglia sustains neuroinflammation
                </a>
              </td>
          <td>
            L. Peruzzotti-Jametti, C. Willis, G. Krzak, R. Hamel, L. Pirvan, Rosana-Bristena Ionescu, J. Reisz, H. Prag, M. E. Garcia-Segura, V. Wu, Y. Xiang, B. Barlas, A. Casey, A. van den Bosch, A. Nicaise, L. Roth, G. R. Bates, H. Huang, P. Prasad, A. E. Vincent, C. Frezza, C. Viscomi, G. Balmus, Z. Takáts, J. Marioni, A. D'alessandro, M. P. Murphy, I. Mohorianu, S. Pluchino
          </td>
          <td>2024-03-13</td>
          <td>Nature</td>
          <td>122</td>
          <td>31</td>

            <td><a href='../recommendations/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

        <tr id="The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited1. Here in our SARS-CoV-2 human challenge study, we used single-cell multi-omics profiling of nasopharyngeal swabs and blood to temporally resolve abortive, transient and sustained infections in seronegative individuals challenged with pre-Alpha SARS-CoV-2. Our analyses revealed rapid changes in cell-type proportions and dozens of highly dynamic cellular response states in epithelial and immune cells associated with specific time points and infection status. We observed that the interferon response in blood preceded the nasopharyngeal response. Moreover, nasopharyngeal immune infiltration occurred early in samples from individuals with only transient infection and later in samples from individuals with sustained infection. High expression of HLA-DQA2 before inoculation was associated with preventing sustained infection. Ciliated cells showed multiple immune responses and were most permissive for viral replication, whereas nasopharyngeal T cells and macrophages were infected non-productively. We resolved 54 T cell states, including acutely activated T cells that clonally expanded while carrying convergent SARS-CoV-2 motifs. Our new computational pipeline Cell2TCR identifies activated antigen-responding T cells based on a gene expression signature and clusters these into clonotype groups and motifs. Overall, our detailed time series data can serve as a Rosetta stone for epithelial and immune cell responses and reveals early dynamic responses associated with protection against infection. A human SARS-CoV-2 challenge study in individuals without previous exposure to the virus or vaccines provides detailed profiles of local and systemic epithelial and immune cell response dynamics over time and infection status.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/380489b0c6f9106219184f0c5fe6612e0b4e165a" target='_blank'>
                Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
                </a>
              </td>
          <td>
            Rik G. H. Lindeboom, Kaylee B. Worlock, L. Dratva, M. Yoshida, David Scobie, Helen R. Wagstaffe, Laura Richardson, A. Wilbrey-Clark, Josephine L. Barnes, Lorenz Kretschmer, K. Polański, J. Allen-Hyttinen, Puja Mehta, D. Sumanaweera, J. M. Boccacino, W. Sungnak, R. Elmentaite, Ni Huang, L. Mamanova, R. Kapuge, L. Bolt, E. Prigmore, B. Killingley, M. Kalinova, Maria Mayer, A. Boyers, Alex J. Mann, Leo Swadling, M. Woodall, Samuel Ellis, Claire M. Smith, V. Teixeira, Sam M. Janes, R. Chambers, M. Haniffa, A. Catchpole, R. Heyderman, M. Noursadeghi, Benjamin M. Chain, Andreas Mayer, Kerstin B. Meyer, Christopher Chiu, Marko Z. Nikolić, Sarah A. Teichmann
          </td>
          <td>2024-06-19</td>
          <td>Nature</td>
          <td>69</td>
          <td>75</td>

            <td><a href='../recommendations/380489b0c6f9106219184f0c5fe6612e0b4e165a' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
          <th>View recommendations</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

  <div data-intro='Recommended articles extracted by contrasting
                  articles that are relevant against not relevant for Oncology'>
    <p>
    <h3 id="recommended_articles">Recommended articles on <i>Oncology</i></h3>
    <table id="table2" class="display" style="width:100%">
    <thead>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </thead>
    <tbody>

        <tr id="CNS infection by HIV-1 contributes to neuroinflammation, cognitive impairments, and the establishment of viral reservoirs. Although HIV-1 is known to enter the brain early in infection via “Trojan horse” leukocytes, including infected monocytes and CD4⁺ T cells, the specific cellular phenotypes facilitating this process during acute infection remain incompletely characterized. This study aims to characterize the roles of brain lymphocytes during acute infection and primary CD4 + T cell phenotypes seeding the SIV to the CNS. scRNA-seq was performed on brain and blood cells of three acutely SIV-infected rhesus macaques. The transcriptomic data were analyzed using bioinformatics approaches and validated through in vitro co-culture assays and re-analysis of a publicly available scRNA-seq dataset. scRNA-seq of brain and blood immune cells from acutely SIV-infected rhesus macaques revealed an expansion of proliferating CD4⁺ cytotoxic T lymphocytes (CTLs) in the blood, characterized by high CD4, CCR5, and adhesion molecule expression, indicating strong potential for CNS infiltration. In the brain, CD4⁺ CTLs, tissue-resident memory cells, and a unique Myeloid–T cell cluster were enriched for SIV⁺ cells. Integration of brain and blood data revealed transcriptomic maturation of CD4⁺ CTLs upon brain entry. To validate the biological relevance of the Myeloid–T cluster, we used a macrophage–T cell co-culture system, which reproduced similar dual-marker expression and identified chemokines (e.g., CCL3, CCL4) as potential markers of T cell–myeloid cell interaction. Our findings suggest that CD4⁺ cytotoxic-like T cells represent a key lymphocyte subset responsible for initiating SIV entry into the brain and triggering neuroinflammatory processes. Furthermore, interactions between infiltrating lymphocytes and brain-resident myeloid cells, potentially through chemokine signaling, may facilitate viral propagation within the CNS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/72fbfac68579326979ef04a1dc07549f993cb4aa" target='_blank'>
              T cell-mediated SIV dissemination into the CNS: a single-cell transcriptomic analysis
              </a>
            </td>
          <td>
            Xiaoke Xu, Meng Niu, Benjamin G. Lamberty, Kathleen M. Emanuel, L. D. Estrella, Howard S. Fox
          </td>
          <td>2025-10-08</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="While males are more likely to suffer severe outcomes during acute COVID-19, a greater proportion of females develop post-acute sequalae of COVID-19 (PASC) despite similar rates of infection. To identify mechanisms of PASC, mice were infected with SARS-CoV-2 and viral, inflammatory, and behavioral outcomes were evaluated through 84 days post infection. Sex differences were not observed in virus replication or persistence of viral RNA in pulmonary or extrapulmonary tissues in acute or PASC phases. Following recovery from infection, female mice exhibited persistent neurocognitive and behavioral impairments, along with greater frequencies of inflammatory myeloid subsets, neuroinflammation, and dysregulated T cell subsets, including Tregs. Sex differences in inflammation and cognitive phenotypes during PASC were mediated by the presence of two X chromosomes. XX animals independent of chromosome Y presented with neuroinflammation and PASC along with infection-induced upregulation of the X-linked genes Xist and Tlr7 that regulate inflammation and chronic disease outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/79890359565389b73c061b8b182c8a9f91a90fcd" target='_blank'>
              Mechanisms of sex differences in acute and long COVID sequelae in mice
              </a>
            </td>
          <td>
            Jennifer A. Liu, Sabal Chaulagain, Patrick S. Creisher, Weizhi Zhong, Tianle Zhang, Maraake Taddese, Karly Shi, Han-sol Park, Haley Hcnir, Arthur P. Arnold, Ralph S. Baric, Natasha B Barahona, Elizabeth Engler-Chiurazzi, Kevin J. Zwezdaryk, Chloe L. Thio, A. Balagopal, J.R. Harkema, Elizabeth A. Thompson, A. Pekosz, Andrea L Cox, S. Klein
          </td>
          <td>2025-10-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Cytomegalovirus is the leading viral cause of congenital infection with neurological sequelae. Effective medical treatments are limited due to an inadequate understanding of the underlying pathogenesis. Here, we applied single-cell transcriptomics to analyze neonatal mouse brains with congenital cytomegalovirus infection (cCMV). We profiled cCMV in 22 cell types and identified neural progenitor cells (NPCs) and monocyte-derived macrophages (MDMs) as the most commonly infected cells. Infected NPCs exhibited dysregulated neurodevelopment-associated signaling pathways, correlating with viral transcript levels that indicate viral replication levels. Genes associated with phagocytosis and antigen presentation were downregulated exclusively in infected MDMs but remained largely unaffected in microglia and barrier-associated macrophages regardless of infection status. Analysis of intrinsic and induced interferon-stimulated gene expression revealed great heterogeneity across cell types but no direct correlation with cCMV susceptibility. Furthermore, our findings indicate that interferon type II is crucial for the control of cCMV and consequent cortical damage and calcification in the neonatal brain. This study advances our understanding of cCMV tropism and the molecular details of cCMV-induced neurodevelopmental impairment, cerebral immune response, and brain pathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/37e868bb50c4bf02ba4bc61b84aaec7d5968b07e" target='_blank'>
              Molecular features of congenital cytomegalovirus infection in neonatal mouse brain at single-cell resolution
              </a>
            </td>
          <td>
            Meng-Jie Mei, Yue-Peng Zhou, Yu-Ting Pan, , , Tong Wu, M. McVoy, William J. Britt, Wen Zhou, Bo Yang, Xuan Jiang, Simon Rayner, Han Cheng, Min-Hua Luo
          </td>
          <td>2025-11-17</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Microglia and neuroinflammation are involved in amyotrophic lateral sclerosis (ALS), but the precise underlying molecular mechanisms remain elusive. We generated single-nuclei transcriptomes from the spinal cord and motor cortex of patients with sporadic ALS (sALS) and C9orf72 ALS (C9-ALS). Here we confirmed that C9orf72 is highly expressed in microglia and observed that the hexanucleotide repeat expansion (HRE) results in haploinsufficiency. Whereas sALS microglia transitioned toward disease-associated cell states, C9orf72 HRE microglia exhibited a diminished response, with alterations in endolysosomal pathways. We confirmed these observations using a human microglia xenograft model, in which C9orf72 mutations led to a reduced activation. We also confirmed the endolysosomal alterations in C9orf72 HRE and C9orf72-deficient induced pluripotent stem cell (iPSC)-derived microglia. We also found a diminished response of C9orf72 HRE astrocytes and provided a map of dysregulated ligand−receptor pairs in microglia and astrocytes. Our data highlight variations in the cellular substrate of sporadic and inherited forms of ALS, which have implications for patient stratification and selection of appropriate treatments. This study shows that C9orf72 mutations impair immune activation in ALS, affecting how brain cells communicate, and highlights key differences in the cellular and molecular pathways underlying sporadic and genetic forms of the disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fe7f84f5920b3b311764064dc59771322202bca6" target='_blank'>
              C9orf72 hexanucleotide repeat expansions impair microglial response in ALS
              </a>
            </td>
          <td>
            Pegah Masrori, Baukje Bijnens, Laura Fumagalli, K. Davie, S. Poovathingal, Tim Meese, Annet Storm, N. Hersmus, Raheem Fazal, Diede van den Biggelaar, B. Asselbergh, Roxane Gruel, Johanna Van Den Daele, Heidi Denton, Paula Polanco Miquel, Simona Manzella, W. D. De Vos, Siddhartan Chandran, L. Van Den Bosch, D. Thal, Renzo Mancuso, Philip van Damme
          </td>
          <td>2025-10-14</td>
          <td>Nature Neuroscience</td>
          <td>2</td>
          <td>57</td>
        </tr>

        <tr id="Growing evidence indicates that Epstein-Barr virus (EBV), a gammaherpesvirus, plays a central role in the pathogenesis of multiple sclerosis (MS). The presence of EBV-infected cells in the central nervous system (CNS) of MS patients, but not in neurologically healthy individuals, suggests that viral persistence in the CNS may drive MS. However, why there is such a long interval between initial infection and the development of disease is unknown. To model the effects of EBV infection on the brain, we intracerebrally infected mice with murine gammaherpesvirus-68 (MHV68), a virus genetically related to EBV that causes transient pathology strikingly similar to that seen in humans after acute EBV infection. One month following MHV68 infection, we administered myelin oligodendrocyte glycoprotein (MOG) peptide to evaluate the effects of prior MHV68 infection on the response to an additional inflammatory stimulus of the CNS. Virus persistence, microglial activation and immune cell infiltration were evaluated over time using flow cytometry. Intracerebral MHV68 infection induced mild brain demyelination and ataxia, a common symptom of MS, that both quickly resolved. However, administration of MOG peptide one month later led to more severe brain demyelination and more sustained ataxia, suggesting that prior MHV68 infection sensitized the mice to a newly introduced immune stimulus. Further investigation revealed that following CNS infection, MHV68 persisted in microglia, where it induced a primed phenotype marked by elevated MHC-II expression and heightened immune reactivity for at least six months. Primed microglia displayed increases in the labile iron pool, and iron chelation reduced microglial priming. Early antiviral treatment during MHV68 infection completely prevented subsequent MOG-induced demyelinating disease. These findings support a two-step mechanism by which CNS infection with a gammaherpesvirus closely related to EBV sensitizes the host to a second unrelated immune stimulus that triggers MS-like disease manifestations. Chronic priming of microglia resulting from the initial infection contributes to this process, and prevention of such priming with early antiviral treatment also prevents neuropathology following the second stimulus. EBV infection may similarly sensitize humans to a second stimulus and, if so, treatment of acute EBV infection may avert subsequent MS development.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bc50305e75ba829510074041add280a2e4049038" target='_blank'>
              Early antiviral treatment following gammaherpesvirus-68 infection of the central nervous system prevents subsequent multiple sclerosis-like disease
              </a>
            </td>
          <td>
            Alexander Muselman, Sameera Kongara, Nathan Hsu, Asha Aggarwal, Joanna Yu, Jayakumar Rajadas, Edgar G Engleman
          </td>
          <td>2025-10-08</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is an autoimmune and neuroinflammation disease characterized by axonal damage, inflammatory demyelination, and neurodegeneration. However, the precise mechanisms underlying MS pathogenesis remain largely unclear. Here, we identify ZNRF1, an E3 ubiquitin ligase, as a critical regulator of experimental autoimmune encephalomyelitis (EAE), a murine model that recapitulates the autoimmune demyelination features of MS. Mice lacking ZNRF1 exhibit increased susceptibility to EAE progression. Notably, ZNRF1 depletion in peripheral myeloid cells, but not in microglia, leads to enhanced immune cell infiltration into the central nervous system, resulting in demyelination and exacerbated disease severity. The heightened EAE severity in Znrf1-deficient mice is associated with increased polarization of Th1 and Th17 cells, elevated antigen-specific T helper cell proliferation, and amplified immune responses. Furthermore, following EAE induction, macrophages from Znrf1-deficient mice display elevated surface expression of MHC class II (MHC-II) molecules. Collectively, our findings suggest that ZNRF1 in peripheral myeloid cells plays a suppressive role in neuroinflammation by regulating MHC-II surface expression, thereby controlling antigen-specific T-cell proliferation and activation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f962a55325851d781ba99d1de0343d57aac16244" target='_blank'>
              Myeloid ZNRF1 suppresses autoimmune demyelination and neuroinflammation by regulating MHC-II-mediated T cell activation
              </a>
            </td>
          <td>
            Yung-Chi Chang, Ching-Chih Wu, Fu-Ting Hsiao, You-Sheng Lin, Ting-Yu Lai, Kang-Hsuan Huang, Shiue-Cheng Tang, Chih-Yuan Lee, Shen-Ju Chou, Li-Chung Hsu
          </td>
          <td>2025-10-22</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Aberrant and sustained activation of microglia is implicated in the progression and severity of multiple sclerosis (MS). However, whether intrinsic alterations in microglial function impact the pathogenesis of this disease remains unclear. We conducted transcriptomic and functional analyses of microglia-like cells (iMGLs) differentiated from induced pluripotent stem cells (iPSCs) from patients with MS (pwMS) to answer this question. We generated iPSCs from six pwMS showing increased microglial activity via translocator protein (TSPO)-PET imaging. We demonstrated that the differentiated iMGL transcriptional profile resembled the microglial signature found in MS lesions. Importantly, compared with healthy controls, MS iMGLs presented cell-autonomous differences in their regulation of inflammation, both in the basal state and following inflammatory lipopolysaccharide challenge. Through transcriptomic profiling, we showed that MS iMGLs display increased expression of genes known to be upregulated in MS microglia. Furthermore, upregulated genes in MS iMGLs were associated with immune receptor activation, antigen presentation, and the complement system, with known MS implications. Finally, functional analyses indicated that the transcriptional changes in MS iMGLs corresponded with alterations in the secretion of inflammatory cytokines and chemokines and increased phagocytosis. Together, our results provide evidence of putative cell-autonomous microglial activation in pwMS and identify transcriptomic and functional changes that recapitulate the phenotypes observed in vivo in microglia from pwMS. These findings indicate that MS disease-specific iPSCs are valuable tools for studying disease-specific microglial activation in vitro and highlight microglia as potential therapeutic targets in MS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ce483627b1620ca8e2ea90bf499e8cad452ba523" target='_blank'>
              Microglia from patients with multiple sclerosis display a cell-autonomous immune activation state
              </a>
            </td>
          <td>
            Tanja Hyvärinen, J. Lotila, Luca Giudice, Iisa Tujula, M. Nylund, S. Ohtonen, Flavia Scoyni, Henna Jäntti, Sara Pihlava, H. Skottman, Susanna Narkilahti, L. Airas, T. Malm, S. Hagman
          </td>
          <td>2024-12-11</td>
          <td>Journal of Neuroinflammation</td>
          <td>2</td>
          <td>47</td>
        </tr>

        <tr id="Severe SARS-CoV-2 infection is characterized by lung hyperinflammation, impaired interferon responses, and defective T-cell activation, yet the molecular drivers of these immune dysregulations remain incompletely understood. Caspase-11 (CASP11), a key mediator of the non-canonical inflammasome, has been shown to mediate an innate hyperinflammatory response and cytokine release in a non-severe, non-lethal SARS-CoV-2 infection model. However, the role played by CASP11 in severe SARS-CoV-2 disease and how it impacts adaptive immunity is not identified. Here, we newly discover that CASP11 exacerbates severe SARS-CoV-2 pathogenesis by amplifying early innate immune responses while concurrently impairing antiviral CD8 T-cell immunity. Using global knockouts, reciprocal bone marrow chimeras, and phagocyte-monocyte system (PMS) cell-specific CASP11 deletion models, we show that CASP11 deletion in monocyte-derived cells reduces lung inflammation, enhances type I and II interferon signaling, and promotes robust virus-specific effector CD8⁺ T-cell response. This was associated with enhanced viral clearance and improved survival, even under lethal infection conditions. Importantly, CASP11 KO mice also exhibited faster resolution of post-viral inflammation, suggesting a role in long-term immune remodeling. These findings position CASP11 as a promising immunomodulatory target for acute and delayed manifestations of severe SARS-CoV-2.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fa0d09c722147bd759ef9cedc307b8c6a5fb7718" target='_blank'>
              Caspase-11 Mediated Hyperinflammation Impairs CD8⁺ T Cell Immunity and Viral Clearance in Severe SARS-CoV-2 Infection
              </a>
            </td>
          <td>
            Mostafa Eltobgy, Mohamed M. Shamseldin, Owen Whitham, Heba M Amer, Jeffery Atkinson, Asmaa Badr, Jesse Hall, Jihad Omran, Gauruv A. Gupta, Yara Hassan, Rabab Abdelaleem, Richard Perez, Sarah Faber, Maciej Pietrzak, Amy Webb, Xiaoli Zhang, A. Kenney, Destiny Bissel, Shady Z K Estfanous, Kylene P. Daily, Andrew Mcnamara, K. Mahesh, M. Peeples, Emily A. Hemann, Shahid M. Nimjee, E. Cormet-Boyaka, Jianrong Li, P. Boyaka, Jacob S. Yount, Benjamin M. Segal, Purnima Dubey, Amal O Amer
          </td>
          <td>2025-11-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>44</td>
        </tr>

        <tr id="In multiple sclerosis (MS), chronic compartmentalized inflammation is thought to drive relentless clinical deterioration. Here, we investigate the link between unresolved parenchymal inflammation and cellular senescence in MS progression. Single-cell transcriptomic analysis of human brain tissue reveals an accumulation of senescent-like glial cells in diseased white matter, especially in chronic active lesions, and to a lesser extent in the cortex. Spatial transcriptomics show gradients of senescence-like signatures extending from lesion cores to periplaque regions, alongside rewired cellular networks. Experimental induction of senescence in MS hiPSC-derived neural organoids demonstrates that microglia are especially vulnerable to inflammation-induced senescence, which can be partially rescued by CNS-penetrant anti-inflammatory drugs. At the patient level (n = 466), increased 3T MRI-estimated brain-age is observed, especially in individuals with more than four chronic active lesions. These findings suggest that chronic inflammation might accelerate senescence-like processes, potentially contributing to disease progression, and that its modulation might help limit further propagation. In multiple sclerosis, smoldering inflammation contributes to clinical progression. Using multi-omics data, here the authors link chronic inflammation to senescence-like processes and cellular network changes, suggesting a potential therapeutic target.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b77d9523c82f1187be87e3bd2154d78aa2798954" target='_blank'>
              Spatially-restricted inflammation-induced senescent-like glia in multiple sclerosis and patient-derived organoids
              </a>
            </td>
          <td>
            Francesca Fagiani, Edoardo Pedrini, Maria Sofia Martire, Gaia Gastoldi, Colin Vanden Bulcke, Jing-Ping Lin, Dragan Maric, Elena Brambilla, F. Ruffini, Carolina Peri, P. Calabresi, Pietro Maggi, Paola Panina-Bordignon, Gianvito Martino, D. Reich, Martina Absinta
          </td>
          <td>2025-09-26</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/22393b9ffca1a3471e0c12f80fd5127144012755" target='_blank'>
              A Human Alveolus-on-Chip Recapitulates SARS-CoV-2-mediated Lung Injury in an Organ-relevant Context for Pre-clinical Applications
              </a>
            </td>
          <td>
            M. Kiener, Lea Lara De Maddalena, Nuria Roldan, P. Chouvardas, Laurène Froment, M. De Menna, Thomas Geiser, J. Stucki, Nina Hobi, Marianna Kruithof-de Julio
          </td>
          <td>2025-10-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e1f062d3d912692ad94fd023b7389eaa8ae74fd9" target='_blank'>
              Temporal Dynamics of Antigen-Specific T Cell Expansion in Primary SARS-CoV-2 Infection
              </a>
            </td>
          <td>
            Andrew Pyo, Adlina Chan, J. Rosenheim, Clare Thakker, Lucy Bell, Gayathrie Nageswaran, Suzanne Byrne, Ben Killingley, David Scobie, M. Kalinova, A. Boyers, A. Catchpole, Alex J. Mann, Rik G. H. Lindeboom, Marko Z. Nikolić, Sarah A. Teichmann, H. Wagstaffe, M. Noursadeghi, Christopher Chiu, Curtis G. Callan, Andreas Tiffeau-Mayer, N. Wingreen, Benjamin M. Chain
          </td>
          <td>2025-11-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>80</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is characterized by invasion of the brain by effector memory T (TEM) lymphocytes that have been activated by repeated auto-antigen stimulation. Existing therapies target these and other autoreactive lymphocytes but their side effects include general immunosuppression and toxicity. Because the Kv1.3 potassium channel is highly expressed by chronically activated autoreactive TEMs, we investigated whether specific targeting of mitochondrial Kv1.3 using the pharmacological inhibitor PAPTP could selectively kill these TEMs in patients and mice with MS. 1 µM PAPTP targeted and reduced the number of autoreactive TEMs in blood samples from relapsing-remitting MS (RRMS) patients, leaving other T cell populations unaffected. Remarkably, pre-treatment of the entire T cell population with PAPTP during adoptive transfer of experimental autoimmune encephalomyelitis (EAE) killed TEMs and completely prevented disease onset in this mouse model. Moreover, PAPTP selectively eliminated activated TEMs and halted EAE progression when administered following disease onset. Our findings reveal the potential of PAPTP as an effective treatment for MS without adverse side effects. PAPTP mitigates multiple sclerosis (MS) progression by targeting mitoKv1.3 in effector memory T cells (TEMs), inducing ROS production and apoptosis. It prevents or halts MS-like disease in animal models and selectively eliminates TEMs from the peripheral blood of MS patients. MitoKv1.3 in TEMs was identified as the key target for PAPTP-mediated suppression of MS pathology. Increased ROS production and subsequent apoptosis were observed in TEMs treated with PAPTP. Selective elimination of peripheral TEMs halts MS-like disease progression in animal models. Therapeutic application of PAPTP curtails MS-like disease in experimental models and reduces TEMs in blood samples from MS patients. MitoKv1.3 in TEMs was identified as the key target for PAPTP-mediated suppression of MS pathology. Increased ROS production and subsequent apoptosis were observed in TEMs treated with PAPTP. Selective elimination of peripheral TEMs halts MS-like disease progression in animal models. Therapeutic application of PAPTP curtails MS-like disease in experimental models and reduces TEMs in blood samples from MS patients. PAPTP mitigates multiple sclerosis (MS) progression by targeting mitoKv1.3 in effector memory T cells (TEMs), inducing ROS production and apoptosis. It prevents or halts MS-like disease in animal models and selectively eliminates TEMs from the peripheral blood of MS patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bafd993e0b224c67ac0c7bb80c427491f7b31907" target='_blank'>
              Selective inhibition of mitochondrial Kv1.3 prevents and alleviates multiple sclerosis in vivo
              </a>
            </td>
          <td>
            Beatrice Angi, T. Varanita, M. Puthenparampil, Valentina Scattolini, M. Donadon, Mitra Tavakoli, Marta Favero, Maguie El Boustani, Matthias Soddemann, L. Biasutto, Diletta Arcidiacono, Alberto Ongaro, Andrea Mattarei, L. Trentin, Gregory C. Wilson, Erich Gulbins, Paolo Gallo, Ildiko Szabo
          </td>
          <td>2025-09-29</td>
          <td>EMBO Molecular Medicine</td>
          <td>1</td>
          <td>56</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1e970d5dbca886907b0e57fb219f06a0768ed7c1" target='_blank'>
              Multimodal single-cell analysis following SARS-CoV-2 breakthrough infection reveals distinct B cell populations
              </a>
            </td>
          <td>
            Laura T M Graus, Denise Guerra, Andreas Chrysostomou, G. Kerster, K. van der Straten, J. van Rijswijk, K. Tejjani, T. Beaumont, G. D. de Bree, R. Sanders, M. V. van Gils, M. Claireaux
          </td>
          <td>2025-10-31</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>89</td>
        </tr>

        <tr id="Since the COVID-19 pandemic, there has been a documented rise in the incidence of neurological manifestations among individuals complicated with encephalitis or myelitis. The spectrum of neurological symptoms associated with HCoVs infections is expanding. However, the infection characteristics and pathogenesis of seasonal HCoVs to the central nervous system remain obscure. No pharmacological agents have demonstrated the capacity to specifically and efficaciously mitigate the neurological symptoms induced by HCoVs infections to date. We developed human cerebral organoids (HCOs) derived from human induced pluripotent stem cells and established a blood–brain barrier (BBB) HCOs co-culture model. We subjected these models to seasonal human coronavirus (HCoV) infections to investigate the viral characteristics within the central nervous system (CNS). Utilizing RNA sequencing, we conducted a preliminary exploration of the mechanisms underlying virus-induced inflammatory responses in the CNS. Furthermore, we assessed the efficacy of antiviral and anti-inflammatory drugs using the HCO model. Our results showed that among seasonal coronaviruses, HCoV-OC43 replicates efficiently within the organoids, primarily targeting neurons and astrocytes, and disrupts the barrier function of the BBB. RNA sequencing analysis revealed that HCoV-OC43 infection triggers an inflammatory response through the TNF and NF-κB signaling pathways, leading to cell death, impaired neuronal function, and disrupted interneuron signaling. Interestingly, Bardoxolone methyl (CDDO-Me) demonstrated antiviral effects comparable to remdesivir, reducing both inflammation and cell death. Conclusively, HCOs infected with HCoV-OC43 offer valuable insights into the pathogenesis of HCoVs in central nervous system (CNS), and might serve as a tool for developing novel therapeutic strategies for HCoVs infections, including COVID-19, especially on exploring treatment candidates.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a7af1533cff73087916db7e2ff185234c9b24e01" target='_blank'>
              Human coronavirus OC43 infection in human cerebral organoids: novel insights on pathogenesis and potential therapeutic interventions
              </a>
            </td>
          <td>
            Juntong Liu, Yao Deng, Weibang Huo, Jingdong Song, Chengcheng Zhai, Lan Wei, C. Wu, Gaoqian Zhang, B. Huang, Wenling Wang, R. Lu, Na Zhu, Wenjie Tan
          </td>
          <td>2025-11-05</td>
          <td>Journal of Biomedical Science</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Intracerebral hemorrhage (ICH) is a severe neurological disease with limited treatment options. Microglia, the primary immune cells of the brain, contribute significantly to secondary injury following ICH, exhibiting heterogeneity in response across different stages of ICH. However, the exact mechanisms regulating this process remain incompletely elucidated. In this study, we utilized single-nucleus RNA sequencing (snRNA-seq) in conjunction with the ICH model of mice to establish a comprehensive single-nucleus transcriptomic atlas for ICH and further elucidate its pathogenesis to identify potential therapeutic targets. We identified five principal brain clusters with cell-type specific gene expression patterns. Focused on microglia and inflammation-associated subgroup, we identified 8 distinct microglia subtypes and the key transcription factors (TFs) involved in the inflammatory response of microglia following ICH, including Stat2, Stat1, Irf7, Nfkb1, Etv6, Cebpb, Batf, and Bach1. Notably, Stat2 and Stat1 were identified as the most central TFs. In vitro experiments revealed that inhibiting Stat2 and Stat1 can attenuate the inflammatory response in microglia after ICH. Overall, our findings enhance the understanding of cell responses in ICH and highlight potential therapeutic targets, specifically suggesting that inhibiting STAT1 and STAT2 could mitigate microglial-mediated inflammation in ICH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3656b9b2cf60fce5d6a414f852d3b6e8b7436a9c" target='_blank'>
              snRNA-seq reveals key transcription factors in the inflammatory response of microglia after intracerebral hemorrhage
              </a>
            </td>
          <td>
            Zhuojin Wu, Danyang Chen, Shiling Chen, Ge Zhang, Xuan Wu, Kai Shu, Chao Pan, Zhouping Tang
          </td>
          <td>2025-11-20</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d74835f8e845ea18beb20340e5bd3f281ac019ce" target='_blank'>
              Tonic type I interferon signaling optimizes the antiviral function of plasmacytoid dendritic cells
              </a>
            </td>
          <td>
            Joseph N. Pucella, Raul A Maqueda-Alfaro, Hai Ni, Fernando Bandeira Sulczewski, Anna Eichinger, E. Esteva, Ai C Ra, Annesa Das, Oriana A. Perez, Jue Feng, Marlon Stoeckius, Peter Smibert, Alireza Khodadadi-Jamayran, Igor Dolgalev, E. Ivanova, Stela Sota, Ken Cadwell, S. Koralov, Judy Zhong, Chetna Soni, Daniel B. Stetson, Stuart P Weisberg, Donna L. Farber, Juliana Idoyaga, Boris Reizis
          </td>
          <td>2025-10-14</td>
          <td>Nature Immunology</td>
          <td>0</td>
          <td>46</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a progressive, chronic, and highly disabling neuroinflammatory disorder characterized by demyelination and T cell–driven inflammation. Pathogenic T cells play a central role in MS, but effective therapeutic targeting remains challenging. Here, we identified ankyrin repeat domain–containing protein 55 (ANKRD55) as a key regulator of T cell function by single-cell transcriptomic analysis of cerebrospinal fluid and blood from MS patients. ANKRD55 was predominantly expressed in CD4+ T cells in both compartments. Genetic ablation of Ankrd55 led to a robustly reduced disease severity and neuroinflammation in experimental autoimmune encephalomyelitis (EAE), a widely used animal model for MS. Furthermore, T cell–specific deficiency of Ankrd55 significantly impaired Th1 polarization and Th17 differentiation, reducing EAE pathogenicity. Mechanistically, we found that Ankrd55 deficiency disrupted T cell receptor (TCR) signaling integrity. We demonstrated that ANKRD55 regulates the formation of the immune synapse, an essential prerequisite for TCR activation, by interacting with subunits of the chaperonin-containing TCP1 (CCT) complex and modulating its activity, enhancing its assembly by competing with CCT5 for binding to TCP1, CCT3, and CCT6. This facilitates proper microtubule organization and TCR activation. These findings establish ANKRD55 as a critical regulator of TCR signaling and highlight its therapeutic potential in pathogenic T cell–driven autoimmune diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/865b26367cf4f5ce2ee12fb7cd224a9d528add57" target='_blank'>
              ANKRD55 is a key regulator of T cell inflammation in multiple sclerosis
              </a>
            </td>
          <td>
            Chuyu Wu, Mei-Ling Jiang, Xue Yang, Yixuan Liu, Bin Huang, Yi Guo, Runjing Cao, Zhihui Cui, Guozhen Deng, Weiyan Wang, Mengdi Guo, Zhiyong Lin, Jiahui Fan, Lin-ming Zhang, Lorenzo Di Cesare Mannelli, Tao Pang, Chenhui Wang, Cun-Jin Zhang
          </td>
          <td>2025-10-15</td>
          <td>The Journal of Clinical Investigation</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a significant global health burden, characterized by complex host–pathogen interactions that drive heterogeneous clinical outcomes. While pulmonary epithelial cells are increasingly recognized as active participants in innate immunity during Mtb infection, how host defense are altered when the epithelial barrier is compromised remains unclear. In this study, we developed a murine model combining naphthalene-induced pulmonary epithelial injury with Mtb infection and mapped the pulmonary cells landscape through single-cell RNA sequencing (scRNA-seq), followed by in vitro stimulation assays to validate macrophage functional changes. Notably, we found a pronounced impairment in pulmonary bacterial clearance. Transcriptomic analysis revealed a widespread suppression of epithelial immune functions and showed that macrophages transitioned from an antimicrobial to an antigen-presenting phenotype, indicating waning pulmonary innate defenses and heightened adaptive immune activation. In vitro experiments further suggested that this macrophage transition may be linked to epithelial cell alterations. These findings indicate that pulmonary epithelial integrity may influence early host immune responses to Mycobacterium tuberculosis and provide a transcriptomic framework for exploring epithelial–immune crosstalk as a potential therapeutic target. Single-cell transcriptomics reveal epithelial–immune crosstalk remodeling during Mtb infection in mice. Pulmonary epithelial injury weakens mucosal defense and increases bacterial burden. Macrophages shift from innate immune defense to adaptive immune activation in response to Mtb challenge.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7e41984afd63dd846e210a4451e9fc159cd48e46" target='_blank'>
              Lung epithelial injury impairs early host immune responses to Mycobacterium tuberculosis
              </a>
            </td>
          <td>
            Xuan Miao, Xue Li, Zuokuan He, Guiying Xu, Yu Li, Youwei Wang, Junping Wu, Qi Wu, Huaiyong Chen
          </td>
          <td>2025-10-03</td>
          <td>Inflammation Research</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7926169db8376b81cfe85e7301b1ef3978ec2753" target='_blank'>
              Innate immune responses to Plasmodium falciparum disrupt the blood-brain barrier
              </a>
            </td>
          <td>
            Alina Batzilla, Pia Dernick, Jon Bezney, A. Gschwind, Fumio Nakaki, Mireia Altadill, Hannah Fleckenstein, Livia Piatti, Silvia Sanz Sender, Manuel Fiegl, O. Oyerinde, Borja Lopez Gutierrez, M. López-Botet, James Sharpe, Lars M. Steinmetz, G. Moncunill, Maria Bernabeu
          </td>
          <td>2025-10-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Abstract Background Intracerebral haemorrhage (ICH) progresses rapidly with complex pathology and limited treatment options, making it a severe subtype of stroke. The extravasation of blood into the brain parenchyma triggers a cascade of inflammatory responses, contributing to secondary injury. Single‐nucleus RNA sequencing (snRNA‐seq) data have enabled more profound insights into the cellular heterogeneity and dynamic interactions within the haemorrhagic brain. Immune cells play a crucial role in shaping neuroinflammation. However, the lack of comprehensive longitudinal studies limits our understanding of the temporal evolution of these inflammatory processes, posing a challenge to the development of targeted therapeutic strategies. Methods We used snRNA‐seq in collagenase‐induced ICH mouse models at Days 1, 3, 7, 14 and 28 post‐injury, alongside naive controls, to profile the dynamics of gene expression over time. Results We obtained 281 577 high‐quality transcriptional profiles representing 21 distinct cell types. Co‐expression network analysis revealed a prominent ‘inflammation module’ that remained active throughout ICH. Integrative single‐cell transcriptomic and immunofluorescence staining suggested that the various Mif‐expressing cells may contribute to local inflammation, potentially engaging macrophages via receptor–ligand pairs such as Cd44 and Cd74. Over time, microglia appeared to serve as key recipients of pro‐inflammatory signals increasingly. During the resolution phase, oligodendrocytes exhibited transcriptional signatures consistent with enhanced maturation and remyelination, which T cell‐mediated interactions may have facilitated. Conclusions These findings offer a systems‐level perspective on cell‐type–specific responses and immune‐mediated interactions during ICH progression and resolution. Key points Establish intracerebral haemorrhage (ICH) mouse models at various time points (Days 1, 3, 7, 14, 28) and construct a high‐quality single‐nucleus RNA sequencing (snRNA‐seq) atlas. Computational analyses suggest that macrophage recruitment in the early stage of ICH potentially involves migration inhibitory factor (MIF) signalling pathways. T cells may interact with myelin‐forming oligodendrocytes during the resolution phase, potentially contributing to remyelination after ICH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/93fbc9517918c734a8d8739f3255c47b54244947" target='_blank'>
              Single‐nucleus transcriptomic profiling reveals temporal dynamics of neuroinflammation and myelin repair after intracerebral haemorrhage
              </a>
            </td>
          <td>
            Zhan Chen, Qinglin Wang, Rong Xiang, Ruoqi Ding, Jin Tao, Qinfeng Peng, Shao-Long Wang, Nannan Cheng, Mengke Zhao, Jiaxin Li, Qidi Xue, Chuanyu Liu, Xuemei Chen, Longqi Liu, Junmin Wang, Jian Wang, Mingyue Wang
          </td>
          <td>2025-09-28</td>
          <td>Clinical and Translational Medicine</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/04432c352cd2ef25b04349bc1413c2277eb91043" target='_blank'>
              Neuronal activity promotes repair by microglial reprogramming following demyelination
              </a>
            </td>
          <td>
            C. Perrot, R. Ronzano, Z Li, M.S. Aigrot, V. Pantazou, P. Stheneur, FX Lejeune, B. Zalc, F. Quintana, B. Stankoff, C. Lubetzki, A. Desmazières
          </td>
          <td>2025-11-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="A growing body of evidence implicates inflammation as a key hallmark in the pathophysiology of Parkinson’s disease (PD), with microglia playing a central role in mediating neuroinflammatory signaling in the brain. However, the molecular mechanisms linking microglial activation to dopaminergic neuron degeneration remain poorly understood. In this study, we investigated the contribution of the PD-associated LRRK2-G2019S mutation to microglial neurotoxicity using patient-derived induced pluripotent stem cell (iPSC) models. We found that LRRK2-G2019S mutant microglia exhibited elevated activation markers, enhanced phagocytic capacity, and increased secretion of pro-inflammatory cytokines such as TNF-α. These changes were associated with metabolic dysregulation, including upregulated glycolysis and impaired serine biosynthesis. In 3D midbrain organoids, these overactivated microglia resulted in dopaminergic neuron degeneration. Notably, treating LRRK2-G2019S microglia with oxamic acid, a glycolysis inhibitor, attenuated microglial inflammation and reduced neuronal loss. Our findings underscore the link between metabolic targeting in microglia and dopaminergic neuronal loss in LRRK2-G2019S mutation, and highlight a potential strategy that warrants further preclinical evaluation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a8e14aa86bc78d1db27bcda8e7aad65c9a7807db" target='_blank'>
              The Parkinson’s disease-associated LRRK2-G2019S variant restricts serine metabolism, leading to microglial inflammation and dopaminergic neuron degeneration
              </a>
            </td>
          <td>
            Henry Kurniawan, Sarah L Nickels, Alise Zagare, Elisa Zuccoli, Isabel Rosety, Gemma Gomez-Giro, Enrico Glaab, J. Schwamborn
          </td>
          <td>2025-10-27</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>46</td>
        </tr>

        <tr id="Human microglia are central regulators and actors in brain infections and neuro-inflammatory pathologies. However, access to such cells is limited, and studies systematically mapping the spectrum of their inflammatory states are scarce. Here, we generated microglia-like cells (MGLCs) from human induced pluripotent stem cells and characterized them as a robust, accessible model system for studying inflammatory activation. We validated lineage identity through transcriptome profiling, revealing selective upregulation of microglial signature genes and enrichment of microglia/macrophage-related gene sets. MGLCs displayed distinct morphologies and produced stimulus- and time-dependent cytokine secretion profiles upon exposure to diverse inflammatory stimuli, including pro-inflammatory cytokines (TNFα, interferon-γ) and agonists of the Toll-like receptors TLR2 (FSL-1), TLR3 (Poly(I:C)), TLR4 (lipopolysaccharide, LPS), and TLR7 (imiquimod). Transcriptome profiling and bioinformatics analysis revealed distinct activation signatures. Functional assays demonstrated stimulus-specific engagement of NFκB and JAK-STAT signaling pathways. The shared NFκB nuclear translocation response of TLR ligands and TNFα was reflected in overlapping transcriptome profiles: they shared modules (e.g., oxidative stress response and TNFα-related signaling) identified by weighted gene co-expression network analysis. Finally, the potential consequences of microglia activation for neighboring cells were studied on the example of microglia-astrocyte crosstalk. The capacity of MGLC supernatants to stimulate astrocytes was measured by quantifying astrocytic NFκB translocation. MGLCs stimulated with FSL-1, LPS, or Poly(I:C) indirectly activated astrocytes via a strictly TNFα-dependent mechanism, highlighting the role of soluble mediators in the signal propagation. Altogether, this platform enables a dissection of microglia activation states and multi-parametric characterization of subsequent neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c6c2e585f64e6cf445d9d321d469983b932dac9d" target='_blank'>
              Differential Responses of Human iPSC-Derived Microglia to Stimulation with Diverse Inflammogens
              </a>
            </td>
          <td>
            Chiara Wolfbeisz, J. Suess, N. Dreser, H. Leisner, Markus Brüll, M. Fandrich, Nicole Schneiderhan-Marra, O. Poetz, Thomas Hartung, Marcel Leist
          </td>
          <td>2025-10-28</td>
          <td>Cells</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="SARS-CoV-2 variants have demonstrated distinct epidemiological patterns and clinical presentations throughout the COVID-19 pandemic. Understanding variant-specific differences at the respiratory epithelium is crucial for understanding their pathogenesis. Here, we utilized human nasal organoid air–liquid interface (HNO-ALI) cell cultures to compare the viral replication kinetics, innate immune response, and epithelial damage of six different strains of SARS-CoV-2 (B.1.2, WA, Alpha, Beta, Delta, and Omicron). All variants replicated efficiently in HNO-ALIs, but with distinct replication kinetic patterns. The Delta variant exhibited delayed replication kinetics, achieving a steady state at 6 days post-infection compared to 3 days for other variants. Cytokine analysis revealed robust pro-inflammatory and chemoattractant responses (IL-6, IL-8, IP-10, CXCL9, and CXCL11) in WA1, Alpha, Beta, and Omicron infections, while Delta significantly dampened the innate immune response, with no significant induction of IL-6, IP-10, CXCL9, or CXCL11. Immunofluorescence and H&E analysis showed that all variants caused significant ciliary damage, though WA1 and Delta demonstrated less destruction at early time points (3 days post-infection). Together, these data show that, in our HNO-ALI model, the Delta variant employs a distinct “stealth” strategy characterized by delayed replication kinetics and epithelial cell innate immune evasion when compared to other variants of SARS-CoV-2, potentially explaining a mechanism that the Delta variant can use for its enhanced transmissibility and virulence observed clinically. Our findings demonstrate that variant-specific differences at the respiratory epithelium could explain some of the distinct clinical presentations and highlight the utility of the HNO-ALI system for the rapid assessment of emerging variants.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2a66e6213ba7653ae3a1d826608bc43258345cb7" target='_blank'>
              Strain-Specific Variability in Viral Kinetics, Cytokine Response, and Cellular Damage in Air–Liquid Cultures of Human Nasal Organoids After Infection with SARS-CoV-2
              </a>
            </td>
          <td>
            G. Aloisio, Trevor McBride, Letisha Aideyan, Emily M. Schultz, Ashley M. Murray, Anubama Rajan, Erin G Nicholson, D. Henke, Laura Ferlic-Stark, Amal Kambal, Hannah L. Johnson, Elina A. Mosa, F. Stossi, S. Blutt, Pedro A. Piedra, V. Avadhanula
          </td>
          <td>2025-10-01</td>
          <td>Viruses</td>
          <td>1</td>
          <td>41</td>
        </tr>

        <tr id="COVID-19 causes a wide range of complications in the central nervous system, including encephalitis and other neurological symptoms such as memory problems, psychological disorders, depression, and anxiety. We present comprehensive data on the changes in gene expression levels in astrocytes infected with the Delta or Omicron variants of SARS-CoV-2. In RNA-seq data, we found 346 genes that were significantly evoked (197 up- and 149 down-regulated) in astrocytes challenged with the Omicron variant, compared to 341 evoked genes (215 up- and 126 down-regulated) in the Delta variant. A surprisingly large number of genes were exclusively evoked by Delta (82 up- and 48 downregulated) and Omicron variants (65 up and 60 downregulated). Numerous pathways, including those pertaining to the neuronal system, metabolism, response to viral infection, signal transduction, cytokine signaling, and homeostasis, were dysregulated in infected astrocytes. In this report we have dissected major pathways that are related to pathogen recognition, integrity of the BBB and glia limitans, and neurological disorders that could lead to neurological symptoms listed above. Our findings also reveal dysregulation of a large number of non-coding RNAs. The data presented here may help us better understand the role of astrocytes in the neurological disorders seen in COVID-19 patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c339992734ddc6d228d9b0178084b42909087023" target='_blank'>
              Comprehensive mapping of the signaling events evoked by SARS-CoV-2 variants delta and omicron in human astrocytes
              </a>
            </td>
          <td>
            K. Bhide, M. Sláviková, Lea Talpašová, Katarína Kucková, Boris Klempa, Punit Tyagi, Mangesh Bhide
          </td>
          <td>2025-10-22</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of coronavirus disease 2019 (COVID-19), is characterized by its high contagiousness. The COVID-19 pandemic has exerted profound impacts on human society. The persistent circulation of SARS-CoV-2 in human populations continues to pose re-exposure risks for both vaccinated individuals and those with prior natural infection. Against this epidemiological background, there is an urgent need to characterize the transmission dynamics of SARS-CoV-2 in the context of pre-existing immunity. Using a ferret infection model, this study systematically addresses critical scientific questions, including viral transmission efficiency, temporal patterns of transmissibility, and the ability of pre-existing immunity to mitigate reinfection and viral shedding. The findings provide robust experimental evidence for elucidating the transmission mechanisms of SARS-CoV-2 and offer scientific insights to inform the rational design of optimized antiviral strategies. IMPORTANCE In this study, a ferret infection model was used to systematically investigate SARS-CoV-2’s in vivo transmission dynamics and modes with pre-existing immunity. By characterizing viral transmission efficiency, temporal shedding patterns, and immunity’s role in mitigating re-infection severity and dissemination, it provides direct evidence for understanding SARS-CoV-2 spread in immune-exposed hosts. It quantifies how humoral immunity modulates viral load (primary/secondary infections) and ferret contact transmission. Findings establish a key SARS-CoV-2 transmission framework—pre-existing immunity shortens shedding, reduces secondary attack rates but retains residual transmissibility—fill knowledge gaps, guide vaccine/herd immunity/public health measures, and lay a foundation for predicting real-world transmission and antiviral policies via integrated endpoints. In this study, a ferret infection model was used to systematically investigate SARS-CoV-2’s in vivo transmission dynamics and modes with pre-existing immunity. By characterizing viral transmission efficiency, temporal shedding patterns, and immunity’s role in mitigating re-infection severity and dissemination, it provides direct evidence for understanding SARS-CoV-2 spread in immune-exposed hosts. It quantifies how humoral immunity modulates viral load (primary/secondary infections) and ferret contact transmission. Findings establish a key SARS-CoV-2 transmission framework—pre-existing immunity shortens shedding, reduces secondary attack rates but retains residual transmissibility—fill knowledge gaps, guide vaccine/herd immunity/public health measures, and lay a foundation for predicting real-world transmission and antiviral policies via integrated endpoints.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/28bd990eb8431c26b9877e0d5998540288695456" target='_blank'>
              Transmission of SARS-CoV-2 between ferrets in presence of pre-existing immunity
              </a>
            </td>
          <td>
            Chong Wang, Lei Shuai, Gongxun Zhong, Z. Wen, Renqiang Liu, Qilong Liu, Jinliang Wang, Jin-ying Ge, Xianfeng Zhang, Y. Guan, Xijun He, Z. Bu
          </td>
          <td>2025-11-04</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="Sterile alpha motif and HD domain-containing protein 1 (SAMHD1) restricts a board spectrum of viruses through multifaceted mechanisms. It also limits spontaneous- and virus-induced innate immune responses by suppressing proinflammatory cytokine and type-I interferon (IFN-I) production. Some viruses escape SAMHD1 restriction by utilizing SAMHD1-mediated innate immune suppression to establish effective infection through viral antagonism. Our previous studies showed that SAMHD1 is a proviral factor facilitating replication of severe acute respiratory syndrome coronavirus (SARS-CoV-2) in human macrophages, monocytic THP-1 and epithelial-like HEK293T cell lines by suppressing IFN responses. However, it is unclear about the function of SAMHD1 in lung epithelial cells during SARS-CoV-2 infection. Here, we report that SAMHD1 facilitates SARS-CoV-2 replication in lung epithelial Calu-3 cells by enhancing endogenous expression of the viral receptor angiotensin-converting enzyme 2 (ACE2) via hepatocyte nuclear factor 1-alpha (HNF1α) and HNF1β. Using pseudotyped SARS-CoV-2 and lentiviral vectors, we found that SARS-CoV-2 spike protein-mediated viral entry was suppressed in Calu-3 cells with SAMHD1 knockout (KO). SAMHD1 KO repressed ACE2 expression in Calu-3 cells at mRNA and protein levels. Functional analyses revealed that HNF1α and HNF1β were crucial for the endogenous ACE2 expression in Calu-3 cells. Additionally, SAMHD1 KO led to a reduction in the expression levels and ACE2-promoting function of HNF1α and HNF1β. Inhibition of IFN antiviral response by baricitinib, a Janus kinase 1 and 2 (JAK 1/2) inhibitor, did not revert the suppression of SARS-CoV-2 in SAMHD1 KO Calu-3 cells. Our findings demonstrate that SAMHD1 facilitates HNF1-mediated ACE2 expression and SARS-CoV-2 replication in Calu-3 cells via a novel mechanism beyond its IFN-suppressive function. Author Summary During viral infection, SAMHD1 acts as a viral restriction factor and a suppressor of the innate immune system, controlling viral replication while also ensuring immune homeostasis. The innate immune suppressive function of SAMHD1 can be proviral for some viruses. SAMHD1 has been shown to facilitate SARS-CoV-2 infection in human macrophages, THP-1 and HEK293T cell lines by promoting IFN antagonism, but its role in lung epithelial cells is unclear. Here, we demonstrated that SAMHD1 promotes SARS-CoV-2 replication in human lung epithelial Calu-3 cells by enhancing expression of the major viral receptor ACE2. We found that SAMHD1 facilitated HNF1-medaited ACE2 expression that was required for spike protein-mediated SARS-CoV-2 entry. However, inhibiting IFN signaling in SAMHD1 KO Calu-3 cells was not sufficient to revert SARS-CoV-2 replication. Our findings shed light on the differential proviral function of SAMHD1 in ACE2 expressing cells and suggest that SAMHD1 can facilitate SARS-CoV-2 infection beyond enhancing IFN antagonism.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1adb144859e1add4bf4fcfba4fbb11e22fcf1d31" target='_blank'>
              SAMHD1 promotes SARS-CoV-2 infection by enhancing HNF1-dependent ACE2 expression in lung epithelial cells
              </a>
            </td>
          <td>
            Pak-Hin Hinson Cheung, Pearl Chan, Hua Yang, Shravya Honne, Baek Kim, Stanley Perlman, Li Wu
          </td>
          <td>2025-10-26</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/92c1925b3210de9f4b794ecb86a6c3424cf3dfde" target='_blank'>
              Cellular and Spatial Drivers of Unresolved Injury and Functional Decline in the Human Kidney
              </a>
            </td>
          <td>
            B. Lake, Ricardo Melo Ferreira, Jens Hansen, Rajasree Menon, J. Basta, Heather R. Thiessen Philbrook, Stephanie Reinert, Robin Fallegger, Asmita K Lagwankar, Xi Chen, Soumya Maity, Katerina V. Djambazova, Brittney L. Gorman, Nicholas J. Lucarelli, D. Gisch, I. Schmidt, V. Nair, Fadhl M. Alakwaa, Eirini Kefaloyianni, Bo Zhang, Amanda Knoten, Madhurima Kaushal, Edgar A. Otto, Melissa A. Farrow, D. Diep, Dušan Veličković, Angela R. Sabo, Elijah Cole, Ian Tamayo, Jovan Tanevski, Kimberly Y. Conklin, Rachel Sealfon, Y. He, Michelle Brennan, Lynn Robbins, Ying-Hua Cheng, Markus Bitzer, Aditya L. Surapaneni, Steven Menez, P. Kharchenko, Charles E. Alpers, Ulysses G J Balis, L. Barisoni, Ian H. de Boer, D. Demeke, Agnes B. Fogo, Joel M Henderson, L. Herlitz, Gilbert W. Moeckel, Parmjeet S Randhawa, Avi Z. Rosenberg, Jennifer A. Schaub, Suman Setty, F. Brosius, M. L. Caramori, Steve Coca, R. Figenshau, Eric H. Kim, Krzysztof Kiryluk, J. Lash, R. T. Miller, John O'Toole, Paul M. Palevsky, Eugene P. Rhee, Ana C. Ricardo, Sylvia E. Rosas, Prabir Roy-Chaudhury, M. Sarwal, J. Sedor, Robert D. Toto, Aydin Turkmen, S. Waikar, James C. Williams, F. P. Wilson, E. S. Woodle, Evan Z. Macosko, Julio Saez‐Rodriguez, P. Dagher, M. E. Grams, Petter Bjornstad, T. El-Achkar, Olga G. Troyanskaya, Nikole Bonevich, Pinaki Sarder, Sanjeev Kumar, C. Anderton, J. Spraggins, Kumar Sharma, Michael Rauchman, Jonathan Himmelfarb, J. Gaut, Kidney Precision Medicine Project, Kun Zhang, Ravi Iyengar, Mathias Kretzler, J. Hodgin, C. Parikh, Michael T. Eadon, Sanjay Jain
          </td>
          <td>2025-09-28</td>
          <td>bioRxiv</td>
          <td>1</td>
          <td>76</td>
        </tr>

        <tr id="SARS-CoV-2 infection is associated with long-lasting neuropsychiatric and cognitive symptoms, collectively referred to as neuro-PASC. Emerging studies indicates that accelerate brain aging and cellular senescence in COVID brain could lead to altered neuroimmune responses and neurodegenerative outcomes. However, little is known about how cellular senescence is development in neuro-PASC. Here, we examined the role of spike protein subunit S1, a persistent viral antigen, in driving the development of cellular senescence in primary human astrocytes. We have demonstrated that S1 enters endolysosomes and induces endolysosome dysfunction and cellular senescence. Moreover, the multibasic motif is critical for such S1-induced damaging effects. Importantly, we identified Toll-like receptor 7 (TLR7), an endolysosome-resident pattern recognition receptor, as a critical mediator of S1-induced damaging effects. Mechanistically, S1 interacts with TLR7 at the site of the endolysosome lumen and activates p38 MAPK signaling of downstream of TLR7, which drive the development of cellular senescence. Together, these findings suggest that TLR7 mediates S1-induced endolysosome dysfunction and cellular senescence, and that TLR7 represents a therapeutic target for mitigating neuro-PASC.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8ee07e08edc89cce8e4214928941b26b2316b896" target='_blank'>
              SARS-CoV-2 spike triggers TLR7-dependent endolysosome dysfunction and senescence in human astrocytes
              </a>
            </td>
          <td>
            Wendie A. Hasler, Emily McKay, Gaurav Datta, Samantha Johnson, Neda Rezagholizadeh, Xuesong Chen
          </td>
          <td>2025-10-31</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Human NK cells exhibit functional heterogeneity, yet the clinical conditions and cellular processes driving this diversity remain insufficiently understood. Here, we report that NK cell diversity emerges during peripheral development, influenced by the divergence of adaptive NK cells from various stages of canonical NK cell maturation during the resolution phase of severe COVID-19. Using scRNA-seq, we analyzed blood NK cells from patients with severe COVID-19 (acute phase and post-intensive care), individuals vaccinated with the SARS-CoV-2 mRNA vaccine (BNT162b2), and healthy donors. The frequencies of immature CD56bright and proliferating NK cells increased following BNT162b2 vaccination. In contrast, the frequency of adaptive CD56dim cells was markedly elevated in patients recovering from severe COVID-19, alongside clonal expansion and enhanced mitochondrial oxidative phosphorylation. Trajectory analysis revealed a bifurcation in peripheral NK cell development, with CD56bright cells diverging into canonical and adaptive CD56dim subsets during the course of severe COVID-19. Notably, adaptive NK differentiation exhibited transcriptional and signaling profiles analogous to those of T-cell activation. Thus, NK cell diversity is shaped by the induction of an intrinsic adaptive program. These findings uncover the mechanisms underlying NK cell heterogeneity and have implications for medical applications, including the development of immunotherapies that leverage adaptive NK cell functions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a0a71ca475b9bbf9d2f431483da1cc2babd0b42" target='_blank'>
              Mapping NK cell diversity in response to COVID-19 and mRNA vaccination
              </a>
            </td>
          <td>
            Yosuke Kishi, Yu-chen Liu, Masakazu Ishikawa, Maika Yamashita, Hisatake Matsumoto, Hiroshi Ogura, Shuhei Sakakibara, Daisuke Okuzaki
          </td>
          <td>2025-10-28</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Background COVID-19, including its post-acute sequelae (Long COVID), is increasingly recognized as involving persistent immune dysregulation and chronic inflammation. Severe and prolonged disease states are often accompanied by sustained cytokine release, immune cell exhaustion, and ongoing cell-cell communication that shapes the inflammatory milieu. Among immune subsets, CD8+ T cells play a central role in antiviral defense, yet the molecular mechanisms linking their dysfunction to prolonged inflammation remain incompletely understood. Methods We analyzed 73,110 peripheral blood mononuclear cells (PBMCs) from individuals across four disease states (Healthy, Exposed, Infected, and Hospitalized) using single-cell RNA sequencing. Immune cell subsets were annotated, and T cell heterogeneity was profiled. Cytokine and inflammatory scores were calculated to assess immune activation. Differentially expressed genes (DEGs) underwent Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. Cell-cell communication was evaluated to map ligand-receptor networks. Additionally, nine machine learning models were trained on a bulk RNA-seq cohort, and the SHapley Additive exPlanations (SHAP) framework was applied to interpret key predictive genes. Results Progressive disease severity was associated with a decline in T cell proportions, enrichment of pro-inflammatory myeloid cells, and elevated cytokine expression, particularly IL-32. Memory CD8+ T cells showed increased exhaustion and inflammatory scores while maintaining a central position in MHC-I-mediated communication networks. Persistent activation of immune and metabolic pathways, including antigen presentation and oxidative phosphorylation, was observed in prolonged disease states. Seven genes (RPS26, RPS29, RPL36, RPL39, RPS28, RPS21, and CD3E) were identified as strong predictors of chronic immune dysregulation, with the XGBoost model achieving the highest AUC. SHAP analysis confirmed their contributions to disease classification. Conclusion This study maps the immune landscape of COVID-19 and Long COVID at single-cell resolution, revealing that persistent immune cell communication, particularly involving memory CD8+ T cells, may sustain chronic inflammation beyond the acute phase. The identified molecular signatures offer potential biomarkers and therapeutic targets for mitigating post-viral inflammatory syndromes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/536000d345ef1e6f7663efc28145b0e979e70e7b" target='_blank'>
              Immune cell communication networks and memory CD8+ T cell signatures sustaining chronic inflammation in COVID-19 and Long COVID
              </a>
            </td>
          <td>
            Hengrui Liu, Zewen Xu, Ilayda Karsidag, Panpan Wang, Jieling Weng
          </td>
          <td>2025-10-22</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/907f1f4b30075c4fd386fadca819b4f5e1e1f8f5" target='_blank'>
              Dysregulation of transcription networks regulating oligodendrogenesis in age-related decline in CNS remyelination
              </a>
            </td>
          <td>
            Penelope Dimas, Samuel Morabito, Khalil S. Rawji, Qing Wang, Fynn N Krause, Juan F. Cubillos, Nejma Belaadi, Peggy Assinck, Zechuan Shi, Zhenkun Cao, Holger Heyn, R. Kawaguchi, Daniel H. Geschwind, Vivek Swarup, Robin J. M. Franklin
          </td>
          <td>2025-11-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>39</td>
        </tr>

        <tr id="Early fetal demise (EFD), defined as the absence of cardiac activity in a visible fetus, represents a severe form of pregnancy loss with incompletely understood mechanisms. While genetic factors constitute the primary etiology, emerging evidence implicates maternal immune dysregulation in EFD pathogenesis, though the specific cellular and molecular pathways remain undefined. We performed single-cell RNA sequencing (scRNA-seq) on peripheral blood mononuclear cells (PBMCs) from a 20-subject cohort comprising EFD patients, healthy pregnant women, and non-pregnant controls. Parallel murine studies involved GFP-labeled monocyte transfer into E8.5 pregnant mice, with subsequent embryonic viability assessment. Human villous tissues from EFD and control pregnancies were analyzed alongside functional characterization using primary neonatal rat cardiomyocytes exposed to IFN-α1. ScRNA-seq revealed significant CD14+ monocyte accumulation in EFD patients versus controls. In murine models, adoptively transferred maternal monocytes breached the placental barrier, inducing 25.7% embryonic lethality. EFD villous tissues exhibited CD14+ monocyte infiltration with selective IFN-α1 elevation (absent in IFN-α2). Cardiomyocyte functional assays demonstrated IFN-α1-mediated contractile impairment through significant reduction in beating frequency. These findings establish maternal CD14+ monocytes as key mediators of EFD via IFN-α1-dependent cardiac dysfunction, revealing a targetable immune axis for pregnancy preservation. The study provides the first direct evidence linking monocyte trafficking with embryonic viability, offering new therapeutic paradigms for miscarriage prevention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/185ea4b0c6ba004d626d528a1bbb76348a0abedd" target='_blank'>
              Maternal monocyte-derived IFN-α1 triggers early fetal demise
              </a>
            </td>
          <td>
            Dandan Wang, Wu Li, Kai Jiang, Yue Xu, Ruhua Deng, Xingbo Yang, Huici Jiang, Jiayi Liang, Ke Wei, Jinlong Qin, Yaozu Xiang
          </td>
          <td>2025-10-14</td>
          <td>Journal of Translational Medicine</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Microglia, the brain’s innate immune cells, can adopt a wide variety of activation states relevant to health and disease. Dysregulation of microglial activation occurs in numerous brain disorders, and driving or inhibiting specific states could be therapeutic. To discover regulators of microglial activation states, we conducted CRISPR interference screens in iPSC-derived microglia for inhibitors and activators of six microglial states. We identified transcriptional regulators for each of these states and characterized 31 regulators at the single-cell transcriptomic and cell-surface proteome level in two distinct iPSC-derived microglia models. Finally, we functionally characterized several regulators. STAT2 knockdown inhibits interferon response and lysosomal function. PRDM1 knockdown drives disease-associated and lipid-rich signatures and enhanced phagocytosis. DNMT1 knockdown results in widespread loss of methylation, activating negative regulators of interferon signaling. These findings provide a framework to direct microglial activation to selectively enrich microglial activation states, define their functional outputs, and inform future therapies. Highlights CRISPRi screening reveals novel regulators of six microglia activation states Multi-modal single-cell screens highlight differences between mRNA and protein level expression iPSC-microglia models show different baseline distributions of activation states Loss of DNMT1 leads to widespread DNA demethylation, promoting some states but limiting the interferon-response state Loss of PRDM1 drives microglial disease-associated state">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb9bb43ca18bcdc65e766eeeb0e1676e8131ed1b" target='_blank'>
              Transcriptional regulation of disease-relevant microglial activation programs
              </a>
            </td>
          <td>
            Amanda McQuade, Reet Mishra, Venus Hagan, Weiwei Liang, Peter J. Colias, Vincent Cele Castillo, Justin P. Lubin, Verena C. Haage, Victoria Marshe, Masashi Fujita, Layla Gomes, Thomas Ta, Olivia M Teter, Sarah E. Chasins, Philip L. De Jager, James K. Nuñez, Martin Kampmann
          </td>
          <td>2025-10-27</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Pediatric acute-onset neuropsychiatric syndrome (PANS) is characterized by the sudden onset of obsessive-compulsive symptoms alongside a constellation of neuropsychiatric and somatic features. Disease progression typically includes flare and recovery states, with some patients exhibiting a persistent disease course (> 12 months of flare). We characterized circulating monocyte subsets during flare and recovery in pediatric patients with PANS, uncovering disease-state–dependent shifts in polarization and trafficking phenotypes. Inflammatory M1-like monocytes and monocyte-derived dendritic cells were elevated during flare, while anti-inflammatory M2-like monocytes were enriched in recovery. We also identified a circulating subset with a surface phenotype consistent with central nervous system (CNS) homing, which was reduced during flare and restored in recovery. These cells were detectable in the cerebrospinal fluid (CSF) of new-onset patients but not in persistent cases, suggesting differential compartmentalization during disease progression. Notably, monocyte phenotypes, including M2 polarization (monocytosis) and circulating CNS-homing profiles, exhibited striking sex-associated differences, particularly during recovery, with several subsets enriched in males but not females. Plasma from flare-phase patients modestly induced CNS-homing markers in monocytes from healthy donors, indicating the presence of circulating modulators. Together, these findings support a model in which distinct myeloid phenotypes—including sex-biased patterns—may contribute to both the pathogenesis and resolution of neuroinflammation in PANS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ab805830c315ccc3f7c69d468623a69aa039f03c" target='_blank'>
              Sex-associated and disease state-dependent monocyte polarization and CNS-trafficking phenotypes in pediatric acute-onset neuropsychiatric syndrome (PANS)
              </a>
            </td>
          <td>
            Shamma S. Rahman, Noor Hussein, Silvia Giulia Galfrè, Fabian Gaertner, Claudia Macaubas, Avis Chan, Laurie Columbo, Jaynelle Gao, Samira Galehdari, Batuhan Bayram, Meiqian Ma, C. Manko, Kate Miles, B. Farhadian, M. Silverman, M. Thienemann, Noga Or-Geva, Keith Van Haren, Kari C. Nadeau, Lu Tian, Jennifer Frankovich, Elizabeth D. Mellins
          </td>
          <td>2025-11-18</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="The central nervous system (CNS) represents a uniquely immune-privileged environment, with inflammatory responses involving several resident CNS-specific cell types. While stereotyped cellular and transcriptional responses recur across varied diseases, relevant signaling pathways and regulatory networks are not fully understood. Here, we investigate multi-modal inflammatory gene networks at large scale by developing a high-throughput RNA-seq screening and analysis workflow. As proof-of-concept, we investigate genetically heterogeneous mice from a large-scale chemical mutagenesis screen to identify novel functionally relevant variants in six genes previously linked to human CNS disorders: Nrros, Ctsd, Smpd1, Idua, Nlrp1a, and Inpp5d. We leverage the readily interpretable data from our large-scale study to demarcate distinct inflammatory states arising from each mutation. In all, our work provides a validated analysis framework for identifying discrete gene expression modules that are engaged divergently across disease contexts, which can be used to discover novel regulators of CNS neuroimmune homeostasis. Brain bulk-tissue RNA-seq database from a large-scale ENU-mutagenized mouse cohort. Variants in Nrros, Ctsd, Smpd1, Idua, Nlrp1a, and Inpp5d alter microglia homeostasis. An Nlrp1a gain-of-function mutation causes widespread astrocyte and microglia activation. Cross-comparison of six disease and inflammatory states facilitates interpretation of bulk tissue transcriptomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a51f54829abe0e8b61931cb5f83b202b5c060ee" target='_blank'>
              Modular inflammation network discovery from large-scale phenotypic screening in genetically heterogeneous mouse brains
              </a>
            </td>
          <td>
            Monica Xiong, L. Miosge, Carolina Correa-Ospina, Claudia M. Y. Yan, Tiffany Cripps, Stefan Bauernfried, Yuanyuan Wang, Maggie Crow, Lucy X Morris, T. D. Andrews, Andrew Trujillo, Mitchell G. Rezzonico, Yuxin Liang, Qixin Bei, Z. Modrusan, Kimberly L Stark, Tracy J Yuen, Brad A Friedman, Jesse E Hanson, Edward M Bertram, Christopher J Bohlen
          </td>
          <td>2025-09-29</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>95</td>
        </tr>

        <tr id="Stimulator of interferon genes (STING) is a cytosolic DNA sensor that activates type I interferon (IFN) signaling, which plays a key role in neuroinflammation. Although the role of STING in experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis (MS), remains debated, its involvement in the development of CNS lesions, particularly within localized pathology, modeled here by targeting the corpus callosum, has yet to be explored. Using a focal EAE model, we compared the induction of lesions in wild-type and STING-deficient (STINGgt/gt) mice. Lesions were analyzed by immunohistochemistry, flow cytometry, and transcriptomics. STING-deficient mice had significantly larger demyelinated lesions, reduced ISG expression, and modified immune cell infiltration. STING signaling limits lesion severity in focal EAE by promoting IFN responses and regulating immune infiltration. These findings position STING as a potential target for MS therapy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4bf6c7ef661fd43e69e6cbc5a450148d7854f91e" target='_blank'>
              STING Signaling Deficiency Exacerbates Demyelination and Immune Infiltration in Focal EAE Lesions
              </a>
            </td>
          <td>
            M. Mørch, Line S Reinert, A. Benmamar-Badel, M. Dubik, M. Burton, M. Thomassen, T. Kruse, N. Asgari, S. R. Paludan, Trevor Owens, Reza Khorooshi
          </td>
          <td>2025-10-17</td>
          <td>NeuroSci</td>
          <td>0</td>
          <td>57</td>
        </tr>

        <tr id="Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by amyloid plaques, tau tangles, and synaptic dysfunction. Despite decades of research, effective disease-modifying therapies remain elusive, highlighting the need for alternative therapeutic targets. While neurons have traditionally been the focus of AD studies, increasing evidence underscores critical roles for glial cells particularly microglia and astrocytes in disease progression. Mitochondrial calcium (mCa2+) dysregulation has emerged as a key contributor to neurodegeneration, yet how mCa2⁺ signaling varies across brain cell types and contributes to AD pathology remains poorly understood. We developed stable human SH-SY5Y (neuroblastoma-derived cells), HMC3 (microglial-like cells), and SVGp12 (astrocytic-like cells) immortalized cell lines expressing APP mutations (Swedish, Florida, and London; APPswe/F/L). We assessed mitochondrial calcium uniporter (mtCU) expression, mCa2+ flux using ratiometric calcium (Ca2+) indicators, and evaluated calcium retention capacity (mito-CRC) as a readout of mitochondrial permeability transition pore opening. Bioenergetic parameters including ATP, NADH, membrane potential, and oxygen consumption rate (OCR) were measured alongside structural mitochondrial changes, ROS levels, and cell death using imaging and biochemical assays. APPswe/F/L expression induced mitochondrial dysfunction across all brain immortalized cell types, with neuroblastoma-derived cells exhibiting the highest susceptibility to mCa2+ overload, energy failure, and cell death. Compared to neuroblastoma-derived cells, glial-like cells (astrocytic-like and microglial-like cells) showed higher expression of mtCU components, elevated mCa2+ uptake at high Ca²⁺ concentrations, and greater mito-CRC. Conversely, neuroblastoma-derived cells displayed faster mCa2+ uptake at low Ca2+ levels, indicating distinct regulatory thresholds. Glial-like cells exhibited more elaborate mitochondrial networks and enhanced metabolic capacity, yet all cell types showed impaired mitochondrial structure, reduced membrane potential and respiration, and increased ROS under mutant APP expression. This study reveals cell-type-specific differences in mCa2+ signaling and mitochondrial function in AD, uncovering unique vulnerabilities in neuroblastoma-derived and glial-like cells. These findings highlight the need for cell-targeted strategies to restore mCa2+ homeostasis and mitochondrial function in AD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2dce50c803ecee4352b0fe0c3ce47a5251a8177a" target='_blank'>
              Cell-type-specific dysregulation of mitochondrial calcium signaling in Alzheimer’s disease
              </a>
            </td>
          <td>
            Shatakshi Shukla, Ashlesha Kadam, Shanikumar Goyani, Natasha Jaiswal, Kunal Samantaray, Shiridhar Kashyap, D. Tomar, P. Jadiya
          </td>
          <td>2025-11-03</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="ABSTRACT Systemic spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to extrapulmonary tissues has been observed following acute infections. Autopsy studies further indicate tissue-specific virus diversity, including in immune-privileged sites. Questions remain on the viral dynamics leading to the tissue tropism of SARS-CoV-2, including evolutionary trajectories and functional adaptations that could impact persistence and transmission. In this study, we characterized SARS-CoV-2 genomes from 27 distinct tissues collected from an autopsy case where the patient had a primary immune deficiency. We identified tissue-specific virus genotypes, in some instances coexisting within the same sites, with mutations primarily in the receptor-binding domain of the spike protein. Protein simulations and isolation of infectious virus indicate combinations of spike substitutions that would lead to increased protein stability and stronger binding of the virus to host cells. This highlights the importance of studying patients with weakened immune responses where potential tissue reservoirs provide an environment permissive for SARS-CoV-2 evolution and diversification. IMPORTANCE Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in immunocompromised individuals are considered a potential source of new viral variants. Beyond the respiratory tract, the virus can spread within days to organs like the brain, heart, and kidneys, where distinct tissue microenvironments may further drive viral evolution and the emergence of new mutations. In this study, we compared the genetic diversity of SARS-CoV-2 genomic RNA isolated from 27 distinct tissue sites collected from an individual with a weakened immune system. By linking viral population dynamics across these tissue sites, we defined the extent of compartmentalization during multi-organ spread, highlighting how non-respiratory tissues can impact SARS-CoV-2 diversification. Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in immunocompromised individuals are considered a potential source of new viral variants. Beyond the respiratory tract, the virus can spread within days to organs like the brain, heart, and kidneys, where distinct tissue microenvironments may further drive viral evolution and the emergence of new mutations. In this study, we compared the genetic diversity of SARS-CoV-2 genomic RNA isolated from 27 distinct tissue sites collected from an individual with a weakened immune system. By linking viral population dynamics across these tissue sites, we defined the extent of compartmentalization during multi-organ spread, highlighting how non-respiratory tissues can impact SARS-CoV-2 diversification.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0c62bea121f229e468290e53c083e5676919d763" target='_blank'>
              Tissue tropism and functional adaptation of the SARS-CoV-2 spike protein in a fatal case of COVID-19
              </a>
            </td>
          <td>
            Katherine E E Johnson, Sydney R. Stein, Rita Afriyie Boateng, Shilpi Jain, Sabrina C. Ramelli, Trevor M Stantliff, Shelly Curran, M. Ramos-Benitez, Andrew P. Platt, S. Banakis, Wei Wang, Stephen M. Hewitt, C. Zerbe, Steven M. Holland, Elizabeth M. Kang, Manmeet Singh, E. de Wit, William A. Lauer, E. Rouchka, Melissa Smith, Mehul Suthar, Daniel Chertow, E. Ghedin
          </td>
          <td>2025-10-31</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>62</td>
        </tr>

        <tr id="Introduction Sepsis is responsible for 1 in 5 deaths globally and the majority of those who survive have lasting health issues. A hallmark of sepsis is a deregulated inflammatory response to infection, with leukocytes playing a critical role. Methods This study utilised a targeted single-cell multi-omics approach to characterise peripheral blood mononuclear cell (PBMC) populations and their transcriptomic profiles in an Irish cohort of people with (i) sepsis and (ii) bacteraemia without sepsis (defined as clinically significant positive blood culture without sepsis as assessed by the Clinical Microbiology service). Results Variable leukocyte distributions were identified, with decreased cytotoxic lymphocytes, including CD8+ T cells, natural killer cells, CD56+ T cells, γδ T cells, mucosal-associated invariant T cells, and increased T helper (Th) cell subsets within sepsis samples. Additionally, PBMCs from sepsis samples displayed an impaired expression profile in effector T cells, resulting in widespread suppression of PBMC cytotoxic activity. Discussion These results identify potential mechanisms underlying the functional impairment witnessed in sepsis. Such mechanisms may inform future diagnostic and treatment strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5f9838d386bc3ba0f9823edf96e48770618f50b6" target='_blank'>
              Multi-omic analysis of PBMCs in sepsis reveals widespread cytotoxic dysfunction and an increased population of CD69 expressing naïve CD4+ T cells
              </a>
            </td>
          <td>
            Joshua Flynn, A. Baird, Eamon Breen, Michael Carty, Ciara S McNevin, Lisa McDermott, Elaine M. Kenny, J. D. Coakley, Thomas Ryan, Derek G. Doherty, O. Sheils
          </td>
          <td>2025-10-24</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>42</td>
        </tr>

        <tr id="Neuroinflammation plays a central role in a wide spectrum of neurological diseases, driven generally by reactive microglia and astrocytes. Inflammatory stimulation of microglia and astrocytes leads to a metabolic shift from oxidative phosphorylation (OXPHOS) to glycolysis, which is required to support pro-inflammatory effector functions. This metabolic reprogramming is associated with impaired mitochondrial dynamics, including reduced biogenesis, increased fragmentation, and loss of membrane potential. Targeting microglia and astrocyte metabolism may offer a novel therapeutic approach for modulating neuroinflammation and restoring homeostatic immune functions. Here, we examined the potential of 2-Deoxy-D-Glucose (2DG), a glycolysis inhibitor, to attenuate neuroinflammation by restoring mitochondrial dynamics. In BV2 and primary glial cultures, low-dose 2DG reversed LPS-induced metabolic reprogramming, restoring OXPHOS, reducing mitochondrial fragmentation, and enhancing biogenesis. In vivo, it preserved spare respiratory capacity and increased complex-V activity in brain mitochondria from LPS-treated mice without affecting oxidative stress. At a mechanistic level, 2DG restored activation of AMP-activated protein kinase, a master regulator of mitochondrial dynamics. In conjunction with these metabolic effects, 2DG suppressed LPS-induced pro-inflammatory gene expression while enhancing markers associated with the resolution of inflammation and tissue repair. Critically, systemic low-dose 2DG reduced neuroinflammation and restored immune homeostasis in two LPS-induced mouse models, highlighting its therapeutic potential in neurological disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/df23e47245588eca6bc8cbd6d462a83f41867576" target='_blank'>
              2-Deoxy-D-Glucose restores glial cell mitochondrial function and attenuates neuroinflammation
              </a>
            </td>
          <td>
            P. Gharibani, Yu Guo, Shruthi Shanmukha, Judy J Lee, Katherine Kopp, Paul M Kim, M. Kornberg
          </td>
          <td>2025-11-06</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/49a5db351ada41d17475ee46b247329414cc1f0f" target='_blank'>
              Dynamics of interactions between three major respiratory pathogens in reconstituted human epithelium
              </a>
            </td>
          <td>
            Aurélien Gibeaud, Charles Terra, Émilie Portier, Pascal Lukas, Audrey Le Gouellec, Jérémie Guedj, Frederik Graw, A. Pizzorno, O. Terrier
          </td>
          <td>2025-11-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="Post-COVID syndrome (PCS) affects approximately 3-17% of individuals following acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and poses a potential global health burden. While improved assessment strategies are emerging, mechanistic insights and treatment options remain limited. This study investigates molecular mechanisms underlying PCS using single-cell RNA (scRNA) transcriptomics combined with in vitro validation. scRNA analysis is performed on nasal biopsies from 25 patients with moderate or severe PCS to investigate differential cell types, signalling pathways, and cell-cell communication. Air-liquid interface cultures are used to validate findings, focusing on the TNFα-TGFβ axis. Severe PCS shows reduced numbers of ciliated cells, increased immune cell infiltration, and heightened inflammatory signaling that drives TGFβ and TNFα upregulation, in the absence of a detectable viral load. These changes trigger epithelial-mesenchymal transition, basal cell expansion and a mis-stratified nasal epithelium. In vitro experiments confirm TGFβ and TNFα as causal cytokines promoting ciliated cell loss and increased basal cell abundance. These findings indicate a sustained severe PCS is not driven by ongoing viral load but by immune cell activity and chronic cytokine production. Targeting the TNFα-TGFβ axis may mitigate immune-mediated nasal tissue damage and support epithelium restoration, offering a potential therapeutic strategy for PCS. In this work, authors apply single-cell transcriptomics to nasal biopsies from post-COVID syndrome patients, revealing chronic inflammation driven by TNFα and TGFβ, alongside persistent airway epithelial remodelling in the absence of viral load.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f11cef8e6987c6f7f18c86a6ad021d44e359f249" target='_blank'>
              scRNA-seq reveals persistent aberrant differentiation of nasal epithelium driven by TNFα and TGFβ in post-COVID syndrome
              </a>
            </td>
          <td>
            K. Reddy, Y. Maluje, F. Ott, R. Saurabh, A. Schaaf, A. Bohnhorst, S. Biedermann, J. Pierstorf, S. Winkelmann, B. Voss, M. Laudien, T. Bahmer, J. Heyckendorf, F. Brinkmann, S. Schreiber, W. Lieb, C. Jakwerth, C. Schmidt‐Weber, G. Hansen, E. von Mutius, K. F. Rabe, A. Dittrich, N. Maison, B. Schaub, M. Kopp, H. Busch, M. Weckmann, A. Fähnrich
          </td>
          <td>2025-10-28</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="The COVID-19 pandemic has left a lasting imprint on immune function, particularly in the elderly—a population already vulnerable to immunosenescence. While acute and long-COVID immune responses have been widely studied, the long-term apoptotic behavior of peripheral blood mononuclear cells (PBMCs) remains underexplored. This study aims to investigate the legacy of SARS-CoV-2 on PBMC apoptosis in elderly individuals during the post-COVID era, shedding light on potential persistent immune dysregulation. In this cross-sectional study, PBMCs were isolated from peripheral blood samples of elderly individuals (> 65 years old) with a documented history of COVID-19 infection at least six months prior. Using multiparametric flow cytometry, we quantified early and late apoptosis markers (Annexin V/PI), mitochondrial membrane potential disruption (ΔΨm), and expression of pro-apoptotic (Bax, Caspase-3) and anti-apoptotic (Bcl-2) proteins. Statistical analyses were performed to assess intergroup differences and correlations with clinical history. This study was conducted in 2025. Elderly post-COVID individuals exhibited a significantly elevated proportion of apoptotic PBMCs compared to controls (p < 0.01), particularly within the CD4 + and CD8 + T-cell subsets. Mitochondrial depolarization and increased Bax/Bcl-2 ratios indicated a shift toward intrinsic apoptotic pathways. Caspase-3 activation was also heightened in the post-COVID group. Notably, apoptotic burden correlated with time since infection and severity of initial illness. Our findings suggest a prolonged apoptotic signature in the immune cells of elderly individuals following recovery from COVID-19. These alterations may reflect a sustained immune exhaustion or maladaptive remodeling of lymphocyte populations, potentially contributing to impaired immunosurveillance and increased vulnerability to secondary infections or chronic inflammatory conditions. COVID-19 may cast a long immunological shadow in the elderly, with persistent PBMC apoptosis representing a novel facet of post-viral immune dysregulation. Flow cytometry reveals a unique apoptotic phenotype that could serve as a biomarker for long-term immune health and guide post-pandemic clinical management strategies for aging populations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/096a986d262753a585b2bfff92537948a29f8c5b" target='_blank'>
              Investigating apoptosis in peripheral blood mononuclear cells among the elderly in the post-COVID-19 era
              </a>
            </td>
          <td>
            Elaheh Abiri, Najmeh Hemmatian
          </td>
          <td>2025-10-31</td>
          <td>BMC Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Abstract Expression of inhibitory Siglec receptors has been described on T cells of patients with viral infection and cancer. However, the exact function and their role in T-cell activation and control of infections have not been well investigated. Here, we show that Siglec-9 levels increase on T cells in patients with acute severe acute respiratory syndrome coronavirus 2 infection relative to levels on healthy controls. T cells of these patients are inhibited by Siglec-9, and specific blocking with antibodies released this inhibition. To further test the role of Siglec-9 in acute viral infections, we characterized a murine model with T-cell intrinsic Siglec-9 overexpression. We found that Siglec-9 restricted T-cell immunity after acute infection with lymphocytic choriomeningitis virus, thereby dampening T-cell-mediated immune pathology. These results show that inhibitory Siglec receptors including Siglec-9 T cell intrinsically modulate and fine-tune antiviral T-cell activation, proliferation, and effector function.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ed06e49b5229600881efcceffb165b8a257a0279" target='_blank'>
              Increase of Inhibitory Siglec receptors on T cells mitigates severe immune reactions during acute viral infections
              </a>
            </td>
          <td>
            N. Rodrigues Mantuano, A. Bärenwaldt, Mirza Sarcevic, Isabelle V M Siqueira, A. Jauch, Manina Maja Etter, Matthias S Matter, Gregor Hutter, Mike Recher, H. Läubli
          </td>
          <td>2025-10-27</td>
          <td>PNAS Nexus</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="Tissue-resident alveolar macrophages (AMs) rely on intrinsic stem-like programs for self-renewal and maintenance, yet the transcriptional networks that support these functions and their relevance to post-viral lung disease remain largely unknown. Here, we identify TCF4 (Tcf7l2) as a critical transcription factor that governs AM maturation and stemness. Loss of TCF4 impaired AM proliferation, shifted their identity toward a pro-inflammatory phenotype, and exacerbated host morbidity following influenza or SARS-CoV-2 infection. Conversely, enforced TCF4 expression promoted the expansion of mature AMs, and supported lung recovery, thereby protecting against severe acute viral disease. Mechanistically, TCF4 antagonized β-catenin-driven inflammatory transcription while preserving oxidative phosphorylation, defining a reciprocal regulatory axis essential for AM function. Notably, respiratory viral infections and exuberant interferon signaling suppressed TCF4 expression, which remains chronically reduced in murine and human lungs with post-COVID fibrosis. This downregulation is associated with persistent KRT8hi dysplastic epithelium and collagen deposition. Moreover, aging diminished TCF4 levels and enforced TCF4 expression dampened age-associated decline of AM self-renewal. Furthermore, in vivo TCF4 overexpression after viral clearance enhanced mature AM accumulation, promoted lung epithelium regeneration, attenuated chronic tissue fibrosis and restored pulmonary physiologial function in aged lungs in a model of persistent pulmonary fibrosis post-acute viral infection. These findings have established TCF4 as a key regulator of AM stemness and identified a promising therapeutic target for long COVID and related chronic lung diseases through the modulation of embryonic-derived macrophage regenerative capacity by targeting TCF4.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/65799dca4a24e6fbcd774c66d4741d26a7a006c5" target='_blank'>
              Targeting a macrophage stemness factor to mitigate diseases post respiratory viral infection
              </a>
            </td>
          <td>
            Mohd Arish, A. Chaudhuri, Janli Tang, H. Narasimhan, An Fang, Jinyi Tang, Xiaoqin Wei, Chaofan Li, I. Cheon, Wei Qian, Farha Naz, Gislane Almeida-Santos, Samuel Young, T. Parimon, Y. Shim, Robert Vassallo, Peter Chen, Jie Sun
          </td>
          <td>2025-10-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="Background Acute rejection is a significant cause of impaired graft survival in the early post-transplantation period, and the early-stage immune cell dynamics with local intercellular communication during this process require further elucidation. Methods We performed single-cell RNA sequencing (scRNA-seq) on CD45+ immune cells isolated from rat renal allografts during the early phase of acute rejection (days 0, 1, 3, and 7). Using unsupervised clustering, functional enrichment analysis, cellular trajectory inference, and intercellular communication network mapping, we delineated the immune cell dynamics and local communication networks at single-cell resolution. Our findings were subsequently validated through multiplex immunofluorescence and therapeutic intervention experiments. Results Macrophages constituted the dominant immune population during acute rejection. Sub-clustering analysis revealed a rapid expansion of the Isg15+Mac subset by post-transplant day 1, which persisted at elevated levels thereafter. Functional enrichment and trajectory inference demonstrated the pro-inflammatory properties of Isg15+Mac, implicating this subset in acute rejection. Cell-cell communication analysis identified Ccl3-Ccr5 ligand-receptor interactions between Isg15+Mac and T cells. Multiplex immunofluorescence confirmed abundance of Isg15+Mac within the allografts. Moreover, the acute rejection after kidney transplantation was alleviated by the FDA-approved Ccr5 blocker Maraviroc. Conclusions Our study establishes an in-depth, early-stage immune landscape of renal transplantation, revealed that the Isg15+Mac subset activates T cells via the Ccl3–Ccr5 axis and thereby serves as a critical driver of acute rejection. And indicating that Maraviroc may potentially be a therapeutic candidate for transplant rejection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0e9d767fb56923b15a4ac52a99263c253eebc577" target='_blank'>
              Single-cell transcriptomics unravels the early immune landscape of renal allograft rejection and nominates Ccl3-Ccr5 as a therapeutic target
              </a>
            </td>
          <td>
            Fanchao Wei, Zhaoxiang Wang, Ruochen Qi, Jingliang Zhang, Shichao Han, Changhong Shi, Tong Lu, Zhite Zhao, Zhengxuan Li, Lang Li, Weijun Qin, Shuaijun Ma, Lijun Yang
          </td>
          <td>2025-10-22</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/929f5e64525cee92d0f3fab0ebf61c85bfdd0623" target='_blank'>
              The spatial landscape of infectious mononucleosis tonsils
              </a>
            </td>
          <td>
            Ciara I Leahy, Matthew Pugh, Aoife Hennessy, Nadezhda Nikulina, Stefan Dojcinov, Gerald Niedobitek, Graham S. Taylor, Paul G Murray, É. Fennell
          </td>
          <td>2025-10-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/eec3faaff4b0b828097a32f1d80401596d822916" target='_blank'>
              GsMTx4 Mitigates Neuroinflammation and Promotes Functional Recovery by Maintaining Microenvironmental Homeostasis During the Acute Phase After Traumatic Brain Injury in Mice
              </a>
            </td>
          <td>
            Rui Hong, Chen Xu, Xuyang Wang, Lin Zhang, Heli Cao, Yao Jing, Shiwen Chen
          </td>
          <td>2025-10-01</td>
          <td>Neurochemical Research</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Sindbis virus (SINV) is a mosquito-borne alphavirus capable of causing neurological and immunological symptoms in humans, yet its effects on neural/immune systems remain insufficiently characterized. This study aimed to examine SINV replication, UV-C light inactivation, apoptosis induction, and immune gene modulation in human SH-SY5Y neuroblastoma cells. Following viral adaptation and infectious dose determination, SINV replication and inactivation were assessed using RT-qPCR and dsRNA immunofluorescence. Apoptotic markers (caspase-3, Bax, Bcl-2) were analyzed by immunofluorescence and immune genes expression kinetics (TLR3/7, RIGI, MDA5, IL-1β, IL-6, TNFα, IL-10, IFNβ and β-catenin) were measured at defined time points post-infection by RT-qPCR. SH-SY5Y cells supported productive SINV infection, with viral RNA detectable as early as 3 hpi and marked cytopathic effects by 24 hpi. A custom-built UV-C chamber achieved complete viral inactivation following 3 × 30 s exposures. We observed SINV time-course replication and UV-C inactivation with conspicuous morphological alterations in SH-SY5Y cells. Furthermore, SINV triggered caspase-dependent apoptosis and robust transcriptional upregulation of innate immune genes, peaking between 12–16 hpi and declining by 30 hpi. These findings elucidate the temporal dynamics of SINV replication, cell death mechanisms, and immune activation in a neuronal context, contributing to a better understanding of SINV neuropathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/83e2cc5a51197d9fec1538c92303d5084a961763" target='_blank'>
              Sindbis Virus–Host Interactions in Human Neuroblastoma Cells: Implications for Viral Pathogenesis and Replication
              </a>
            </td>
          <td>
            Kornélia Bodó, Zoltán Kopasz, Viktória Nyári, Krisztina Leiner, Péter Engelmann, Brigitta Zana, R. Hetényi, Dániel Hanna, Krisztián Bányai, M. Madai, Gréta Varga, A. Kuczmog
          </td>
          <td>2025-10-01</td>
          <td>Viruses</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="Macrophages have a critical role in mucosal barrier immunity, demonstrating dynamic phenotypes that promote and resolve inflammation. However, the regulation of this polarization is not fully understood. Triggering receptor expressed on myeloid cells 2 (TREM2) is an immunoregulatory receptor expressed on macrophages. The role of TREM2 in mucosal immunity has not been previously studied. Our objective was to investigate TREM2 on macrophages during periodontal disease (PD), a chronic inflammatory condition affecting the oral mucosa. PD was induced using a ligature method in wild-type (WT) and TREM2−/− mice. Macrophages were isolated from oral mucosa and analyzed via flow cytometry. PD severity was assessed via quantification of bone loss and local inflammatory cytokine expression. Lastly, oral mucosal macrophages from WT mice and humans were analyzed via single-cell RNA sequencing (scRNA-seq). We demonstrated TREM2 expression on oral mucosal macrophages, and the proportion of TREM2+ macrophages significantly increased during resolution of PD and decreased during active PD. Analysis of TREM2−/− mice revealed a more severe PD phenotype with significantly increased tissue destruction and increased Il1b, Tnfa, and Il6 expression in the oral mucosa compared to WT. Transcriptional characterization of oral mucosal macrophages from mice and humans using scRNA-seq demonstrated subpopulations of TREM2+ macrophages characterized by similar gene signatures and pathways consistent with immunoregulatory functions. This study improves our understanding of macrophage polarization and introduces TREM2 as an important immunoregulator in the oral mucosa.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/962d98a853e2f7ac29c83c71bc0aa2dbf444bc5c" target='_blank'>
              Macrophage dynamics and the role of TREM2 at the oral mucosal barrier
              </a>
            </td>
          <td>
            Taiana C. Leite, Jiamiao Chen, A. Diacou, Sangmin Park, Andrew H Jheon, Jie Yin, Quinn T. Easter, Nicholas F. Fitz, K. Byrd, D. Clark
          </td>
          <td>2025-10-21</td>
          <td>Journal of Translational Medicine</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0f99bb18019cd4b39bd05d6d11bec440e5d21593" target='_blank'>
              B cell transcriptomics reveals lasting dysregulation and rapid decline of protective immune memory after chronic hepatitis C cure
              </a>
            </td>
          <td>
            Fang Chen, E. Giang, Padmaja Natarajan, Tony S. Mondala, Steven R. Head, Sing Chau Lau, Aishwarya Sundaresan, Liudmila Kulakova, Xiaohe Lin, Jasneet Aneja, R. Andrabi, Yun Zhang, Richard H. Scheuermann, Eric A. Toth, Thomas R. Fuerst, Lia Lewis-Ximenez, Arthur Y Kim, Paul Pockros, Georg M Lauer, M. Law
          </td>
          <td>2025-10-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>40</td>
        </tr>

        <tr id="The COVID-19 pandemic, which began in 2019 due to SARS-CoV-2, remains a global health crisis, especially as new variants emerge that could trigger widespread outbreaks again. While various aspects of SARS-CoV-2 infection warrant attention, the antiviral innate immune response is a crucial area of focus. Understanding how viruses evade host defenses is vital for developing effective vaccines and therapies. SARS-CoV-2 targets key components of the innate immune system for its survival, and this interference with the host immune system is central to the virus's ability to cause disease. However, the specific mechanisms by which the innate immune response counteracts SARS-CoV-2 infection have not been fully clarified. This review examines key elements of the antiviral innate immune response to SARS-CoV-2 infection, concentrating on viral evasion strategies and potential therapeutic targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2283fdb7927a9966d77a4f3f180d82163d69d72b" target='_blank'>
              Host’s innate immune response to SARS-CoV-2 infection—Current understanding and trends
              </a>
            </td>
          <td>
            Nitin Saksena
          </td>
          <td>2025-11-08</td>
          <td>Journal of Cellular and Molecular Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bfebb60d4d4f02fb39194b81fd4a071f887608f9" target='_blank'>
              Enrichment of a CD4-CD8- NK-like cytotoxic Vδ1/3 T cell subset in tuberculosis disease
              </a>
            </td>
          <td>
            Kendall Kearns, R. Tippalagama, Ashu Chawla, Jason A. Greenbaum, A. D. de Silva, Wathsala Gunasinghe, Judy Perera, Hansani Gunasekera, Darsha D Senevirathne, Thomas J. Scriba, Julie G. Burel, C. L. Lindestam Arlehamn, Bjoern Peters
          </td>
          <td>2025-11-13</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="Sphingosine-1-phosphate receptor (S1PR) modulators are effective therapies for multiple sclerosis (MS) that block lymphocyte egress from secondary lymphoid organs. This migration inhibition carries the risk of reduced infection-control as reported for the non-selective S1PR modulator, fingolimod. CXCL13:CXCR5-associated immune activities play a key role in protective antibody-based immunity but are also linked to inflammation in MS. Utilizing the ongoing SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pandemic, we aimed to determine whether selective S1PR modulation with ozanimod acts on the CXCL13:CXCR5 axis for modulating MS activity and whether this impacts anti-viral immune responses. This 1-year observational study included 20 patients with MS receiving ozanimod and 10 healthy probands. CXCR5+ T cells, B cells, serum CXCL13, anti-SARS-CoV-2 serostatus, and SARS-CoV-2-spike protein (ProtS)-reactive T cell responses were measured at 3-month intervals. CXCR5+ T and B cell frequencies and serum CXCL13, but not anti-SARS-CoV-2 responses, declined after ozanimod initiation. Anti-SARS-CoV-2 antibody and ProtS-reactive T cell responses peaked after recall vaccinations and break-through infections. Notably, ProtS-reactive T cell frequencies shifted from CD4+ to CD8+ T cell responses in patients treated with ozanimod compared to controls. Selective S1P receptor modulation with ozanimod affects the CXCL13:CXCR5 axis by reducing circulating CXCR5+ lymphocytes and serum CXCL13, which may contribute to reduce meningeal inflammation in MS. Moreover, the anti-SARS-CoV-2 immune defense appeared to be preserved during treatment with SARS-CoV-2-reactive CD8+ T cells, possibly compensating the lack of CD4+ T cell responses. Our immunological data may well apply to other viral infections and underscore the favorable safety and efficacy profile of ozanimod.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e4a5d524256ca24b7d9653ca688695b9cdf80bc2" target='_blank'>
              Selective S1P Receptor Modulation in Multiple Sclerosis Alters CXCL13:CXCR5-Associated Immune Activities Without Impacting Anti-SARS-CoV-2 Immunity
              </a>
            </td>
          <td>
            A. Harrer, RF Radlberger, Beate Buchegger, Brooke Slade, Thomas Haybaeck, Hannes Oberkofler, Konstantin E Thiel, Ferdinand Otto, Tobias Moser, P. Wipfler
          </td>
          <td>2025-10-08</td>
          <td>Neurology and Therapy</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Host factors influencing susceptibility to rhinovirus-induced asthma exacerbations remain poorly characterized. Using organotypic bronchial epithelial cultures from well-characterized children with asthma and healthy children, this study investigated viral load kinetics and resultant host responses by bulk and single-cell transcriptomics and targeted protein analyses. Bronchial epithelium from exacerbation-prone children exhibited greater rhinovirus replication and a cascade of exaggerated downstream interferon (IFN), inflammatory, epithelial stress, and remodeling responses. These transcriptional patterns were confirmed and further refined using single-cell transcriptomics, revealing cell type-specific contributions—particularly from non-ciliated cell populations including secretory immune response, tuft, and basal cells. We observed that these post-infection differences were associated with lower pre-infection IFN-stimulated gene (ISG) expression and protein levels of the ISG CXCL10. Prophylactic IFN-β treatment reduced viral replication and normalized downstream responses, supporting low baseline (pre-infection) IFN tone as a modifiable causal determinant of host susceptibility to adverse rhinovirus-induced responses in exacerbation-prone children with asthma.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e04af21df289e3bf6b7df85957ae65de21226d43" target='_blank'>
              Transcriptomic Profiling of Bronchial Epithelium Reveals Dysregulated Interferon and Inflammatory Responses to Rhinovirus in Exacerbation-Prone Pediatric Asthma
              </a>
            </td>
          <td>
            N. Jayavelu, Basilin Benson, P.C. Dela Cruz, Weston T. Powell, Lucille M. Rich, Elizabeth R. Vanderwall, C. Gates, Andrew J Nagel, M. White, N. Samanas, Kourtnie Whitfield, T. Hallstrand, Steven F. Ziegler, Matthew C. Altman, J. Debley
          </td>
          <td>2025-10-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/083cd9665e2adce6c636caf445e71437ffb29674" target='_blank'>
              Astrocytes control the Neuroinflammation and ILC2 response through IL-33/ST2 signaling, during protection against Cerebral Malaria in Toxoplasma-P. berghei coinfected Mice
              </a>
            </td>
          <td>
            Inès Leleu, Tarun Keswani, Fabien Herbert, Capucine Picavet, Manon Arnaud, Marion Sabrina, Corine Glineur, Pied Sylviane
          </td>
          <td>2025-10-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="ABSTRACT Eosinophils are versatile cells that participate in a multitude of homeostatic and inflammatory responses in the lung, ranging from allergic asthma to antiviral defense against respiratory viral infection. In the context of vaccination followed by viral infection, such as breakthrough infection, eosinophils have been linked to aberrant Th2 responses like vaccine-enhanced respiratory disease. Here, we demonstrate that the lung immune cell composition, cytokine and chemokine repertoire, histopathological profile, and systemic humoral response of breakthrough influenza infection in mice are distinct from those of primary influenza infection or allergic sensitization, canonical Type 1 and 2 immune responses, respectively. Longitudinal comparison of breakthrough infection with allergic sensitization and primary influenza infection demonstrated major differences in lung immunity between treatment groups in female BALB/c mice. Breakthrough infection mice exhibit lung eosinophil infiltration that peaks at 7–10 days post-challenge, enriched for the Siglec-Fhi subset, but in the absence of overt pro-inflammatory cytokine/chemokine signals, high viral titers, severe lung lesions, goblet cell hyperplasia, allergic levels of total IgE, or enhanced morbidity. Multiparameter fluorescence imaging corroborated findings from flow cytometry and also unveiled interactions between CD101+Siglec-F+ cells and CD3+ cells in the lung tissue space. Imaging also revealed a marked absence of eosinophil or neutrophil extracellular traps in the lungs of breakthrough infection mice, in contrast with allergic sensitization and primary influenza infection, respectively. Altogether, our findings provide a deeper understanding of the kinetics and cell-cell interplay during non-pathological, balanced Type 1/2 immune responses in vaccinated hosts during breakthrough infection. IMPORTANCE Our findings reveal that eosinophilic recruitment during influenza breakthrough infection is non-pathological and represents a balanced immune response, distinct from highly inflammatory environments seen in primary influenza infection or allergic sensitization. We observed eosinophil enrichment in the lungs of vaccinated hosts following infection, which coincided with rapid viral clearance and minimal lung damage, challenging traditional associations of eosinophils with adverse outcomes in vaccinated hosts, like for respiratory syncytial virus. We identified a phenotypic shift toward Siglec-Fhi eosinophil subset in breakthrough infection mice. Additionally, we highlight preservation of alveolar macrophages and absence of neutrophil and eosinophil extracellular traps in vaccinated hosts, key features that distinguish breakthrough infection from both Type 1- and Type 2-skewed disease models. These insights have broad implications for exploring eosinophil plasticity and cell-cell interactions in the lung, which could inform the development of strategies to harness the benefits of balanced Type 1/2 immune responses across different vaccine/respiratory virus pairs. Our findings reveal that eosinophilic recruitment during influenza breakthrough infection is non-pathological and represents a balanced immune response, distinct from highly inflammatory environments seen in primary influenza infection or allergic sensitization. We observed eosinophil enrichment in the lungs of vaccinated hosts following infection, which coincided with rapid viral clearance and minimal lung damage, challenging traditional associations of eosinophils with adverse outcomes in vaccinated hosts, like for respiratory syncytial virus. We identified a phenotypic shift toward Siglec-Fhi eosinophil subset in breakthrough infection mice. Additionally, we highlight preservation of alveolar macrophages and absence of neutrophil and eosinophil extracellular traps in vaccinated hosts, key features that distinguish breakthrough infection from both Type 1- and Type 2-skewed disease models. These insights have broad implications for exploring eosinophil plasticity and cell-cell interactions in the lung, which could inform the development of strategies to harness the benefits of balanced Type 1/2 immune responses across different vaccine/respiratory virus pairs.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/706a4c5f7c88c12b504934a6602bb5e4836d79a7" target='_blank'>
              Transient lung eosinophilia during breakthrough influenza infection in vaccinated mice is associated with protective and balanced Type 1/2 immune responses
              </a>
            </td>
          <td>
            Lauren A. Chang, Stephen T Yeung, Prajakta Warang, M. Noureddine, Gagandeep Singh, Brett T Webb, Eleanor Burgess, Michael Schotsaert
          </td>
          <td>2025-11-05</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Severe influenza virus infection often triggers acute lung injury, and the efficacy of respiratory functional recovery critically depends on timely alveolar regeneration. However, the cellular dynamics and regulatory mechanisms underlying post-infectious alveolar repair remain incompletely understood. Utilizing Sftpc-CreER; Rosa26-mTmG lineage-tracing model, we determine the main stem cell population responsible for alveolar regeneration following influenza-induced injury. Through integrated single-cell RNA sequencing (scRNA-seq), immunofluorescence, and electron microscopy approaches, we mapped cellular transcriptional landscapes and spatial interactions. Key macrophage-epithelial crosstalk was further investigated via in vitro co-culture systems and in vivo conditional depletion models using diphtheria toxin receptor-transgenic mice. Putative regulatory factors were predicted through ligand-receptor interaction analysis and functionally validated in ex vivo organoid models. In this study, we revealed that the severely damaged alveolar barrier after influenza virus infection was rebuilt by the proliferation and differentiation of residual type II alveolar epithelial (AT2) cells in an inflammatory niche. In particular, monocyte-derived macrophage (Mo-Macs) expand, displaying intimate spatial proximity with AT2 cells. In addition, the cellular transcriptional status determined by scRNA-seq revealed that Mo-Macs regulate epithelial cell proliferation. Mo-Macs promoted the formation of AT2 spheres in vitro. Moreover, Mo-Mac depletion resulted in delayed repair of the alveolar epithelial structure in vivo. In addition, the mechanism by which Mo-Macs regulate alveolar epithelial repair involves the secretion of oncostatin M (OSM), which stimulates p-STAT3 activation and promotes AT2 cell proliferation. Our findings revealed that residual AT2 cells act as stem cells in the alveolus and are regulated by Mo-Macs through OSM secretion. These findings increase our understanding of the role of inflammatory signals in regulating tissue repair after severe injury, which may provide a potential avenue for therapeutic intervention in recovered patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c77e7cb9a0802132b1fb5c49fb2be2fef756fe89" target='_blank'>
              Monocyte-derived macrophages support alveolar regeneration via oncostatin M post-H1N1 infection during the recovery phase
              </a>
            </td>
          <td>
            Xiaoan Shang, J. Jia, Jiapei Yu, Shumei Zou, Zeyi Wang, Jiuyang Xu, Hui Li, Bin Cao
          </td>
          <td>2025-10-08</td>
          <td>Respiratory Research</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Objective: The diverse differentiation states of mononuclear macrophages are closely associated with the pathogenesis of auto-immune diseases. This study integrates single-cell RNA sequencing data from six autoimmune diseases to characterize shared and disease-specific alterations in mononuclear macrophages, with the aim of enhancing our understanding of the immune landscape in autoimmune diseases and refining clinical treatment strategies. Methods: We collected single-cell RNA-sequencing data of autoimmune diseases including primary Sjogren’s syndrome (pSS), Behçet’s disease (BD), juvenile dermatomyositis (JDM), rheumatoid arthritis (RA), relapsing-remitting multiple sclerosis (RRMS), and systemic lupus erythematosus (SLE). We performed scRNA-seq analysis on 350,043 peripheral blood immune cells from autoimmune diseases patients and healthy controls, followed by validations with flow cytometry, immunohistochemical staining, and immunofluorescence. Results: Fifteen mononuclear phagocyte subpopulations were clustered from peripheral blood mononuclear cells (PBMCs), we identified a new subpopulation named CCL3 + classical monocytes (cMo) that is co-amplified in multiple autoimmune diseases (BD, JDM, pSS, RRMS, SLE). The CCL3 + cMo cells are characterized by high M1-like score, exhibiting strong inflammatory characteristics and high chemotaxis toward other monocytes. In addition, CCL3 + cMo cells upregulated antigen presentation-related signaling pathways, and the cytotoxic CD8 + T or memory CD8 + T cells were strongly perturbed by their signaling crosstalk. Conclusion: This study delineates a comprehensive landscape of mononuclear phagocyte heterogeneity in autoimmune diseases and reveals CCL3 + cMo as a commonly amplified immune subset associated with multiple autoimmune diseases. These findings highlight its potential role in disease mechanisms and nominate CCL3 + cMo as a candidate therapeutic target.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/269a9362a06b2318fda9ed667637c721b24e2759" target='_blank'>
              Single-Cell Transcriptomics Reveals CCL3+ Classical Monocyte Subset Linked to Autoimmune Pathogenesis
              </a>
            </td>
          <td>
            Heng Xu, Kai Yuan, Guangyao Chen, Jing Luo, Aimin Yan, Huaijuan Huang, Xinbo Yu, Qingwen Tao, Guangrui Huang, Anlong Xu
          </td>
          <td>2025-11-01</td>
          <td>Journal of Inflammation Research</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="African swine fever virus (ASFV) is an important transboundary animal pathogen with significant impacts on the global swine industry. Overwhelming proinflammatory responses are a major virulence mechanism for ASFV, but the dynamics of these changes during clinical disease are not completely understood. We constructed a detailed portrait of the innate immune responses during acute African swine fever (ASF) at the cellular, transcriptomic, and cytokine levels. Samples serially obtained from infected piglets show that progression of acute ASF is characterized by rapid increases in plasma type I interferons, TNF-α, IL-12p40, and IL-10, which coincide with the manifestation of clinical disease and viral DNAemia. Lymphocytes and natural killer (NK) cells progressively declined, with fluctuations in B cell, CD8+ T cell, and CD4+/CD8+ T cell populations. Blood monocytes and macrophages were highly variable throughout infection, with an abrupt spike in CD203+ mature macrophages immediately prior to death. Transcriptomic analysis of blood showed downregulation of cellular translation as early as 1 day post-challenge (DPC) and significant upregulation of antiviral immune processes at 5 DPC and 7 DPC, which overlapped with the onset of clinical disease. Together, these results present a detailed delineation of fatal ASF which involves an initial infection and damage of susceptible myeloid cells prior to symptomatic disease characterized by pro-inflammatory immune responses, lymphoid depletion, and clinical deterioration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b6a3491e33824aacb30f83f82721a1e7ae4367b7" target='_blank'>
              Temporal Dynamics of Cytokine, Leukocyte, and Whole Blood Transcriptome Profiles of Pigs Infected with African Swine Fever Virus
              </a>
            </td>
          <td>
            Daniel W Madden, B. Artiaga, J. Trujillo, Patricia Assato, Chester D. McDowell, Isaac Fitz, T. Kwon, K. Cool, Yonghai Li, N. Gaudreault, Igor Morozov, Juergen A Richt
          </td>
          <td>2025-10-01</td>
          <td>Pathogens</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Severe COVID‐19 is an immunological disorder characterized by a hyper‐inflammatory reaction of the immune system. SARS‐CoV‐2 anti‐spike antibodies of the IgG isotype are known to strongly contribute to this hyperinflammation by overactivation of alveolar macrophages. However, while the pathogenic function of IgG has been extensively studied, very little is known about the function of IgA, the most abundant immunoglobulin isotype in the airways. Although IgA is generally considered noninflammatory, in this study, we show that anti‐spike IgA induces pronounced proinflammatory responses. We demonstrate that stimulation of macrophages with anti‐spike IgA immune complexes in combination with a viral stimulus amplifies proinflammatory cytokine production. This IgA‐induced inflammation is particularly driven by IgA2, the IgA subclass that is increased in the plasma of severely ill COVID‐19 patients. We identified that IgA2‐induced inflammation is predominantly dependent on FcαRI‐Syk signaling. Mechanistically, IgA2‐induced inflammation is linked to enhanced glycolysis and altered mitochondrial function, indicating subclass‐specific immunometabolic reprogramming. Taken together, these data indicate a pathogenic role for IgA2 in severe COVID‐19 and highlight its signaling cascades and metabolic pathways as potential druggable targets to counteract hyperinflammation in severe coronavirus infections, such as COVID‐19, SARS, MERS, and potential future outbreaks.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/108f6fbe490f0df81a3f8e4a427171366e4fce33" target='_blank'>
              Anti‐SARS‐CoV‐2 Spike IgA2 Induces Inflammation by Human Macrophages
              </a>
            </td>
          <td>
            Lynn Mes, Jennifer Veth, Julie Van Coillie, J. Keijser, Elise Mantel, R. van der Mast, Theo Rispens, G. Vidarsson, M. van Egmond, J. den Dunnen, Hung-Jen Chen
          </td>
          <td>2025-10-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>55</td>
        </tr>

        <tr id="Host responses – autophagy, cell death, and inflammation – limit the growth of bacterial pathogens while minimizing tissue damage. During the early stages of infection, Mycobacterium tuberculosis (Mtb) thwarts these and other innate immune defense mechanisms in alveolar macrophages (AMs) derived from the yolk sac; in later stages, it circumvents defenses in recruited mononuclear cells (MNCs) and survives within them despite additional cytokine stimulation from recruited T cells. The mechanisms that drive variable rates of Mtb growth in different macrophage subtypes and how Mtb manipulates inflammatory responses to grow within innate immune cells remain obscure. Here we explored the role of the host factor, Tax-1 binding protein 1 (Tax1bp1), an autophagy receptor that targets pathogens for degradation through selective autophagy and terminates pro-inflammatory cytokine responses. Unexpectedly, we found that Tax1bp1-deficient mice were less susceptible to Mtb infection, and generated reduced inflammatory cytokine responses, compared to wild-type mice; the same mutant mice exhibited decreased growth of, and inflammatory cytokine responses to, Listeria monocytogenes, suggesting that Tax1bp1 plays a role in host responses to multiple intracellular pathogens. Contrary to our previous ex vivo findings in bone marrow-derived macrophages (BMDMs), in vivo growth of Mtb in AMs and a subset of recruited MNCs was more limited in mice lacking Tax1bp1 relative to wild-type mice. To better understand these differences, we performed global protein abundance measurements in mock- and Mtb-infected AM samples ex vivo from wild-type mice. These experiments revealed that Tax1bp1 protein abundance does not significantly change early after infection in AMs but does in BMDMs; moreover, early after infection, Tax1bp1-deficiency reduced necrotic-like cell death -- an outcome that favors Mtb replication -- in AMs but not BMDMs. Together, these results show that deficiency of Tax1bp1 plays a crucial, cell type-specific role in linking the regulation of autophagy, cell death, and anti-inflammatory host responses and overall reducing bacterial growth.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7346e21902a5204769fdc46d4603e81b0700379e" target='_blank'>
              Mycobacterium tuberculosis triggers reduced inflammatory cytokine responses and virulence in mice lacking Tax1bp1
              </a>
            </td>
          <td>
            Jeffrey Chin, Nalin Abeydeera, Teresa Repasy, Rafael Rivera-Lugo, Gabriel Mitchell, Vinh Q Nguyen, Weihao Zheng, Alicia L. Richards, Erica Stevenson, Danielle L. Swaney, N. Krogan, J. Ernst, Jeffery S. Cox, Jonathan M Budzik
          </td>
          <td>2025-10-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="ABSTRACT Down syndrome (DS) is associated with immune dysfunction, which led to higher hospitalization and mortality rates during the COVID-19 pandemic. We previously showed that antibody concentrations were lower in adults with DS after primary SARS-CoV-2 vaccination. However, knowledge on cellular vaccine-induced responses in DS is limited. Here, we investigated the T-cell response induced by SARS-CoV-2 vaccination in adults with DS. We included adults with DS and healthy controls (HC) between 18 and 64 years following primary (mRNA and vector) and booster (mRNA) SARS-CoV-2 vaccination. Using flow cytometry, SARS-CoV-2-specific T cells were analyzed after spike peptide re-stimulation. Additionally, interferon-gamma (IFNγ) production by SARS-CoV-2-specific T cells was measured with an IFNγ release assay (IGRA) after antigen stimulation. We observed major deficits in naive CD4+ and CD8+ T cells in adults with DS as previously described. However, overall there was no difference in the percentage of SARS-CoV-2-specific T cells or IFNγ production by these cells after primary vaccination, albeit with vaccine-specific differences. IFNγ concentrations measured by IGRA after primary vaccination were comparable between DS and HC. Booster vaccination increased SARS-CoV-2-specific T cells in HC but not in DS, while IFNγ release (IGRA) increased to similar concentrations. In conclusion, we show that while functional T-cell responses (IFNγ production) are comparable after primary and booster vaccination, the magnitude (percentage of SARS-CoV-2-specific T cells) may be lower after mRNA vaccination. We previously showed lower antibody concentrations and profound abnormalities in the naive T-cell compartment, warranting further investigation into T-cell-B-cell-interactions after vaccination in adults with DS. Clinical trial registration: NCT05145348 https://www.clinicaltrials.gov/study/NCT05145348?locStr=Netherlands&country=Netherlands&cond=Down%20Syndrome&term=SARS-CoV-2%20Vaccination&rank=1. Start date: 2021–02-03.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2448268bbfee83f7ff147f95f3dffc2e0f35b5a8" target='_blank'>
              T-cell responses to SARS-CoV-2 vaccinations in adults with Down syndrome – a prospective cohort study
              </a>
            </td>
          <td>
            Lobke C M Hensen, Bianca M M Streng, F. van Wijk, S. Nierkens, Robert S. van Binnendijk, A. Buisman, Antonia M W Coppus, Corine H. Geurts van Kessel, Gert de Graaf, Fiona van der Klis, Regina Lamberts, G. Vidarsson, Tracy J Ruckwardt, Esther de Vries, R. D. de Vries, M. Weijerman, Daniel M Weinberger, J. Wildenbeest, Louis J. Bont, E. Delemarre
          </td>
          <td>2025-11-06</td>
          <td>Human Vaccines & Immunotherapeutics</td>
          <td>0</td>
          <td>55</td>
        </tr>

        <tr id="The mechanisms by which SARS-CoV-2 infection lead to neuroinflammation and cognitive impairment in COVID-19 and Long COVID are unclear. Cerebrovascular Wnt/β-catenin pathway activity is suppressed in association with neuroinflammation and cognitive impairment in a mouse model of COVID-19. In this study, we asked whether SARS-CoV-2 (NY Iota strain) infection of astrocytes would result in cell-autonomous changes in Wnt/β-catenin pathway components. We report that induced pluripotent stem cell (hiPSC)-derived human astrocytes (iAs) are susceptible to sustained infection with SARS-CoV-2 in vitro. Real-time PCR revealed that SARS-CoV-2 infection of iAs decreased transcripts for Wnt3a, Wnt10b, and the downstream pathway effectors β-catenin and TCF3. Wnt7b was increased, as was the proinflammatory chemokine CXCL10. No changes were noted in Wnt3, Wnt7a, TCF1, TCF4, or LEF1. These data indicate that SARS-CoV-2 infection differentially influences Wnt/β-catenin pathway components in astrocytes. These data could have implications for the mechanistic basis of COVID-19 and Long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2df9142f8c924fe780ce7108a7ee825da25ea8a8" target='_blank'>
              SARS-CoV-2 Infection Influences Wnt/β-Catenin Pathway Components in Astrocytes
              </a>
            </td>
          <td>
            KaReisha F. Robinson, Avantika I. Ahiya, Justin M. Richner, Sarah E. Lutz
          </td>
          <td>2025-10-01</td>
          <td>Pathogens</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/61f2942696de914b8ddcd3d63d15f096d71ddb29" target='_blank'>
              Progenitor T cells drive chronic pulmonary type 2 inflammation
              </a>
            </td>
          <td>
            Radomir Kratchmarov, Xiaojiong Jia, Jun Nagai, Hiroaki Hayashi, Kinan Alhallak, Juying Lai, Chunli Feng, Jakob von Moltke, Joshua A. Boyce, Patrick J. Brennan
          </td>
          <td>2025-10-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Respiratory virus infections have been presenting significant global public health challenges. The virulence of SARS-CoV-2 and seasonal influenza largely relies on triggering abnormal host immune responses, particularly the production of a cytokine storm, which is notably increased in elderly patients. However, as the mechanisms underlying this age-associated exacerbation remain unclear, we investigated the role of the aging tissue microenvironment in promoting inflammation associated with viral infection. Our research, based on clinical samples, cellular experiments, and mouse models, provides evidence that the aging lung microenvironment induces severe inflammatory responses and leads to tissue damage, with senescent cells playing a crucial role in this process. Further mechanistic insights reveal that elevated levels of downstream inflammatory factors result from a significant and robust activation of the NF-κB pathway. This increase is attributed to the accumulation of reactive oxygen species in senescent cells and subsequent reduced expression of PDLIM2, an E3 ubiquitin ligase regulating P65 degradation. Finally, restoring PDLIM2 significantly inhibits viral infection-mediated inflammatory responses and organ damage in the aging body. Therefore, this study offers a novel perspective by elucidating the molecular mechanism and exploring the therapeutic potential behind viral infection-related inflammatory responses, particularly the mechanism accelerating inflammatory storms in elderly patients post-infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e07f24dbbacd6b1011804f10fdf4109e7d35e755" target='_blank'>
              Senescent cells promote viral infection-associated inflammation and tissue damage through a robust NF-κB pathway
              </a>
            </td>
          <td>
            Mingfu Tian, June Ma, Zhiqiang Li, Chenglin Ye, Xianghua Cui, Guolei Wang, Siyu Liu, Muhammad Suhaib Qudus, Uzair Afaq, Hong Fan, Jiali Xiong, Guangli Li, Chuanjin Luo, Zhen Wang, Zhengjiang Jin, Ming Guo, Xin Wang, Zhixiang Huang, Fang Zheng, Kailang Wu, Chengliang Zhu
          </td>
          <td>2025-10-28</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="Current understanding of how immunodeficiencies impact protective responses against viral infections and vaccination is primarily derived from adult cohorts that may not accurately reflect the pediatric, adolescent, and young adult population. This cross-sectional study aimed to evaluate immune responses in this underrepresented population affected by various immunodeficiencies after SARS-CoV-2 infection, two doses of the mRNA BNT162b2 vaccine, or after a combination of both. We analyzed blood samples from 102 immunocompromised patients (IC) (5–25 years) categorized into groups of primary immunodeficiencies (PID, n=17), bronchial asthma and allergic rhinitis (BA-AR, n=39), rheumatoid diseases (RD, n=21), and individuals who had undergone hematopoietic stem cell transplantation (HSCT, n=28), as well as 30 healthy individuals (9–26 years). We measured titres of Spike-specific IgM, IgA, and IgG antibody classes (including IgG subclasses) in plasma using ELISA and evaluated their inhibitory potential in a Spike-ACE2 cell-based internalization assay. Spike-specific CD4 T-cells were examined using a flow cytometry-based proliferation assay (FASCIA). In the IC group, all participants except eight generated detectable levels of IgG antibodies. The IgG titres induced by vaccination (Geometric mean titre (GMTvac) = 205023, 95% CI: 116074-362136) and a combination of vaccination and infection (GMThyb = 172819, 95% CI: 33133-901403) were higher than after infection (GMTinf = 3323, 95% CI: 578-19109, Pvac/inf = .006 and Phyb/inf = .001). On the other hand, the hybrid immunity induced the highest IgA titres (GMThyb = 2672, 95% CI: 566-12623) compared to vaccination (GMPvac = 275, 95% CI: 97-777, Phyb/vac = .016) and infection (GMTinf = 60, 95% CI: 13-280, Phyb/inf = .002). The IgG titres in vaccinated and hybrid immunity groups strongly correlated (rSpearman = 0.86, P <.0001) with the levels of antibodies inhibiting the internalization of Spike protein (S protein) in a cell-based assay. Most IC patients (except five) also developed above-threshold Spike-specific CD4 T-cell responses, which were not statistically different from the responses in the healthy control group. Our data show that infection and vaccination can induce protective humoral or cellular responses against SARS-CoV-2 in IC patients. The activated cellular response in patients with agammaglobulinemia may assist them in overcoming viral infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/19b89871eb1064300bee81872f1566b7ef8c8974" target='_blank'>
              Impact of immunodeficiencies on immunity induced by SARS-CoV-2 infection, mRNA BNT162b2 vaccination, and their combination in children and young adults
              </a>
            </td>
          <td>
            L. Fialova, Birivan Macek-Nabova, M. Zilkova, Natalia Turic-Csokova, Denisa Palova, Stanislav Katina, Gabriela Paulikova-Rolkova, Peter Ciznar, Julia Horakova, Ľubica Wojčiaková, Karina Markova, Eva Kontsekova, B. Kovacech
          </td>
          <td>2025-11-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e1cac498108b5305e7d2a1dde250a33c8a3e03b2" target='_blank'>
              Acute SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Amy C. Sherman, Glenda E Gray, Bin Cao, Kelvin K W To, Nadine G Rouphael, A. Henao-Restrepo, Anthony C Gordon, Lindsey Baden
          </td>
          <td>2025-10-24</td>
          <td>Nature Reviews Disease Primers</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/665f165b957f86528ff80ab0f0694c6033a2c825" target='_blank'>
              Activation of IRF7/ISG15 axis in microglia inhibits NLRP3 Expression and Improves the Prognosis of Ischemia/Reperfusion in Mice
              </a>
            </td>
          <td>
            Hao Yan, Xiangyang Cao, Meng Ma, Qianxiong He, Feiyang Li, Ruxiang Xu, Yangyang Wang, Yi Zheng, Jing Yang, Ying Xiao
          </td>
          <td>2025-11-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Viral infections impose a substantial threat to human health, characterized by a wide range of pathogens, clinical manifestations, and complex immune responses. Single-cell multi-omics technologies have revolutionized the study of antiviral immunity by resolving cellular heterogeneity, transcriptional reprogramming, and clonal dynamics. However, no resource has yet comprehensively integrated such datasets in the context of viral infections. Here, we present scMOVIR, a single-cell multi-omics database for human viral infections and immune responses. The database systematically integrates transcriptomic, proteomic, and immune receptor repertoire profiles at single-cell resolution, compiling 8532 human samples across 114 viral species, subtypes, and strains. These datasets span 59 well-defined disease states, including acute and chronic infections, virus-associated malignancies, and immune-related disorders, and extend across >30 tissue types. In addition, these datasets incorporate vaccination cohorts, therapeutic interventions, and time-course models of infection. To ensure consistency and interoperability, all datasets undergo standardized preprocessing, including batch correction and unified cell-type annotation, with metadata harmonized using authoritative ontologies. scMOVIR provides user-friendly interfaces for dataset exploration and interactive visualization of cellular dynamics and molecular profiles, offering a high-resolution reference for investigating virus-host immune interactions and supporting antiviral research. The database is freely accessible at https://pgx.zju.edu.cn/scmovir.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/130c5b82f9725db7d1697918120f36ba3e49fd02" target='_blank'>
              scMOVIR: a single-cell multi-omics database for human viral infections and immune responses.
              </a>
            </td>
          <td>
            Xue Zhang, Shounan Yang, Xiaobin Xu, Yitao Lin, Huaicheng Sun, Bangyu Zhu, Wenyi Zhao, Binbin Zhou, Yan Lou, Xinyu Wang, Shuqing Chen, Qiaojun He, Feng Zhu, Zhan Zhou
          </td>
          <td>2025-11-13</td>
          <td>Nucleic acids research</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/68a61536fdb213f77defcf43b41942dda2c2a3d0" target='_blank'>
              SARS-CoV-2 Variant-Dependent Alterations in Nasopharyngeal Microbiota and Host Inflammatory Response
              </a>
            </td>
          <td>
            Mario Maulen, Ignacio Pezoa-Soto, Daniel León, Ela M. Dominguez, Alberto J. M. Martin, W. Díaz-Vásquez
          </td>
          <td>2025-10-30</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="Bacterial infection is a key trigger of inflammatory pathways that damage the preterm brain, even without direct bacterial brain invasion. However, the mechanisms underlying the involvement of intracranial tissues and cells in early immune responses to acute systemic inflammation in preterm infants remain unknown. Lipopolysaccharide (LPS) was administered with a single intraperitoneal injection into postnatal day (P) 7 mice. Four hours later, the leptomeningeal macrophages initiated an intracranial reaction by producing IL-1β, which set the stage for the arachnoid, pial, and perivascular fibroblasts to act. These brain fibroblasts produced CCL2, which increased the number of brain parenchymal macrophages/microglia and led to their hypertrophy. The macrophages/microglia isolated from the brains of mice with systemic inflammation showed marked transcript expression of genes including Saa3, Irg1, Lcn2, and Cxcl9. The expression level of Saa3 reached its peak 4 and 12 h after LPS administration. Saa3 expression was upregulated in the macrophages in the leptomeninges, perivascular space, and cerebellar medulla, as well as in the fibroblasts of the leptomeninges, choroid plexus stroma, and perivascular space. The leptomeningeal macrophages expressing Saa3 continued their developmental migration from the leptomeninges to the brain parenchyma. The blood-brain barrier of pups remained intact up to 72 h after LPS administration at P7. The expression levels of Irg1, Lcn2, and Cxcl9 peaked 4 and 12 h after LPS administration. The cells that prominently expressed Irg1, Lcn2, and Cxcl9 were the leptomeningeal macrophages, perivascular fibroblasts and choroid plexus epithelial cells, and leptomeningeal fibroblasts, respectively. The early enhancement of Saa3 expression played a key role in priming inflammation initiated by macrophages and fibroblasts. Early enhancement of Irg1 expression was crucial for determining the direction of the inflammatory response. The increase of Lcn2 was vital, sequestering the iron siderophore to limit bacterial growth. It was interesting to observe how the early immune responses to systemic inflammation in the postnatal mouse brain were initiated by migrating macrophages and leptomeningeal fibroblasts, leading to immediate gene upregulation to protect immature brain tissue.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f0b35f26b99383b11b5240dc52d6f9e54408658a" target='_blank'>
              Early immune responses to systemic inflammation in the postnatal mouse brain initiated by migrating macrophages and leptomeningeal fibroblasts
              </a>
            </td>
          <td>
            Rei Settsu, Aki Obara, Takehiko Tarui, S. Hasegawa-Ishii, Atsuyoshi Shimada
          </td>
          <td>2025-10-11</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e819f35bfc49ec2545e41780dc01e007f076a26d" target='_blank'>
              Immune Cell Dysfunction of SARS-CoV-2: Mathematical Modeling of the Within-Host Immune Dynamics
              </a>
            </td>
          <td>
            Pagnapech Ngoun, Nicolas Alvarez, Ayesh Awad, Hwayeon Ryu
          </td>
          <td>2025-10-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Enterovirus D68 (EV-D68) is a significant global pathogen associated with severe respiratory infections and acute flaccid myelitis in children. Currently, there are no vaccines or antiviral drugs available for EV-D68, and a robust model to elucidate the pathogenesis of EV-D68 and evaluate treatment methods is lacking. We developed a mouse-adapted EV-D68 strain that caused progressive limb paralysis after intramuscular inoculation in 7-day-old mice. Viral load analysis showed that the skeletal muscle and spinal cord had the highest titers and most severe injuries. RNA sequencing of the infected muscle, brain, spinal cord, and lung tissues revealed differentially expressed genes (DEGs) associated with viral infection and pathogenesis. DEGs were significantly enriched in various pathways associated with antiviral immunity, interferon responses, and cytokine signaling. In the spinal cord, DEGs highlighted mitochondrial dysfunction and oxidative stress as crucial contributors to neural damage. Flow cytometry analysis of spinal cord cells showed that EV-D68 activates the immune system, leading to systemic inflammation and significant increases in CD8+ and CD4+ T cells, but limited neutrophil and monocyte infiltration. This mouse model provides a valuable tool for studying EV-D68 pathogenesis and evaluating antiviral and vaccine efficacy, thereby advancing the understanding of its neuropathological mechanisms. Importance: We developed a novel mouse model of EV-D68 that provides a valuable tool for studying its pathogenesis and evaluating antiviral and vaccine efficacy, deepening the understanding of its neuropathological basis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ec65cdb91c340614db24a50d4f78be18da8803ac" target='_blank'>
              Spinal Cord Injury in Enterovirus D68 Infection: Mechanisms and Pathophysiology in a Mouse Model
              </a>
            </td>
          <td>
            Wei Duan, Jichen Li, Ying Liu, Rui Wang, Qian Yang, Huijie Li, Yucai Liang, Qi Shi, Jiao Wang, Jinbo Xiao, Jianfang Zhou, Qiang Sun, Yong Zhang
          </td>
          <td>2025-11-06</td>
          <td>Viruses</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Introduction Neuroinflammation triggered by viral infections is increasingly recognized as a driving force in neurodegenerative disease, promoting chronic neuronal injury and cognitive decline. A central mechanism in this process is impaired glutamate clearance due to downregulation of the astrocytic glutamate transporter GLT-1 (EAAT2/SLC1A2), which exacerbates excitotoxicity and neuronal death. Methods In this study, we assessed the neuroprotective effects of the β-lactam antibiotic ceftriaxone—a known upregulator of GLT-1—in an in vitro tri-culture model of neurons, microglia, and astrocytes challenged with the viral mimic polyinosinic:polycytidylic acid (Poly I:C). Results and discussion Poly I:C exposure elicited robust microglial and astrocytic activation and increased levels of TNF-α, IL-6, and IL-10. Concomitantly, we observed significant downregulation of GLT-1, synapse loss, impaired synaptic plasticity, and disrupted amino acid metabolism. A complementary Mendelian randomization analysis of GWAS data revealed that genetically determined alterations in plasma amino acid levels are significantly associated with the risk of five major neurodegenerative disorders, underscoring the role of metabolic dysregulation in disease pathogenesis. Treatment with ceftriaxone effectively reversed the Poly I:C–induced phenotypes: GLT-1 expression, dendritic spine density, and measures of synaptic plasticity were all restored, and abnormalities in amino acid and tricarboxylic acid cycle metabolites normalized. These findings highlight ceftriaxone’s multifaceted neuroprotective profile—modulating glutamate homeostasis, preserving synaptic integrity, and rebalancing metabolic pathways—and support its potential as a therapeutic agent to prevent neuronal degeneration in the context of virus-driven neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/40b63bf1f6fcbfab7da258e50a2adaf9994182d6" target='_blank'>
              Ceftriaxone attenuates Poly I:C–induced neuroinflammation in vitro by modulating glutamate transport, synaptic integrity, and immunometabolic reprogramming
              </a>
            </td>
          <td>
            Xizi Shi, Yesheng Sun, Shirin Hosseini, Fangfang Chen, Thekla Cordes, Kristin Michaelsen-Preusse, Martin Korte
          </td>
          <td>2025-10-28</td>
          <td>Frontiers in Cellular Neuroscience</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="Mutations or polymorphisms in GRN, encoding the CNS glycoprotein progranulin (PGRN), have been linked to several neurodegenerative diseases. In this study, we explored the role of PGRN in prion diseases. We observed that prion infection upregulated microglial PGRN expression. Following intracerebral inoculation with RML6 prions, Grn-/- mice exhibited accelerated disease progression compared to Grn+/- and Grn+/+ littermates. Histological analysis revealed augmented microglial activation in Grn-/- mice. Temporal analysis revealed enhanced early microglial activation and prion clearance at 120 dpi, followed by excessive complement activation but inadequate clearance by 150 dpi. Additionally, Grn-/- brains exhibited exacerbated astrogliosis and vacuolation. RNA-seq analysis indicated that complete PGRN deficiency in prion-infected mice shifted microglia from homeostatic to pro-inflammatory states. Notably, microglia-specific depletion of PGRN did not affect prion pathogenesis, suggesting that PGRN deficiency affects microglial activation and prion progression in a non-cell autonomous manner. These findings suggest that microglia respond to prion infection in a stepwise manner, and PGRN plays a critical role in modulating prion-induced microglial activation. Our results highlight the neuroprotective role of PGRN in prion disease and suggest that supplementation or boosting expression of PGRN could represent a promising therapeutic strategy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9ee59fe5ea0f47a6b4d9e13f7f501e11376bf5ad" target='_blank'>
              Ablation of progranulin augments microglial activation and accelerates prion progression
              </a>
            </td>
          <td>
            Bei Li, Yiyue Shi, Wenyu Hou, Haoyuan Guan, Jun Li, Tuo Yi, Wei Li, Donglin Cai, Petra Schwarz, Adriano Aguzzi, Caihong Zhu
          </td>
          <td>2025-10-13</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7dd7e2293a57dd4e62cbe09d1fa7709fea72127a" target='_blank'>
              Astrocytic FABP5 drives non-cell-autonomous oligodendrocyte injury in multiple system atrophy by promoting TNF signaling and ferroptotic stress
              </a>
            </td>
          <td>
            Chuantao Wu, Jiejing Lin, Yi Chen, Nozomi Takahashi, Qikai Chen, Baiyao Liu, Fangmeng Dai, Wenxue Zhao, David I. Finkelstein, I. Kawahata, Kohji Fukunaga, An Cheng
          </td>
          <td>2025-11-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="Elderly individuals represent a population at disproportionate risk for severe outcomes following SARS-CoV-2 infection. The humoral immune response critically controls viral replication and disease progression. However, the antibody responses and B-cell subsets to mutant strains of SARS-CoV-2 in elderly patients have not yet been fully elucidated. This study aims to elucidate the humoral immune response and B-cell subsets distribution in elderly patients infected with SARS-CoV-2 Omicron variant, thereby providing insights for identifying prognostic biomarkers and developing therapeutic strategies. Using enzyme-linked immunosorbent assays and pseudotyped virus neutralization assays, we determined plasma levels of RBD-specific IgA, IgM, IgG, and neutralizing antibodies from 46 elderly patients with SARS-CoV-2 Omicron variant infection within the first two weeks post-symptom onset (PSO). Using a multicolor flow cytometry approach, we analyze the frequencies of different B-cell subsets and assess the functional characterization of B-cells. In elderly non-severe patients, SARS-CoV-2 RBD-specific antibody levels (IgA, IgM, and IgG) increased progressively within the first two weeks post-symptom onset (PSO). In contrast, severe patients exhibited lower initial antibody levels during 0-3 days PSO but experienced a transient surge (11-fold for IgA, 12-fold for IgM, and 48-fold for IgG) during 4-7 days PSO, which was followed by a decline between 8-14 days. Despite this early elevated response in severe patients, both groups ultimately demonstrated generally weak neutralizing activity against the SARS-CoV-2 Omicron variant. Both elderly patient groups exhibited an higher proportion of plasmablasts (PB). Among these, class-switched IgM-IgG+ PB were significantly more abundant than IgM+IgG-PB. Notably, elderly severe patients showed a further lower in class-unswitched IgM+IgG-PB. Concurrently, IgA expression on PB was upregulated during early disease in all elderly patients. Beyond PB changes, IgG+double negative B (DNB) cells were higher than IgM+DNB cells in both groups. however, severe patients demonstrated a significant reduction in IgG+DNB cells frequencies. Furthermore, these elderly severe patients also exhibited a decline in co-stimulatory molecule expression (HLA-DR+CD80+) within both naive B (NB) and DNB cells, indicating a dysregulated humoral immune response. Elderly individuals generate RBD-specific and neutralizing antibody responses after SARS-CoV-2 Omicron variant infection, which correlate significantly with disease severity and infection duration. Clinically, these findings highlight the potential utility of antibody kinetics as prognostic biomarkers for stratifying elderly patients at high risk of severe outcomes, thereby informing tailored intervention strategies and vaccine booster optimization. Furthermore, SARS-CoV-2 Omicron variant infection affects the distribution of B-cell subsets, which may predict the long-term immune reconstitution capacity post-recovery. Notably, elderly patients exhibit pronounced PB expansion, a response pattern that facilitates antibody class-switching to enhance antiviral immunity. Such expansion represents a key immunologic feature in elderly patients with SARS-CoV-2 Omicron variant infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a46658b01f8e375d2ecb7d1a689cb7e49abb258f" target='_blank'>
              Differential immune profiles in elderly patients with non-severe versus severe SARS-CoV-2 omicron variant infection: dysregulation of antibody responses and B-cell subsets
              </a>
            </td>
          <td>
            Xue Li, Yuanyuan Li, Shiyang Liu, Juanjuan Zhou, Xinxin Yang, Junlian Yang, Wen Xu, Weiwei Chen
          </td>
          <td>2025-11-04</td>
          <td>Immunity & Ageing : I & A</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="As primary immune sentinels of the central nervous system (CNS), microglia respond rapidly to acute brain injury and engage in dynamic crosstalk with infiltrating peripheral immune cells. This interplay critically shapes the neuroinflammatory microenvironment—a key determinant of secondary brain injury (SBI) following intracerebral hemorrhage (ICH). Fatty acid-binding protein 4 (FABP4), an adipokine associated with metabolic disorders, is recognized as a pivotal modulator of inflammatory responses; however, its role in ICH-induced SBI remains undefined. To investigate the pathogenic functions of FABP4 in microglia after ICH, elucidate its molecular mechanisms, and develop targeted therapeutic strategies. Blood and brain tissue samples from ICH patients were analyzed to evaluate the relationships between FABP4 expression and prognosis. Behavioral tests, Nissl staining, and Golgi-Cox staining were used to quantify neuronal damage. Immunofluorescence and flow cytometry were used to assess microglial activation and immune cell infiltration. Transcriptomic, proteomic, co-immunoprecipitation, western blotting, and ChIP‒qPCR analyses were used to examine the FABP4 regulatory network. Brain-targeted nanoparticles were engineered to deliver FABP4-specific siRNA. Clinical analyses revealed microglia-specific FABP4 upregulation in ICH patients, correlating with poor neurological outcomes. Microglial Fabp4 knockout in mice attenuated neuronal loss, ameliorated cerebral edema, and enhanced functional recovery after ICH. Mechanistically, FABP4 promoted lipid droplet accumulation and inhibited the ubiquitin–proteasome-mediated degradation of S100A9 in microglia, synergistically amplifying neuroinflammation. Moreover, the activity of FABP4 in microglia facilitated neutrophil transendothelial migration into the brain parenchyma, exacerbating injury via the release of neutrophil extracellular traps (NETs). Finally, pharmacological FABP4 inhibition using brain-targeted nanoparticles conferred significant neuroprotective effects in ICH models. This study establishes that FABP4 acts as a novel orchestrator of post-ICH neuroinflammation through dual enzymatic and nonenzymatic pathways. We also demonstrate a targeted nanotherapeutic strategy to suppress FABP4 and improve neurological outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cbd6afea19f2780d62b43438f150276eb07542a8" target='_blank'>
              Fatty acid-binding protein 4 drives microglia-mediated neuroinflammation through promoting S100A9 expression and lipid droplet accumulation after intracerebral hemorrhage
              </a>
            </td>
          <td>
            Jiaqing He, Zijuan Qin, Haixiao Liu, Yaning Cai, Hao Wu, Tinghao Wang, Qing Hu, Yanni Xu, Pan Yang, Xun Wu, Yan Qu, Wei Guo
          </td>
          <td>2025-11-07</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="COVID-19 is a multi-system disease that affects not only the respiratory system but also the neurological, hematological, and immune cells and tissues. The understanding of how the virus infiltrates and impacts a diverse set of human cells is still incomplete. This work examined bulk RNA-seq data from recovered COVID-19 patients (COVID-19 survivors with or without post-acute complications) to uncover the persisting perturbations in biological pathways. The investigation also analyzed the transcriptomic signatures in the lungs and brain tissues of deceased patients during the acute phase of infection to understand COVID-19 impact on these organs. In recovered COVID-19 patients, the severity of acute COVID-19 influenced the subsequent disturbance of gene expression patterns in the post-acute disease phase. Gene expression patterns in the lungs and brain tissues of deceased COVID-19 patients correlate with the diverse pulmonary and neurological symptoms observed in these patients. We have detected significant alterations in the expression of mitochondrial genes, such as COX7C, COX7A2, ATP5PO, ATP5F1C and NDUFB8, which reflect a compensatory upregulation in response to viral suppression of mitochondrial function. This COVID-19 induced response persists up to 24 weeks post-infection, suggesting a sustained effort of the host to mitigate mitochondrial dysfunction. Additionally, in critical and severe COVID-19 cases, gradual upregulation of UBE3A expression was detected, which previously has been linked to favorable COVID-19 outcomes. Long-term anosmia related SHH gene was upregulated in recovered critically-ill COVID-19 patients. IL6 emerged as a central hub gene consistently expressed in both lung and brain tissues of deceased COVID-19 patients, underscoring its role in driving the inflammatory pathophysiology of COVID-19 within these organs. Collectively, our study emphasizes IL6 as a central cytokine driving the inflammatory response in both lung and brain tissues, and demonstrates the virus’s capacity to induce long-lasting changes in nuclear-encoded mitochondrial gene expression in the blood of recovered patients. Our findings have significant implications for developing targeted interventions for post-COVID-sequelae.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a404a8f1d8876ed3a8c4d5cb1c99d51ab2f6b6a8" target='_blank'>
              Peripheral blood, lung and brain gene signatures in recovered and deceased patients with COVID-19
              </a>
            </td>
          <td>
            Eric Twum, Ancha Baranova, Aman Ullah
          </td>
          <td>2025-10-22</td>
          <td>In Silico Pharmacology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/457edd651d4907a73956f326ac6e7f12061d9fc7" target='_blank'>
              Fluid-Niche and Microglial Signatures Prime Robust Intraventricular Macrophage Response to Blood During Brain Development
              </a>
            </td>
          <td>
            Miriam E. Zawadzki, C. Hehnly, Jordan C. Benson, Dario X. Figueroa Velez, Sivan Gelb, Ceva Stanley, Lillian I.J. Byer, Huixin Xu, Cameron Sadegh, Aja Pragana, Maria K. Lehtinen
          </td>
          <td>2025-10-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Recent advances in single-cell transcriptomics have led to the identification of disease-associated microglia (DAM) as a distinct, conserved microglia state associated with mouse models of Alzheimer’s disease (AD) and amyotrophic lateral sclerosis, and with aging. DAM are characterized by downregulation of homeostatic genes and upregulation of lipid metabolism and phagocytosis genes, including key risk factors for AD in humans. Although characterized in models of AD, whether DAM acts as universal sensor across all neurodegenerative diseases remains unknown. This Essay discusses the dynamics, origins, and therapeutic potential of DAM in neurodegeneration, alongside evidence supporting a protective role for them in regulating disease processes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5bad4366689126c5807b6043f573a793e1757f43" target='_blank'>
              Disease-associated microglia in neurodegenerative diseases: Friend or foe?
              </a>
            </td>
          <td>
            Yi-Hsuan Cheng, Margaret S. Ho
          </td>
          <td>2025-10-01</td>
          <td>PLOS Biology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Introduction Despite extensive research, the pathogenesis and predispositions underlying long COVID (long-term coronavirus disease 2019) remain poorly understood. Methods To address this, we analyzed the immunological landscapes of 44 patients with long COVID and 44 matched convalescents using single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) and validated the findings with plasma cytokine measurements via Luminex technology. Results While the immune cell compositions showed minimal quantitative differences only among natural killer (NK) cells, the transcriptome analyses identified distinct gene expression patterns, particularly in classical monocytes: patients with long COVID exhibited downregulation of the inflammation-associated genes, including IL1B and CXCL2. Imputation of the transcription factor activity hinted at a reduced inflammasome activity (via SNAI1) and an impaired monocyte differentiation (via ATF2) in long COVID. The RNA velocity data supported the presence of immature classical monocytes in these patients. Discussion These findings show that monocytes might be dysregulated and/or exhausted in patients with long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3892a0439deb222191d646b042b2e39ae2bf0fef" target='_blank'>
              Transcriptome analysis of classical blood cells reveals downregulation of pro-inflammatory genes in the classical monocytes of long COVID patients
              </a>
            </td>
          <td>
            Florian Fricke, Franz Mai, Christine Wossidlo, Felix Steinbeck, Wendy Bergmann-Ewert, Marcel Kordt, Karin Kraft, Britta Müller, Emil C. Reisinger, Brigitte Müller-Hilke
          </td>
          <td>2025-11-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Immunosuppressive therapies used in clinics to reduce the risk of rejection in transplanted patients unfortunately also decrease the response of the immune system to the pathogens. Previous data has shown that the most diffuse SARS-CoV-2 variants of concern between 2020 and 2021 showed a different modulation of the host immune response in healthy subjects, with the Delta B.1.617.2 variant leading to a failure in the activation of the adaptive immune response. In this study, the transcriptomic profiles of monocyte-derived macrophages (MDM), isolated from four immunosuppressed kidney transplant patients and exposed to SARS-CoV-2 VOCs, were analyzed and compared with previously published data gathered from immune-competent subjects. Human monocytes were isolated from peripheral blood mononuclear cells (PBMCs) of four kidney transplant patients admitted to the IRCCS Policlinico San Matteo of Pavia (Italy), differentiated into macrophages, and exposed to the active and the UV-inactivated particles of the different SARS-CoV-2 VOCs (D614G, Alpha B.1.1.7, Gamma P.1, Delta B.1.617.2 and Omicron BA.1). Bulk RNA-Seq was performed and significant transcripts were assessed based on Student’s t-test (p-value < 0.05) and Fold change > 2. RNA-Seq data analyses of immunosuppressed MDMs showed that SARS-CoV-2 VOCs, although transcriptionally active, did not induce strong alterations in the transcriptomic profiles of these cells, while a strong down-regulation of key genes involved in the innate immunity pathways was observed when comparing these data to the ones obtained from immunocompetent participants. Overall, this study suggests that patients under immunosuppressive therapies do have an altered macrophage response to SARS-CoV-2 viral infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/04f26f9af852ab5923f6e34e833030407d8ac128" target='_blank'>
              Attenuated Molecular Response to SARS-CoV-2 in MDMs Isolated from Immunosuppressed Transplanted Patients
              </a>
            </td>
          <td>
            Roberta Vazzana, J. Sammartino, N. Cuscino, Roberto Giambruno, C. Carcione, V. Miceli, Matteo Bulati, Valentina Agnese, D. Lilleri, P. Conaldi, Fausto Baldanti, I. Cassaniti, Alessia Gallo
          </td>
          <td>2025-10-28</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="Mpox re-emerged globally in 2022 with atypical clinical features and efficient human-to-human transmission, which underscores the need to better understand host immune responses. We conducted an integrative transcriptomic analysis of mpox virus (MPXV) infection in nonhuman primates by leveraging RNA-Seq datasets from whole-blood and skin. We applied the Generalized Linear Model with Quasi-Likelihood F-test and Magnitude-Altitude Score (GLMQL-MAS), a method that combines rigorous statistical testing with a ranking metric to identify and prioritize differentially expressed genes (DEGs), and the Cross-Magnitude-Altitude Score (Cross-MAS) gene selection strategy, which integrates results across multiple time points to identify reproducible signatures, to define compact and robust markers of infection. Longitudinal analysis of whole-blood revealed a staged immune trajectory: early induction of interferon-stimulated genes (IFI27, ISG15) was followed by proliferative and hematopoietic programs and later enrichment of adaptive immune signatures, including B cell activation and TNF signaling. A minimal six-gene panel (IFI27, ISG15, MYO7B, HEY1, VASH1, CNTD2) distinguished infected from control animals with 100% accuracy in both training and independent held-out test sets. In contrast, skin transcriptomes showed upregulation of keratinocyte-related genes (KRT10, KRT1, SOSTDC1) and downregulation of immune mediators (IL1B, CXCL8, S100A8, ISG15), which suggests epithelial remodeling with limited local immune activation. Cross-tissue comparisons revealed that under stringent criteria (BH-adjusted p-value < 0.05 and |log₂FC|> 1), only 10 genes were commonly significant between whole-blood and skin, and all (100%) exhibited opposite regulation. When thresholds were relaxed for exploratory purposes (unadjusted p-value < 0.05 and |log₂FC|> 1), 58 common significant immune-related genes were identified from the curated nCounter® Host Response Panel, of which 74.1% were oppositely regulated. Shared immune genes such as ISG15, MX1, IFIT2, and OAS2 were upregulated in blood but suppressed in skin, and Reactome enrichment of discordant genes highlighted interferon and cytokine signaling pathways. These contrasts suggest that MPXV may trigger systemic interferon activation while suppressing local antiviral responses in lesions; however, because they are derived from independent secondary datasets in different species, they should be regarded as hypothesis-generating signals that require confirmation in matched, longitudinal studies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f42e167ab73e8ee0f1b9da83613dfa3150236874" target='_blank'>
              Opposite regulation of immune genes in blood and skin highlights tissue-specific dynamics of mpox virus
              </a>
            </td>
          <td>
            Mostafa Rezapour, Sean V. Murphy, D. Ornelles, Patrick M. McNutt, Anthony Atala
          </td>
          <td>2025-11-07</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Mpox virus (MPXV), a member of the Orthopoxvirus genus in the Poxviridae family, has long been endemic in Africa. The interaction between MPXV infection and peripheral immune responses is of great significance. However, the activation of signaling pathways and molecular changes in peripheral blood mononuclear cells (PBMCs) following MPXV infection remain poorly understood. This study evaluated the transcriptomic profiles of rabbit PBMCs during the mpox acute and recovery phases. The results showed that MPXV infection significantly altered the transcriptomic profiles of PBMCs. At 6 days post-infection, pathways related to pathogenic infection and IL-1 response were enriched, while at 14 days post-infection, the T cell receptor signaling pathway was enriched. During the mpox acute phase, inflammatory cytokines in serum such as IL-1α, IL-1β, IL-8, and IL-21 were upregulated, while MMP-9 and NCAM-1 were downregulated. In rabbits and rhesus monkeys, key genes upregulated in common during the mpox acute period were associated with the interferon pathway (e.g., the ISG15, OAS, and IFIT families), while downregulated genes were related to B-cell activation and differentiation (e.g., the MS4A1 and FCRL families). Additionally, rabbits developed protective immunity against reinfection, with neutralizing antibodies effectively activated. These findings provide insights into the molecular characteristics of PBMCs changes in in vivo models of MPXV infection, and offer references for the diagnosis, vaccine development, and therapeutic research of mpox.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5a49c159e81a5446db89fd6f6f36a9c258007cfb" target='_blank'>
              Transcriptome Analysis Reveals Host Peripheral Blood Mononuclear Cells Response to Mpox Virus Infection
              </a>
            </td>
          <td>
            Chaode Gu, Caiyun Wang, Chenlu Zhang, Jie Ni, Yun Xia, Hongwei Wang
          </td>
          <td>2025-09-28</td>
          <td>Viruses</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Patients recovering from post-coronavirus disease 2019 (COVID-19) often experience cognitive dysfunction, including difficulties with focusing, conversation, or memory issues, which can persist for weeks or even months after infection. Although the persistence of the SARS-CoV-2 spike protein has been reported in both the brain and serum, and is thought to potentially contribute to the long-term effects of SARS-CoV-2 infection on the brain, the underlying mechanisms leading to cognitive dysfunction remain unclear. This study investigates the molecular mechanisms by which the SARS-CoV-2 S1 protein (hereafter S1) induces cognitive impairment and explores the therapeutic potential of metformin in mitigating these effects. We demonstrate that intranasally administered S1 quickly entered the hippocampus and was associated with cognitive impairment by 6 weeks post-injection. Transcriptomic analysis of hippocampal tissue revealed early alterations in gene expression associated with synaptic function. We observed that the expression of hypoxia-responsive genes was also altered, suggesting the involvement of HIF-1α signaling. Further analysis confirmed that S1 stabilized the HIF-1α protein in a hypoxia-independent manner, and siRNA-mediated knockdown of HIF-1α restored synaptic gene expression, including GRIN2A, SHANK1, and JPH3. By 6 weeks post-injection, hippocampal neuronal loss was accompanied by the accumulation of phosphorylated tau (p-tau) and aggregated α-synuclein. Notably, treatment with metformin rescued synaptic gene expression and attenuated p-tau and α-synuclein aggregation. These findings suggest that S1 disrupts synaptic homeostasis and promotes neurodegenerative processes, and that metformin may serve as a potential therapeutic strategy to mitigate long-term cognitive sequelae of COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/84de4b7486f57559b1501422871292c22c896ef0" target='_blank'>
              SARS-CoV-2 spike protein causes synaptic dysfunction and p-tau and α-synuclein aggregation leading cognitive impairment: The protective role of metformin
              </a>
            </td>
          <td>
            Hye-Kyung Lee, Ji-Young Choi, Jung Hyun Park, Moon Han Chang, Jung Ho Park, Young Ho Koh
          </td>
          <td>2025-11-07</td>
          <td>PLOS One</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Understanding Alzheimer’s disease (AD) at the cellular level requires insights into how diverse cell types respond to hallmark pathologies, including amyloid plaques and tau aggregates. Although single-cell transcriptomic approaches have illuminated the trajectories of AD progression in both animal models and human brains, they often lack the spatial context necessary to fully comprehend cell–cell interactions and microenvironmental influences. In this review, we discuss recent advances in spatial transcriptomics—integrating both imaging- and sequencing-based methods—that map gene expression within intact brain tissues. We highlight how these technologies have revealed regional heterogeneity and functional diversity among microglia, and their dynamic interactions with astrocytes, neurons, and oligodendrocytes in both aging and AD. Emphasis is placed on the interactions of microglia within the amyloid plaque niche, their contribution to synaptic degeneration, and how aging accelerates microglial and glial activation. By synthesizing findings from AD mouse models and physiologically characterized human tissues, we provide a comprehensive view of the cellular interplay driving AD pathogenesis and offer insights into potential therapeutic avenues.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/72aed1e9c6c402508fd3f06875f598180ad2a5a8" target='_blank'>
              Microglia networks within the tapestry of alzheimer’s disease through spatial transcriptomics
              </a>
            </td>
          <td>
            Yi Zhou, Christopher K. Glass
          </td>
          <td>2025-09-29</td>
          <td>Molecular Neurodegeneration</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Introduction Long COVID (LC) affects approximately 10% of individuals post-SARS-CoV-2 infection, with symptoms persisting beyond 12 weeks. The underlying mechanisms remain unclear, and current models often focus on pre-existing comorbidities. Methods This cohort study aimed to identify robust biomarkers and clarify LC pathogenesis through a comprehensive analysis performed in 32 LC individuals 26 months post-infection compared with 35 fully recovered individuals recruited between March and July 2022. Blood and fecal samples were collected, and multiple parameters associated with immune dysfunction, endothelial damage, bacterial translocation, and coagulation alterations, alongside signs of viral persistence and sociodemographic and clinical features, were analyzed. Results Although viral RNA was undetected on blood or stool, elevated plasma IgG against the nucleocapsid may indicate frequent reinfections, greater infection severity, or delayed immune normalization. Increased levels of prothrombin, thrombin, fibrinogen, sEPCR, and CRP pointed to persistent endothelial dysfunction and coagulation imbalance. Lower levels of the bactericidal protein REG3A suggest potential disruptions in mucosal immune response. We found no major differences in traditional comorbidities, highlighting that LC may stem from distinct pathogenic mechanisms beyond pre-existing conditions. Importantly, our study revealed impaired humoral immunity and identified an association between vaccine heterogeneity and increased LC risk, emphasizing the relevance of consistent vaccination strategies. A Random Forest model using the measured biomarkers achieved 100% accuracy in classifying LC individuals, reinforcing their diagnostic potential. Discussion These findings support a multifactorial model of LC involving immune dysregulation and persistent endothelial damage that led to coagulation abnormalities and a pro-thrombotic profile, supporting that LC is more closely related to a sustained, uncontrolled inflammatory response rather than immunodeficiency, and underscoring the value of multidimensional biomarker profiling for guiding clinical management and prevention strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/06f623d391f1681dd1b187cc2fd209fa57362606" target='_blank'>
              Immune dysregulation and endothelial dysfunction associate with a pro-thrombotic profile in Long COVID
              </a>
            </td>
          <td>
            Alicia Simón-Rueda, Clara Sánchez-Menéndez, G. Casado, Daniel Fuertes, María Aránzazu Murciano-Antón, E. Mateos, Susana Domínguez-Mateos, Francisco Pozo, Javier García-Pérez, M. Pérez-Olmeda, Miguel Cervero, M. Massanella, Gemma Moncunill, Montserrat Torres, M. Coiras
          </td>
          <td>2025-10-16</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d6db7c438373e1be32f3e8f8962c7eb002d2e0ff" target='_blank'>
              Single-cell profiling reveals that dynamic lung immune responses distinguish protection from susceptibility to tuberculosis
              </a>
            </td>
          <td>
            Fergal J. Duffy, M. L. Neal, Courtney R. Plumlee, Sarah Cohen, B. Gern, A. Diercks, Michael Y Gerner, K. Urdahl, J. Aitchison
          </td>
          <td>2025-10-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="At birth, the mucosal immune system of neonates is not fully developed, making them more susceptible to respiratory and intestinal diseases. Previously described host‐directed therapies using toll‐like receptor (TLR) activation‐based strategies have proven effective in controlling neonatal diseases, including cryptosporidiosis. In this study, we investigated the effect of nucleotide‐binding oligomerization domain (NOD) receptors stimulation on the control of enteric infection by the protozoan Cryptosporidium parvum in neonatal mice. NOD2 stimulation by intraperitoneal injection of muramyl dipeptide (MDP) resulted in a rapid reduction in the parasite burden. The protective effect was associated with increased pro‐inflammatory cytokine and antimicrobial peptide gene expression and a rapid influx of neutrophils to the site of infection, whereas NOD1 stimulation did not show a protective effect. The protective mechanism did not involve microbiota participation but involved IFN‐γ and IL‐22 cytokines and was associated with increased intestinal epithelium renewal in infected neonates. Our findings showed that stimulating neonatal mice with the bacterial ligand MDP, which targets the NOD2 receptor, actively contributes to the nonspecific clearance of C. parvum infection by eliminating or renewing infected epithelial cells.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/401f962b1ff15853d44a39d0ba2bd5cf546d9e2e" target='_blank'>
              Administration of the NOD2 Agonist MDP Reduces Cryptosporidium parvum Infection in Neonatal Mice Through IL‐22 Involvement
              </a>
            </td>
          <td>
            Mégane Fernandez, T. Pezier, Julien Pichon, Y. L. Vern, C. Werts, S. Lacroix-Lamandé
          </td>
          <td>2025-10-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="Lung mononuclear phagocyte (MNP) subsets differ in their ability to restrict Mycobacterium tuberculosis (Mtb) during chronic infection, yet the mechanisms underlying this difference are not well defined. Here, we show that CD11clo monocyte-derived cells (MNC1), the subset of lung cells that is most permissive for Mtb viability during chronic infection, express lower levels of interferon-gamma (IFNγ) signaling proteins, resulting in reduced responses to IFNγ compared to alveolar macrophages (AM) and CD11chi MNC2. Moreover, type I IFN signaling suppresses IFNγ-mediated MHC-II expression, impairing CD4 T cell activation by MNC1 cells. Importantly, prior immunity conferred by contained Mtb infection enhances IFNγ responsiveness of monocyte-derived cells, reducing bacterial burdens in lungs and within MNC subsets. Our findings indicate that heterogeneous IFNγ responsiveness is exploited by Mtb for persistence in vivo. Overcoming or bypassing impaired IFNγ responsiveness may guide the development of more effective TB vaccines and host-directed therapies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1185bf27cd38b33e534c27d9aa87381e2cd898fa" target='_blank'>
              Impaired IFNγ responsiveness of monocyte-derived lung cells limits immunity to Mycobacterium tuberculosis
              </a>
            </td>
          <td>
            Weihao Zheng, J. Limberis, Zachary P. Howard, Alexander Mohapatra, Enzo Takagi, J. Ernst
          </td>
          <td>2025-11-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2fef0ecf5b990a10a1f0fae7554cfa28ceb163d2" target='_blank'>
              SARS-CoV-2-induced damage to rat cortical neuronal networks ex vivo is mediated by the pro-inflammatory activation of the cGAS-STING pathway.
              </a>
            </td>
          <td>
            Pamela Martinez-Orellana, Matteo Manzati, Diletta Pozzi, Yingying Xiao, Alessio Di Clemente, Marika Mearelli, Chiara Kalebić, Valentina Perrera, Denise Ferrarini, Tea Carletti, Carmen Falcone, Michele Giugliano, Alessandro Marcello
          </td>
          <td>2025-10-25</td>
          <td>Journal of neurovirology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Despite effective viral suppression with antiretroviral therapy (ART), people living with HIV (PLWH) experience persistent inflammation, immune dysfunction, and premature onset of cardiovascular and aging-related comorbidities. To define the underlying mechanisms, we performed longitudinal transcriptomic profiling in peripheral blood mononuclear cells (PBMCs) from a cohort of simian immunodeficiency virus (SIV)-infected rhesus macaques spanning four key stages: pre-infection, acute infection, short-term ART, and long-term ART. Bulk RNA sequencing revealed dynamic immune remodeling across infection and treatment. Acute SIV infection induced robust antiviral and inflammatory programs, with upregulation of interferon-stimulated genes (ISGs), IL-27, JAK/STAT, and NF-κB signaling, coupled with suppression of T- and B-cell activation pathways. Short-term ART effectively reversed these transcriptional perturbations, restoring adaptive immune gene expression and reducing innate antiviral responses to near-baseline levels. In contrast, chronic SIV infection on long-term ART maintained viral suppression but was characterized by reactivation of innate immune pathways, including TLR2/TLR4/MYD88, NF-κB, and inflammasome (NLRP3/or NLRP12, caspase-1) signaling, along with sustained macrophage activation, platelet/coagulation signaling, and senescence-associated secretory phenotype. Protein analyses confirmed persistent CASPASE-1 and NF-κB activation in spleen tissue. Pathologic evaluation of a carotid artery from an SIV-infected, long-term ART– treated macaque revealed macrophage-rich plaques with p21⁺ senescent cells with intraluminal thrombus formation, recapitulating key features of HIV-associated atherogenesis. Together, these findings demonstrate that while ART normalizes acute infection–induced immune dysregulation, chronic SIV infection sustains a chronic, macrophage- and TLR-driven inflammatory state linked to vascular injury and aging process regardless of long-term suppression of viremia. Targeting inflammasome, NF-κB, and senescence pathways may mitigate non-AIDS comorbidities in PLWH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c7a8f96a2324d1327914a92bba9009e04dbf070e" target='_blank'>
              Persistent Activation of Monocytes/Macrophages and Cell Senescence in SIV-Infected Macaques on ART
              </a>
            </td>
          <td>
            Yilin Chen, Xiaofeng Ding, Sonalika Ray, Siva Thirugnanam, Robert V. Blair, Ahmad Saied, S. Sukhanov, J. Kolls, Woong-Ki Kim, P. Delafontaine, Jay Rappaport, Xuebin Qin, Namita Rout
          </td>
          <td>2025-11-06</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>46</td>
        </tr>

        <tr id="Background: The COVID-19 pandemic prompted investigation into the interaction between SARS-CoV-2 infection and immune checkpoint inhibitor (ICI) therapy in lung cancer patients. Understanding this interplay is crucial for optimizing cancer immunotherapy. Methods: A retrospective analysis was conducted on lung cancer patients, characterizing changes in peripheral immune cells and plasma cytokines (including IL-10 and IL-12p70) before, during, and after SARS-CoV-2 infection. Progression-free survival (PFS) was compared between ICI-treated patients with and without COVID-19. Cytokine dynamics were further analyzed in a non-infected cohort. Results: SARS-CoV-2 infection induced a prolonged systemic cytokine storm, with elevated IL-10 and IL-12p70 levels and reduced monocyte proportions lasting up to 10 weeks post-recovery. Despite this immune perturbation, COVID-19 did not impair long-term PFS; instead, a transient improvement in disease control was observed in infected patients. In non-infected patients, sustained or increased IL-10 and IL-12p70 levels during ICI therapy were associated with longer PFS (p < 0.05). Conclusions: SARS-CoV-2 infection transiently alters the immune landscape in lung cancer patients without compromising ICI efficacy. The sustained elevation of IL-10 and IL-12p70 may contribute to short-term clinical benefits. Monitoring cytokine dynamics could serve as a prognostic tool for predicting ICI response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/751116a96b162ead6a92605da6ef16112bc11bf9" target='_blank'>
              SARS-CoV-2 Infection Alters the Immune Microenvironment in Lung Cancer Patients Undergoing Immunotherapy and Affects Treatment Outcomes
              </a>
            </td>
          <td>
            Yanjing Peng, Panjian Wei, Meng Gu, Guirong Wang, Teng Ma, Jinjing Tan
          </td>
          <td>2025-09-28</td>
          <td>Viruses</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c67902287b707e2a864fa94a99930bc5171cdb8e" target='_blank'>
              Susceptibility of Human Neural Stem Cells to SARS-CoV-2: Entry Mechanisms and Glycocalyx Influence
              </a>
            </td>
          <td>
            Ann Song, Cori Zuvia, P. Talbot
          </td>
          <td>2025-11-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="Introduction Neuroinflammation is a critical factor contributing to secondary brain injury following traumatic brain injury (TBI). This process engages diverse cell types within the central nervous system (CNS), including significant infiltration of myeloid lineage cells–primarily neutrophils and macrophages–during the acute and subacute phases of TBI. These myeloid-derived cells represent a major population that critically influences the development and progression of neuroinflammation. Microglia and peripherally infiltrating macrophages exhibit polarization phenotypes that play a pivotal role in modulating inflammatory changes. Due to their functional and phenotypic similarities, their distinct contributions to the inflammatory response in TBI remain a subject of considerable debate. Lysozyme 2 (Lyz2) is a well-established marker for myeloid lineage cells (including monocytes, macrophages, and neutrophils) in mice, allowing specific targeting and depletion of these cells to dissect their functional roles in TBI. Methods In the present study, we investigated the trend of inflammatory factors during the early stage of TBI using Lyz2-IRES-DTREGFP transgenic mice, which specifically target and deplete Lyz2-positive myeloid cells. Tissue samples for RT-qPCR and flow cytometry were harvested from the perilesional cortex (within a 2-mm radius of the impact site) and the underlying hippocampus. Results and discussion Our findings revealed a considerable reduction in the expression of pro-inflammatory factors (e.g., IL-1β, iNOS, IL-6, IFN-γ) and an increase in the expression of anti-inflammatory factors (e.g., IL-4, IL-10, IL-13, Arg-1). Furthermore, we observed a shift in polarization phenotypes, characterized by a decreased proportion of M1 macrophages and an increased proportion of M2 macrophages. However, during the chronic phase, behavioral and histological analyses revealed worse outcomes. These findings demonstrate that targeted depletion of Lyz2-positive myeloid cells during acute TBI attenuates neuroinflammation. However, this early immunomodulatory shift correlates paradoxically with exacerbated chronic neurological deficits, suggesting that transient suppression of myeloid-driven inflammation may disrupt long-term reparative processes critical for functional recovery after TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f2b62a25efa9a7379563b95a2c6aaa7cdabd0939" target='_blank'>
              Dual role of Lyz2-positive myeloid cells in traumatic brain injury: acute anti-inflammatory effects vs. chronic neurological deterioration
              </a>
            </td>
          <td>
            Hua-Zheng Yan, Yi-Wan Fang, Shi-Yu Zhou, Jian-Xiong Gao, Ming-ming Bian, Yao-Mei Xu, Lin Zhang, Nan Zhang, He-Zuo Lü
          </td>
          <td>2025-10-07</td>
          <td>Frontiers in Cellular Neuroscience</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c16fa24cd98d9256f720e2572ee30a101c020f82" target='_blank'>
              Spatial analysis reveals the cellular microenvironments and mechanisms of inflammation and kidney injury in acute interstitial nephritis
              </a>
            </td>
          <td>
            Megan L. Baker, Vijayakumar R. Kakade, Tifanny Budiman, Marlene Weiss, Joseph M. Cunningham, Sagar Sadarangani, Gabriel Lerner, Gilbert W. Moeckel, Avi Z. Rosenberg, C. Parikh, Y. Kluger, D. Moledina, Lloyd G. Cantley
          </td>
          <td>2025-10-30</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>69</td>
        </tr>

        <tr id="BACKGROUND
Severe fever with thrombocytopenia syndrome (SFTS), caused by Dabie bandavirus (DBV) infection, is characterized by early cytokine storm as a primary pathological feature, although the precise mechanisms remain unclear. Low-density neutrophils (LDNs) are elevated in the peripheral blood of patients with autoimmune or infectious diseases and are closely associated with inflammatory damage and disease severity. However, the pathogenic contribution of LDNs to the progression of SFTS is largely unexplored. This study employed single-cell RNA sequencing (scRNA-seq) to profile the transcriptomic characteristics of LDNs during the acute phase of SFTS, aiming to reveal their compositional and functional heterogeneity following DBV infection, explore their role in the cytokine storm, and further understand their impact on disease progression.


METHODS
Cells were isolated from 13 acute-phase SFTS patients with varying disease severity and 3 healthy controls using density gradient centrifugation, followed by preparation of single-cell suspensions for 3'-end scRNA-seq. Sequencing data were processed using the Seurat pipeline, including dimensionality reduction, clustering, cell-type annotation, and visualization with Uniform Manifold Approximation and Projection (UMAP). Low-density granulocytes (LDGs) and their subclusters were identified using canonical gene markers. Functional enrichment of differentially expressed genes (DEGs) was analyzed by high-dimensional Weighted Gene Co-expression Network Analysis (hdWGCNA), Gene Ontology (GO), AddModuleScore, single-sample Gene Set Enrichment Analysis (ssGSEA), and immune-related Gene Set Enrichment Analysis (irGSEA), while cellular interactions were explored using CellCall.


RESULTS
1. Compositional heterogeneity: The proportion of LDNs in peripheral blood increased in SFTS patients with greater disease severity during the acute phase. 2. Functional heterogeneity: (1) LDN subclusters showed functional diversity but consistently displayed pro-inflammatory or anti-infective properties. (2) With intensification of the systemic inflammatory response, the expression of multiple cytokine genes (e.g., IL6, IL8, TNFA) and gene sets of the inflammatory pathway (e.g., TNFA-SIGNALING-VIA-NFKB, INFLAMMATORY-RESPONSE) were significantly upregulated in LDNs. Concurrently, the expression of gene sets of type I interferon response pathway (e.g., INTERFERON-ALPHA-RESPONSE, INTERFERON-GAMMA-RESPONSE) and genes of interferon-induced antiviral proteins (e.g., EIF2AK2, OAS1, MX1) were also elevated. (3) In severe cases, glucocorticoid therapy downregulated expression of these inflammatory genes, demonstrating anti-inflammatory effects but potentially increasing infection risk.


CONCLUSIONS
This study revealed an increased proportion and heightened pro-inflammatory activity of LDNs during the acute phase of SFTS, closely correlating with disease severity. These findings suggest that LDNs may serve as potential early-warning biomarkers for predicting severe progression in patients with SFTS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/62012696e9ca27f0eac4cc9d153a1400a881b2d3" target='_blank'>
              Single-cell Analyses Highlight the Proinflammatory Contribution of Low-density Neutrophils in the Acute Phase of Severe Fever With Thrombocytopenia Syndrome.
              </a>
            </td>
          <td>
            Jiaying Zhao, Chunhui Wang, Ke Jin, Yan Dai, Yaqin Zhang, Tingting Zhou, Zhan Yang, Tao Yang, Yuan Liu, Nannan Hu, Yinghua Mao, Chuanlong Zhu, Ping Shi, Xuewei Sun, Jin Zhu, Jun Li
          </td>
          <td>2025-09-29</td>
          <td>Frontiers in bioscience</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Abstract Janus kinase inhibitors (JAKis) are widely prescribed for autoimmune diseases, but their use is associated with increased infection risk. The mechanisms underlying this susceptibility remain unclear. CD8 T cells play a central role in antimicrobial defense, yet little is known about how JAKis reprogram their activation and effector programs. Here, we investigated naïve and memory CD8 T cells from healthy donors stimulated in vitro with baricitinib, tofacitinib, or upadacitinib. Flow cytometry, SCENITH, transmission electron microscopy, and RNA-seq were used to evaluate metabolic and functional programs. We found that JAKis uncoupled phenotypic activation from metabolic reprogramming. Functionally, JAKi-treated CD8 T cells exhibited reduced activation and produced lower amounts of cytokines and cytotoxic molecules. Notably, even JAKi-treated memory CD8 T cells that upregulated CD69 and CD25 failed to engage glycolysis, showing decreased GLUT1 expression and glucose uptake. SCENITH profiling confirmed diminished glucose dependence and a shift toward mitochondrial reliance, despite reduced mitochondrial potential and structural alterations. Transcriptomic and protein analyses further revealed decreased mTOR activity and increased p53-associated transcripts, consistent with impaired growth and stress signaling. CD8 T cells from rheumatoid arthritis patients under JAKi therapy were analyzed ex vivo for translational validation. These cells showed similar metabolic and signaling alterations, underscoring their clinical relevance. Altogether, these findings identify JAKis as disruptors of metabolic and signaling pathways in CD8 T cells, providing a mechanistic link between impaired effector function and the increased infection risk observed in treated patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3631e94d8c181426251424980791a3b091872438" target='_blank'>
              Disruption of metabolic licensing by JAK inhibitors constrains CD8 T cell activation and effector function
              </a>
            </td>
          <td>
            Eva Acosta Rodriguez, Luisina Onofrio, Carolina Abrate, Ingrid Strusberg, Liliana Morales, Danilo Ceschin, Carolina Montes, Cinthia Stempin
          </td>
          <td>2025-10-27</td>
          <td>Research Square</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Long COVID (LC) is characterized by a wide range of symptoms, the causes of which remain unclear. We investigated associations between inflammatory and coagulation factors, adaptive immune response to SARS-CoV-2, and LC. We enrolled 196 unvaccinated individuals with SARS-CoV-2 (March–June 2020). Blood samples were collected at three (T3M) and twelve (T12M) months post infection. Plasma concentrations of coagulation factors (D-Dimer, E-Selectin, ICAM-1, VCAM-1) and inflammatory markers (IL-6, IL-8, TNF-α, IL-1β) were measured by ELISA, and SARS-CoV-2-specific T-cell response was assessed by Elispot. LC occurred in 66/196 patients (34%); 77.8% had been hospitalized. Respiratory symptoms were present in 54%, fatigue in 30%, and neuropsychological symptoms in 14%. At T3M, hospitalized patients exhibited higher levels of ICAM-1, VCAM-1, and IL-6, along with increased immunoreactivity. LC patients exhibited elevated IL-8 and TNF-α and enhanced immunoreactivity at T3M, though these differences were not observed at T12M. Inflammatory and coagulation markers were altered at three months after acute infection, with some changes persisting at one year, suggesting a long-term immunological impact of SARS-CoV-2 on the inflammatory response. A SARS-CoV-2-specific T-cell response was still detectable at T12M, albeit at a lower level than at T3M, suggesting the persistence of protective memory T-cells beyond the acute phase.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/661662040cb49d22a81b08c21000921af6c27b9d" target='_blank'>
              Inflammatory Milieu and Specific T-Cell Response Observed Three Months and One Year After SARS-CoV-2 Infection in Long COVID Subjects
              </a>
            </td>
          <td>
            E. Cimini, A. Vergori, C. Cimaglia, Eleonora Tartaglia, S. Notari, F. Colavita, G. Matusali, I. Mastrorosa, V. Mazzotta, P. Chinello, P. Mencarini, M. L. Giancola, A. Abdeddaim, R. Casetti, G. Grassi, Simona Gili, Flavia Cristofanelli, F. Maggi, P. Piselli, E. Girardi, A. Antinori, M. Camici
          </td>
          <td>2025-10-27</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/23255e236b243137831746d2bc7daea27bf313a4" target='_blank'>
              Circulating cell-free RNA reflects inflammatory and airway remodeling signatures in an equine model of asthma
              </a>
            </td>
          <td>
            Birong Zhang, Hanna Agdour, M. Riihimäki, Sanni Hansen, Amanda Raine
          </td>
          <td>2025-10-26</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="
 Background:
 SARS-CoV-2 and influenza infections are associated with an increased risk of cardiovascular events. While the underlying mechanisms remain incompletely defined, mounting evidence points towards endothelial dysfunction and thrombotic activation, caused either directly or indirectly by viral infection.


 Aims:
 We sought to characterise the temporal effects of mild SARS-CoV-2 and H3N2 influenza infection on plasma biomarkers of endothelial, thrombotic and renal function.


 Methods:
 Plasma samples were collected from healthy volunteers enrolled in SARS-CoV-2 (n=7-10) and H3N2 (n=7-11) human challenge studies. Samples were taken at baseline (day 0/–1) and at days 3, 7, 10, 14, and 28 post-inoculation. Commercial ELISAs/colorimetric assays were used to quantify endothelial dysfunction using biomarkers of endothelial-mediated vasomotor control (endothelin-1, nitrate/nitrite, prostacyclin, ADMA, arginine), thrombosis (sCD40L, P-selectin, PSGL-1, tPA, PAI-1, D-dimer, factor IX), and renal function (uromodulin, NGAL, cystatin C, TFF3, OPN). One-way ANOVA, or a mixed effects model, and Dunnet’s test to correct for multiple comparisons, were used to compare baseline biomarker levels with levels at subsequent timepoints.


 Results:
 Infection with SARS-CoV-2 significantly increased thrombosis biomarkers (Figs. 1&2): P-selectin (p=0.025), PSGL-1 (p=0.024), sCD40L (p=0.048), PAI-1 (p=0.008) and tPA (p=0.006&0.008) at days 7 to 14. In contrast, infection with H3N2 resulted in a significant increase in D-dimer levels at day 14 (p=0.025) and no changes in other biomarkers of thrombosis. No changes from baseline were detected in biomarkers of endothelial dysfunction in either group. Uromodulin levels declined by day 28 in the SARS-CoV-2 group (p=0.034), otherwise no changes in biomarkers of renal function were noted in either group.


 Conclusions:
 There are two striking results of this study. Firstly, that for both H3N2 and SARS-CoV-2 infection, it was markers of platelet activation/thrombosis, without changes in endothelial or renal function, that increased after infection. Secondly, that a broader spectrum of these markers was increased in volunteers infected with SARS-CoV-2. These findings suggest distinct thrombotic mechanisms are activated by SARS-CoV-2 and H3N2 and support further investigation of thrombotic profiles in patients infected with other respiratory viruses allowing for strategies to identify and mitigate associated cardiovascular events.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/107604fa6ee17ee4f404ea6d1e3e14fcc6268770" target='_blank'>
              Abstract 4367854: The impact of viral infection with SARS-CoV-2 and influenza on plasma endothelial, thrombotic and renal biomarkers
              </a>
            </td>
          <td>
            Ahmed Bakr, Helen Wagstaffe, L. Papargyris, R. Vaja, Christopher Chiu, N. Kirkby, Jane A Mitchell
          </td>
          <td>2025-11-04</td>
          <td>Circulation</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="ABSTRACT In May 2022, a large outbreak of monkeypox virus (MPXV) occurred in several non‐endemic regions worldwide. Another outbreak in 2024 raised global concerns, particularly for immunocompromised individuals like people with HIV (PWH). Since the latent HIV‐1 reservoir remains a major barrier to a cure, we investigated how past mpox infection affected reservoir dynamics in this population. PWH who had mpox at an average of 9 months before sampling showed a significantly smaller HIV‐1 reservoir than MPXV‐unexposed PWH. This reduction was accompanied by enhanced antigen‐driven proviral reactivation in CD4+ T cells, especially central memory cells (TCM), and increased expression of T‐cell activation and proliferation markers like CD32 and Ki67. Mpox also induced sustained immune stress, as reflected by a prolonged decrease in CD4+ T naïve (TN) cells, increased expression of immune senescence and exhaustion markers like PD‐1, LAG‐3, and CD57, as well as metabolic dysfunction in CD4+ TN and TCM cells, which showed impaired glucose uptake and reduced proliferative capacity. These findings suggest that MPXV‐induced immune activation leads to long‐lasting changes in T‐cell homeostasis and reprograms the HIV‐1 reservoir, which may have implications for monitoring immune competence and vaccine responses in this population. Understanding the interplay between HIV‐1/MPXV co‐infection, T‐cell dynamics, and HIV‐1 reservoir modulation provides novel insights into how controlled proviral reactivation may inform the design of cure‐oriented strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1e1c898eee022b0af0e1160cf61d3e9d8a240272" target='_blank'>
              Changes in HIV‐1 Reservoir Dynamics After Mpox Infection
              </a>
            </td>
          <td>
            G. Casado-Fernández, Olivia de la Calle-Jiménez, Inés Armenteros, Luis Lemus Aguilar, Daniel Fuertes, Juan Cantón, E. Mateos, Noemí Cabello, Javier Rodríguez Añover, A. Negredo, Miguel Cervero, M. P. Sánchez Seco, Montserrat Torres, Vicente Estrada, M. Coiras
          </td>
          <td>2025-11-01</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="ABSTRACT In vitro studies have repeatedly showed that extracellular vimentin (eVIM) promotes the penetration of viruses by acting as an adhesion factor, suggesting that reducing eVIM density in the blood could be an effective approach to treat viral infections. However, despite solid evidence, it has not been previously investigated whether eVIM plays a pathogenic role during viral infections in vivo experiments. Here, we provide in vivo evidence that eVIM plays a critical role during viral infections. The severity of COVID-19 in Roborovski SH101 hamsters was positively correlated with blood concentrations of eVIM during the infection period. The reduction of blood eVIM in the SARS-CoV-2-infected Roborovski SH101 hamster through intravenous injection of hzVSF-v13, a humanized anti-eVIM monoclonal antibody, dramatically improved disease manifestations, such as body weight reduction, body temperature, death rate, and more. It also inhibited the formation of blood clots and systemic inflammation compared to remdesivir or a SARS-CoV-2 neutralizing antibody (6D11F2). Histological examination confirmed the significantly better therapeutic efficacy of anti-eVIM compared to remdesivir or the neutralizing antibody. Quantification of SARS-CoV-2 in the hamsters’ lungs revealed that the viral titer in the anti-eVIM-treated groups was 77% to 80% lower than that in the infection group, while remdesivir and the neutralizing antibody resulted in reductions of 41.9% and 34.7% to 44.1%, respectively. We believe that this work provides a foundation for the development of hzVSF-v13 as an antiviral drug for COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4aeac131b55b918a235c7cedc73efe1a44e4a271" target='_blank'>
              Reduction of extracellular vimentin in blood provides protection against SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Hae-Mi Kim, Mingda Wang, Chongkai Zhai, Sura Kim, Jungha Park, Seong-Tshool Hong
          </td>
          <td>2025-10-07</td>
          <td>Virulence</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e5897a60d341e7e87d77fe14a00583999f5220e9" target='_blank'>
              Single nuclear RNA sequencing shows altered microglial and astrocytic functions in post-mortem Parkinson’s disease tissue
              </a>
            </td>
          <td>
            Indra Roy, R. Thomas, Georgina Jiménez Ambriz, S. Farhan, V. Piscopo, T. Durcan
          </td>
          <td>2025-11-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="A certain degree of self-repair is initiated following spinal cord injury (SCI). Although intraneuronal regeneration and a supportive growth environment are limited, they serve as the foundation for functional recovery after SCI. In this study, we conducted single-cell RNA sequencing combined with spatial transcriptomics and spatial metabolomics to reveal the spatial molecular characteristics of self-repair processes after SCI at single-cell resolution. We identified three cell subsets-Mic2 (a microglia subset), Mac4 (a macrophage subset), and Fib4 (a fibroblast subset)-that express markers associated with spinal cord repair. Mic2 and Mac4 exhibit clustered spatial distribution patterns, whereas Fib4 is predominantly located around the injured spinal cord. Additionally, Mic2 is predominantly distributed in the white matter, particularly in the dorsal region of the injured spinal cord, and exhibits high expression of taurine. Mac4 and Fib4 exhibit high expression of copalic acid and uridine, respectively. In this study, we have identified three distinct cell subsets that express markers associated with wound healing and may promote regenerative processes, and we have determined their spatial transcriptional and metabolic features enriched within these regions. Our dataset represents a valuable resource that offers novel mechanistic insights into the pathobiology of spinal cord injury.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ac7f990261ab040d2dcb9732e55fa91a396956f2" target='_blank'>
              Integrating single-cell RNA sequencing and spatial multi-omics reveals the molecular signature of regeneration after spinal cord injury
              </a>
            </td>
          <td>
            Haoru Dong, Yuanqing Ding, Xingyu Chen, Xiao Xiao, Longnian Zhou, Haiyue Lin, Zezhen Zhang, Yiming Tao, Shiyi Cai, Jianlan Zhao, Xiaomu Li, Rong Xie
          </td>
          <td>2025-10-21</td>
          <td>Biomarker Research</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Primary open-angle glaucoma (POAG), a leading cause of irreversible blindness, involves complex neurodegeneration in which the contribution of systemic immunity remains enigmatic. Here, we dissect the circulating immune landscape in POAG patients via high-resolution single-cell RNA sequencing of ~1.4 million peripheral blood mononuclear cells (PBMCs) from 110 patients and 110 controls of Chinese ancestry. We revealed significant immune remodeling in POAG, characterized by increased CD4+ T lymphocytes and myeloid cells and impaired cytolytic potential, as evidenced by reduced cell proportions of terminally differentiated CD8+ GZMK+ T cells and NK cells. Transcriptomic analysis revealed a sophisticated dual transcriptional landscape in which both proinflammatory and neuroprotective signaling pathways coexist across multiple immune cell lineages. While TNF and IFNG pathway genes were broadly downregulated, specific inflammatory activation components and neuroprotective genes were upregulated in distinct cell populations, suggesting that POAG represents a complex immunometabolic syndrome characterized by a dysregulated balance between inflammatory and neuroprotective signaling. Cell type-specific eQTL mapping and SMR analysis revealed that POAG genetic risk loci exert their effects through immune gene regulation in specific PBMC subsets. Functional validation using Ifng-/- and Tnf+/- mice in an LPS/NMDA-induced retinal injury model, which mirrored the immune alterations observed in human POAG, demonstrated that genetic deficiency in these pathways markedly exacerbated retinal ganglion cell loss and visual pathway deficits. Our study establishes a crucial link between systemic immune dysregulation—specifically the disrupted balance between inflammatory and neuroprotective signaling—and retinal health, highlighting the importance of restoring this balance for future POAG therapeutic strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fae6abc08a14880e3feddb70f5fc769e7cfeff07" target='_blank'>
              Single-cell RNA-seq reveals cell type-specific molecular and genetic associations with primary open-angle glaucoma
              </a>
            </td>
          <td>
            Huaping Tian, Yuhong Chen, Tujing Zhao, Lin Ye, Hongjing Li, Zheng Li, Wenqiao Qiu, Wentao Wang, Runze Li, Fulin Liu, Haojue Xue, Ruilin Liao, Chao Qu, Jie Li, Liang Zou, Yi Shi, Zhenglin Yang, Lulin Huang
          </td>
          <td>2025-10-10</td>
          <td>Signal Transduction and Targeted Therapy</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Alveolar macrophages are well known as the first responders to pulmonary cryptococcosis; however, their dynamic molecular responses to Cryptococcus gattii infection in vivo remain limited. Here, we investigated the transcriptional profiles of lung alveolar macrophages purified from mice intranasally infected with C. gattii and compared them to those infected with C. neoformans using RNA sequencing analysis. Alveolar macrophages from C. gattii-infected mice exhibited distinct transcriptional alterations, particularly in genes associated with sterol biosynthesis, whereas those from C. neoformans-infected mice showed enrichment in interferon and cytokine signaling pathways. Treatment with the sterol biosynthesis inhibitor lovastatin significantly reduced cholesterol accumulation in C. gattii-infected RAW 264.7 cells. Furthermore, lovastatin treatment of C. gattii-infected RAW 264.7 and bone marrow-derived macrophages suppressed intracellular cryptococcal proliferation and augmented inflammatory response, as evidenced by increased expression of Nos2 and Il6. Lovastatin also potentiated the antifungal effect of fluconazole by promoting intracellular fungal clearance and increasing nitric oxide activity in macrophages. In C. gattii-infected mice, lovastatin treatment enhanced the efficacy of fluconazole, resulting in improved pulmonary fungal clearance, increased lung CD4 ⁺ T cell numbers, and elevated nitric oxide activity. Collectively, these findings reveal a unique macrophage response to C. gattii infection and highlight the role of sterol metabolism in modulating host defense, offering potential avenues for therapeutic intervention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/361ffc878c85e98584a1bba17834f9329df4592a" target='_blank'>
              Transcriptomic profiling of lung alveolar macrophages reveals distinct contribution of sterol metabolism in macrophage response to Cryptococcus gattii infection
              </a>
            </td>
          <td>
            Siranart Jeerawattanawart, Adithap Hansakon, Rudi Alberts, Yongliang Zhang, P. Angkasekwinai
          </td>
          <td>2025-09-30</td>
          <td>PLOS One</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Atherosclerosis is a chronic inflammatory disease characterized by lipid accumulation and immune dysregulation, including expansion of pro-inflammatory monocytes and effector T cells, alongside reduced regulatory T cells (Tregs). Bacillus subtilis natto, a spore-forming probiotic, has shown anti-atherosclerotic effects, though its systemic immunomodulatory mechanisms remain unclear. In this study, we employed an AAV-mPCSK9-induced murine atherosclerotic model to investigate the effects of daily B. subtilis natto NTU-18 administration over 16 weeks. High-dimensional flow cytometry using two 13-marker panels enabled longitudinal profiling of 18 peripheral immune cell subsets across lymphoid and myeloid compartments. While no significant changes in serum cholesterol and mild decrease of body weight were observed, B. subtilis natto NTU-18-treated mice presented a significant reduction in aortic lesion area compared to PBS-treated controls. Immune profiling revealed a transient expansion of peripheral myeloid cells and CD44⁺ trained CD8⁺ T cells, followed by increased frequencies of naïve CD8⁺ T cells and reduced central/effector memory subsets at longer time point treatment. In the CD4⁺ T cell compartment, a transient increase in trained cells was accompanied by a sustained enrichment of CD25⁺CD4⁺ Tregs throughout the daily B. subtilis natto NTU-18 treatment. In contrast, no significant differences were observed in Ly6C⁻ or Ly6C⁺ monocytes, neutrophils, or eosinophils. These findings suggest that B. subtilis natto NTU-18 attenuates atherosclerosis progression not through lipid lowering or broad myeloid modulation, but via targeted reprogramming of peripheral T cell responses. This work provides mechanistic insight into the immunotherapeutic potential of B. subtilis natto NTU-18 in atherosclerosis prevention and treatment. • B. subtilis natto NTU-18 significantly reduces aortic plaque burden in atherosclerotic mice without affecting serum cholesterol levels. • B. subtilis natto NTU-18 induces transient immune remodeling, marked by early expansion of trained CD8⁺ and CD4⁺ T cells, followed by increased naïve and regulatory T cells. • The atheroprotective effect is primarily mediated through adaptive immunity as myeloid subsets remain unchanged throughout B. subtilis natto NTU-18 treatment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/45dd339de260cb5a70cef21d3c450ab6682f7820" target='_blank'>
              Bacillus subtilis natto NTU-18 attenuates atherosclerosis progression by modulating peripheral immune cell alterations
              </a>
            </td>
          <td>
            Jian-Da Lin, Yu-Zhen Ye, Sin-Ren Wang, Wen-Yi Kao, Kung-Ta Lee
          </td>
          <td>2025-10-17</td>
          <td>Applied Microbiology and Biotechnology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2d6e91515a8577a13c2aa3d6af7329fea8d2e1e5" target='_blank'>
              Brain infiltrating T cells mediate microglial dysregulation and neuronal loss following SAH
              </a>
            </td>
          <td>
            F. Moro, E. Mazzone, R. Pascente, M. Bataclan, S. Monticelli, F. Pischiutta, MC Trolese, C. Vasco, J. Geginat, M. Di Feliciantonio, F. Ortolano, T. Zoerle, E. Zanier
          </td>
          <td>2025-10-11</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>44</td>
        </tr>

        <tr id="Inflammation and excess cytokine release are hallmarks of severe COVID-19. While programmed cell death is known to drive inflammation, its role in SARS-CoV-2 pathogenesis remains unclear. Using gene-targeted murine COVID-19 models, we here find that caspase-8 is critical for cytokine release and inflammation. Loss of caspase-8 reduces disease severity and viral load in mice, and this occurs independently of its apoptotic function. Instead, reduction in SARS-CoV-2 pathology is linked to decreased IL-1β levels and inflammation. Loss of pyroptosis and necroptosis mediators in gene-targeted animals provides no additional benefits in mitigating disease outcomes beyond that conferred by loss of caspase-8. Spatial transcriptomic and proteomic analyses of caspase-8-deficient mice confirm that improved outcomes are due to reduced pro-inflammatory responses, rather than changes in cell death signalling. Elevated expression of caspase-8 and cFLIP in infected lungs, alongside caspase-8-mediated cleavage of N4BP1, a suppressor of NF-kB signalling, indicates a role of this signalling axis in pathological inflammation. Collectively, these findings highlight non-apoptotic functions of caspase-8 as a driver of severe COVID-19 through modulation of inflammation, not through the induction of apoptosis. During SARS-CoV-2 infection caspase-8 fuels harmful inflammation independent of apoptosis. Genetic loss of caspase-8 reduces cytokine levels, lowers viral load and mitigates disease severity, revealing non-apoptotic caspase-8 as a key driver of severe COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5fdd57c7d51f242c164bb60fdb057ec943038a10" target='_blank'>
              Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Stefanie M. Bader, Lena Scherer, Reet Bhandari, Allan J. Motyer, James P. Cooney, Liana Mackiewicz, Merle Dayton, Dylan Sheerin, David V. L. Romero, Jan Schaefer, J. Pang, Siqi Chen, Kael Schoffer, Le Wang, Xinyi Jin, D. Batey, Raymond K. H. Yip, Ishrat Zaman, P. Rajasekhar, Matthew J. Gartner, Stephen Wilcox, Lachlan L Whitehead, S. R. Georgy, Ana Maluenda, Kathryn C. Davidson, C. Allison, R. Bowden, Kerstin Brinkmann, M.-L. Asselin-Labat, B. Phipson, Maria C. Tanzer, Marco J. Herold, A. Samson, J. Vince, Andreas Strasser, Marc Pellegrini, Marcel Doerflinger
          </td>
          <td>2025-11-13</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>50</td>
        </tr>

        <tr id="ABSTRACT Human cytomegalovirus (HCMV) is a prolific human herpesvirus that infects most individuals by adulthood. While typically asymptomatic in adults, congenital infection can induce serious neurological symptoms, including hearing loss, visual deficits, cognitive impairment, and microcephaly in 10%–15% of cases. HCMV has been shown to infect most neural cells, with our group recently demonstrating this capacity in stem cell-derived forebrain neurons. Infection of neurons induces deleterious effects on calcium dynamics and electrophysiological function paired with gross restructuring of neuronal morphology. Here, we utilize an induced pluripotent stem cell-derived model of the human forebrain to demonstrate how HCMV infection induces syncytia, drives neurite retraction, and remodels microtubule networks to promote viral production and release. We establish that HCMV downregulates microtubule-associated proteins while largely sparing other cytoskeletal elements. Furthermore, we pharmacologically modulate microtubule dynamics using paclitaxel (stabilize) and colchicine (destabilize) to examine the effects on neurite structure, syncytial morphology, and viral release. With paclitaxel, we found improvement of neurite outgrowth, but neither paclitaxel nor colchicine impacted viral titers. Together, these data suggest that HCMV infection-induced disruption of microtubules in human cortical neurons can be partially mitigated with microtubule stabilization, suggesting a potential avenue for future neuroprotective strategies. IMPORTANCE Infection by human cytomegalovirus (HCMV) continues to cause significant damage to human health. In the absence of a vaccine, vertical transmission from mother to fetus can result in profound neurological damage impacting quality of life. These studies focus on understanding the impact of HCMV infection on forebrain cortical neurons derived from induced pluripotent stem cells (iPSCs). We show that infection results in loss of neurite extension accompanied by cell-to-cell fusion. These pathogenic changes involve HCMV infection-mediated disruption of the microtubule network in iPSCs from different patient backgrounds. The microtubule stabilization agent paclitaxel partially protected neurite length and altered syncytia morphology without impacting viral replication. This work is part of our continued efforts to define putative strategies to limit HCMV-induced neurological damage. Infection by human cytomegalovirus (HCMV) continues to cause significant damage to human health. In the absence of a vaccine, vertical transmission from mother to fetus can result in profound neurological damage impacting quality of life. These studies focus on understanding the impact of HCMV infection on forebrain cortical neurons derived from induced pluripotent stem cells (iPSCs). We show that infection results in loss of neurite extension accompanied by cell-to-cell fusion. These pathogenic changes involve HCMV infection-mediated disruption of the microtubule network in iPSCs from different patient backgrounds. The microtubule stabilization agent paclitaxel partially protected neurite length and altered syncytia morphology without impacting viral replication. This work is part of our continued efforts to define putative strategies to limit HCMV-induced neurological damage.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/43ff406a50f0e094bdc2efb44261948bcae00376" target='_blank'>
              HCMV infection of terminally differentiated neurons disrupts microtubule organization, resulting in neurite retraction
              </a>
            </td>
          <td>
            Jacob W. Adelman, Andrew T Sukowaty, Kaitlyn J Partridge, Jessica E. Gawrys, Allison Akins, S. Terhune, Allison D. Ebert
          </td>
          <td>2025-10-08</td>
          <td>Microbiology Spectrum</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Patients with systemic lupus erythematosus (SLE) are susceptible to bacterial infections, but the underlying dysfunction remains unclear. We found that Staphylococcus aureus triggers mitochondria-dependent suicidal NETosis via lactate sensing in healthy neutrophils, but this response is defective in SLE. Herein, we show that chronic Toll-like receptor (TLR) 7/9 signaling represses mitochondrial lactate dehydrogenase B (LDHB), thereby impairing lactate sensing and downstream suicidal NETosis. Instead, SLE neutrophils default to vital NET release; a less bactericidal, type I interferon (IFN)-driven process amplified by staphylococcal pore-forming toxins and sustained by elevated systemic IFNα levels observed in SLE. Combined treatment with hydroxychloroquine (HCQ) and interferon-alpha/beta receptor (IFNAR) blockade restores LDHB expression, NET homeostasis, and bacterial clearance in lupus-prone mice. Neutrophils from SLE patients exhibit similar defects, which are reversed by HCQ and the IFNAR-blocking antibody anifrolumab. These findings identify a clinically actionable immunometabolic checkpoint linking chronic autoimmune signaling to defective antibacterial defense in SLE.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3d493562d9cbf669c771bb336ea8a59baf52c39a" target='_blank'>
              A TLR7/9-IFNα-LDHB axis drives vital NET release and compromises antibacterial defense in lupus
              </a>
            </td>
          <td>
            Eden G. TenBarge, Ashley D. Wise, Morgan L. Hetzel, Helene A. Hoover, Helia Esfandiari, Bailey E. Holder, Eva Belevska, Ellie C. Mennen, Sarah R. McDaniel, Nicole M. Vaccaro, Courtney C. Lucca, Jonathan M. Williams, Jennifer Ferris, Timothy E Sparer, Leslie J. Crofford, Jeffry D. Bieber, Andrew J. Monteith
          </td>
          <td>2025-10-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Parkinson’s disease (PD) is clinically characterized by motor dysfunction, and its pathology primarily involves the progressive loss of dopaminergic neurons. Despite extensive research, the precise etiological mechanisms remain elusive. Recent findings have revealed a significant role of astrocytes in PD onset and progression. However, fully elucidating their function has been challenging because of the heterogeneity of cells and the complexity of the disease progression. Here, we successfully used single-nuclear RNA sequencing to characterize diverse genes expressed by astrocytes and analyzed changes in biological processes in a PD mouse model. Pseudotime analysis (Monocle2) indicated that as PD progressed the status of astrocytes transitioned from immune activation states to neurotoxic subtypes, which correlates with marked upregulation of inflammation-related genes, including Nlrp3 and IL-1β. Furthermore, CellChat analysis demonstrated that BMP signaling exhibited significant specificity in PD, with Bmp6 as the primary ligand and astrocytes as crucial mediators and responders. Thus, we demonstrated that BMP signaling activation in astrocytes exacerbates dopamine neuronal death. Rather, inhibiting BMP signaling in astrocytes significantly improved motor dysfunction and reduced the loss of dopamine neurons in a PD mouse model. Mechanistically, we found that activation of the BMP signaling pathway promoted the release of Nlrp3, IL-1β, and TNF-α, suggesting that increased neuroinflammation aggravated dopaminergic neuronal death. Together, these findings highlight the crucial role of astrocytes in the pathogenesis of PD and reveal a novel cellular mechanism that offers potential therapeutic targets for PD intervention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb1218eb2ef206119c35fe143ddaae9d52da6a97" target='_blank'>
              Inhibition of astrocyte BMP signaling alleviates neuroinflammation in experimental models of Parkinson’s disease
              </a>
            </td>
          <td>
            Yibo Li, Jiaxin Hao, Wenyu Wang, Zhaowen Su, Xiaofeng Tian, Hongfang Wang, Qing Liu, Jiamin Gao, Dandan Geng, Lei Wang
          </td>
          <td>2025-11-10</td>
          <td>Cell Death Discovery</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c48ccb41d3f252f85b5277e853ac6cb2ae72c91e" target='_blank'>
              Human immune response to primary cryptosporidiosis parallels murine infection models
              </a>
            </td>
          <td>
            Dana M. Van Fossen, Haroldo J. Rodriguez, Farha Naz, Carol A. Gilchrist, Justin J. Taylor, W. A. Petri, Audrey C. Brown
          </td>
          <td>2025-10-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Circulating lymphocytes are essential for the immune response to helminth infections, as they secrete cytokines and thus coordinate subsequent immunological processes. In canine angiostrongylosis, a potentially fatal disease caused by the metastrongylid nematode Angiostrongylus vasorum, the underlying immune mechanisms driving disease progression remain poorly understood despite the severe clinical consequences. Canine peripheral blood mononuclear cells (PBMCs) were isolated from healthy dogs and stimulated with three different antigens of A vasorum, including adult excretory-secretory products (ESP), adult full-worm somatic antigen, and first-stage larval (L1) somatic antigen. Temporal dynamics and magnitude of relative cytokine expression (IFNγ, TNF, IL-4, IL-6, IL-10, IL-13) was evaluated after 4 h, 24 h, and 5 days of antigen exposure via quantitative reverse transcription PCR. To determine whether the cytokine expression changes translated into shifts in circulating mononuclear cell subsets or proliferative activity, phenotypic characterisation by flow cytometry was conducted after a 72 h stimulation with L1 antigen or ESP, and compared to unstimulated controls. Early responses varied across antigen types, with ESP promoting a regulatory cytokine profile with modest upregulation of IL-4, IL-6, and IL-10, and downregulation of IFNγ, TNF, and IL-13. Adult antigen induced increased expression of all examined cytokines, while L1 antigen triggered the strongest inflammatory response compared to the other antigens. At 24 h, all responses were amplified, particularly those to L1 and adult antigen, and showed a shift towards a Th2 cytokine profile with increased IL-4 and IL-13 expression. By five days, IL-4 and IL-13 remained predominant. No change in the relative abundance of major immune cell populations (CD4⁺ T cells, CD8⁺ T cells, B cells, neutrophils, monocytes, and CD14⁻ CD22⁻ antigen-presenting cells) was observed in flow cytometry following stimulation. However, a notable increase in Ki67 expression, a marker of cell proliferation, was detected in CD8⁺ T cells after L1 antigen stimulation. Distinct cytokine profiles elicited by different A. vasorum antigens suggest that the parasite’s modulation of host immunity and induction of stage-specific responses are key to persistence and clinical presentation of canine angiostrongylosis. Further investigation into the antigenic components and immune pathways may lead to tailored therapies, improved clinical management, and to a deeper understanding of stage-specific aspects of helminth infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/966d24f4232243990a6917d702fdc78980641c19" target='_blank'>
              In vitro cytokine response of circulating mononuclear cells from healthy dogs to stage-specific antigens of Angiostrongylus vasorum
              </a>
            </td>
          <td>
            Janine Hertaeg, U. Salazar, J. vom Berg, S. Leibundgut-Landmann, Andreas W. Oehm, Manuela Schnyder
          </td>
          <td>2025-10-02</td>
          <td>BMC Veterinary Research</td>
          <td>0</td>
          <td>40</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/18ab1920649f9abec4eb117758bcfc5aa50f5be0" target='_blank'>
              Diverse infection models demonstrate robust resistance of Mycobacterium tuberculosis to innate immunity
              </a>
            </td>
          <td>
            Marian R. Fairgrieve, Ella C. Brydon, Roberto A. Chavez, Dmitri I. Kotov, Russell E. Vance
          </td>
          <td>2025-11-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Managing multiple sclerosis (MS), a chronic, neuroinflammatory and demyelinating disease, remains an unmet medical need. A great obstacle to developing therapeutic interventions altering the disease process is the lack of a suitable disease model recapitulating its core pathologies, especially the process of myelin damage and regeneration against the backdrop of persistent neuroinflammation. Now we report the generation and characterization of a new demyelination/remyelination model with key pathological features of MS through repeated ablations of Tmem10+ oligodendrocytes. Using the Tmem10-Cre driver that targets expression of diphtheria toxin receptor (DTR) in Tmem10+ (mature myelin-forming) oligodendrocytes, we conducted 3 rounds of Tmem10+ oligodendrocyte ablations over the span of 9 weeks in young adult mice by injecting diphtheria toxin (DT). Three rounds of the oligodendrocyte ablation caused prolonged demyelination and axonal injury in the backdrop of chronic neuroinflammation, including gliosis and lymphocyte infiltration. In response to the oligodendrocyte ablations, the proliferation and differentiation of OPCs were accelerated for the regeneration of myelin-forming oligodendrocytes, leading to spontaneous remyelination. This de-/re-myelination model presents a wide “time window” between the onset of demyelination and spontaneous remyelination, which makes it suitable for assessing the efficacy of therapeutic pro-remyelinating agents, as demonstrated by administering Benztropine to this demyelination model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/15c50e33696d9eaa75824b92a0deb5a876072433" target='_blank'>
              Repeated ablations of mature Tmem10+ oligodendrocytes recapitulates key pathological features of multiple sclerosis with prolonged demyelination
              </a>
            </td>
          <td>
            Feiyan Zhu, Haijiao Huang, Yuting Shu, Guoru Ren, Bo Jing, Honglin Tan, Wanxiang Jiang, Yiyuan Cui, Paul F Worley, B. Xiao, Mina Chen
          </td>
          <td>2025-10-06</td>
          <td>Cell Death & Disease</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Despite heavy exposure to Mycobacterium tuberculosis (Mtb), some individuals are resistant to TST and IGRA conversion (RSTRs). The functional and immunological mechanisms governing resistance are poorly understood. We hypothesized that RSTR and LTBI alveolar macrophages (AMs) respond differently to Mtb infection with transcriptional programs that are distinct from peripheral blood monocytes. We examined media and Mtb-infected AMs from bronchoalveolar lavage fluid collected from a RSTR cohort in Uganda with over 10 years of clinical follow-up. With transcriptional profiles of BAL cells analyzed immediately after collection, gene set enrichment analysis (GSEA) revealed 13 differentially expressed gene sets between RSTR (n = 19) and LTBI (n = 26) groups, including one (Hallmark E2F targets) which was positively enriched in the RSTR group (FDR < 0.3). In a subset of this cohort (n = 7 RSTR and 8 LTBI), AMs were examined with and without Mtb infection. When comparing the RSTR and LTBI groups, we identified 52 DEGs including 22 in the media condition, 15 with Mtb stimulation, and 11 with the interaction term (FDR < 0.2, Log 2-fold change > 1/<-1). Notably, RSTR AMs appear to upregulate inflammation more strongly than LTBI counterparts, including Hallmark inflammatory response (FDR < 0.2), IFNγ response (FDR < 0.1), and IFNα response (FDR < 0.1) while existing in a more non-inflammatory state at baseline (Hallmark TNF signaling via NF-kB (down, FDR < 0.1), inflammatory response (down, FDR < 0.1). In a comparison of peripheral blood monocyte gene expression profiles from the same cohort, there were both shared and AM-specific RSTR profiles detected. Together, these results suggest that RSTR and LTBI AMs have different basal and Mtb-induced transcriptional profiles, including some that differ from peripheral blood monocytes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/74f6f6a91106ca8fedadea27abfb904beaf5f882" target='_blank'>
              Alveolar macrophage transcriptional signatures associated with resistance to TST/IGRA conversion following Mycobacterium tuberculosis exposure
              </a>
            </td>
          <td>
            Austin M. Haynes, Cristian Ovadiuc, G. Peterson, W. Worodria, Sophie Nalukwago, Timothy Muwanguzi, M. Nsereko, Catherine M. Stein, Kimberly A. Dill-McFarland, Harriet Mayanja-Kizza, W. H. Boom, R. M. Segnitz, T. Hawn
          </td>
          <td>2025-10-31</td>
          <td>BMC Genomics</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/49cdf4d2b06dc0c77173ce97caf0d6a3fa0e9a28" target='_blank'>
              Single-Cell Immune Profiling Reveals Non-classical Monocyte-Driven Immunodepression in Tuberculosis Treatment Non-Responders
              </a>
            </td>
          <td>
            Yang Che, Yiqun Xiong, Dongliang Zhang, Yahong Qu, Hao Shen, Weixin Wang, Junshun Gao, ZhenBo Wang, Yi Chen, Zhihong Shen
          </td>
          <td>2025-10-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Innate immunity is the first line of defense against infections, including the detection and response to SARS-CoV-2. Cells of the innate system are usually activated within hours after pathogen exposure and do not generate conventional immunological memory. In this review, the current knowledge of the innate immune cells and of pattern-recognition receptors in sensing and responding to SARS-CoV-2 to mount a protective response has been shortly reviewed. Subsequently, the evasion strategies of the virus, as the inhibition of IFN-I/III production and autophagic response, counteracting the innate cell activity (including NK cells), have been briefly outlined. In the course of the infection, these strategies are also capable of rendering dysfunctional most innate cells, thus deeply interfering with the onset and maintenance of adaptive immunity. Possible mechanism(s) for the maintenance of dysfunctional innate immune response are also discussed. In this context, the importance of a rapid and robust activation of innate immunity through toll-like receptor (TLR) 4 as a key paradigm central to host defense against COVID-19 pathogenesis is also illustrated. We also discuss how the viral excess plus inflammatory signals upregulating TLR4 on innate cells may initiate a vicious loop which maintains and improves hyperinflammation, leading to the most critical outcomes. Targeting the TLR4 or its signaling pathway may be a promising therapeutic strategy, offering the dual benefits of viral suppression and decreasing inflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cf626753ecf348c0167bafcded213489d5356d66" target='_blank'>
              The innate immune response in SARS-CoV2 infection: focus on toll-like receptor 4 in severe disease outcomes
              </a>
            </td>
          <td>
            Enrico Maggi, Nadine Landolina, Francesca Romana Mariotti, E. Munari, N. Tumino, P. Vacca, B. Azzarone, Lorenzo Moretta
          </td>
          <td>2025-10-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="Viral encephalitis, characterized by inflammation of the brain parenchyma, poses a significant threat to public health due to its high rates of morbidity and mortality. Microglia, the central nervous system’s resident immune cells, are crucial in the pathophysiology and development of this condition. These microglia exhibit a dual function, being involved in both neuroprotection and neurotoxicity during viral encephalitis. To address this complex interplay, targeted therapeutic strategies that modulate microglia activation state have emerged as a promising approach. These strategies aim to either inhibit excessive microglia activation or promote their neuroprotective functions. By targeting microglia, these therapies hold the potential to improve outcomes for patients with viral encephalitis. This review synthesizes current evidence revealing that microglial responses during viral encephalitis exhibit context-dependent heterogeneity that extends beyond traditional M1/M2 paradigms. Critically, our review reveals a significant translational gap, with no current clinical trials investigating microglial-targeted therapies for viral encephalitis despite promising preclinical evidence. This review provides a comprehensive framework for understanding microglial complexity in viral encephalitis and establishes research priorities for advancing these insights toward clinical application.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7e0caaffaa21a65c0a881f9db458d953a11cab66" target='_blank'>
              Dual immune modulation of microglia in viral encephalitis: current understanding and future perspectives
              </a>
            </td>
          <td>
            Li Zong, Pei Chen, Jing Shi, Huijie Chen, Wenwen Lin, Guanyong Ou, Xuxiang Chen
          </td>
          <td>2025-10-27</td>
          <td>Frontiers in Molecular Biosciences</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/eaf43845c509a3749cf591b678f0bedd9e366627" target='_blank'>
              Alzheimer’s disease causes bone marrow myelopoiesis dysfunction
              </a>
            </td>
          <td>
            M. A. Abellanas, Leyre Basurco, Maitreyee Purnapatre, Chiara Burgaletto, Giulia Castellani, Sarah Phoebeluc Colaiuta, Javier Maria Peralta-Ramos, Angham Ibraheem, Sama Murad, Paola Antonello, Mariángeles Kovacs, Yuliya Androsova, Bar Nathansohn, Hannah Partney, L. Cahalon, Rafael Valdes-Mas, Joseph M. Josephides, T. Salame, M. Espelosin, M. Cuadrado‐Tejedor, A. García-Osta, Aleksandra Deczkowska, Michal Schwartz
          </td>
          <td>2025-10-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Epigenetic scarring of terminally dysfunctional (TDysf) CD8+ T cells hinders long-term protection and response to immune checkpoint blockade during chronic infections and cancer. We developed a faithful in vitro model for CD8+ T cell terminal dysfunction as a platform to advance T cell immunotherapy. Using TCR-transgenic CD8+ T cells, we found that 1-week peptide stimulation, mimicking conditions in previous models, failed to induce a stable exhaustion program. In contrast, prolonged stimulation for 2–3 weeks induced T cell dysfunction but triggered activation-induced cell death, precluding long-term investigation of exhaustion programs. To better mimic in vivo exhaustion, we provided post-effector, chronic TGF-β1 signals, enabling survival of chronically stimulated CD8+ T cells for over 3 weeks. These conditions induced a state of terminal dysfunction, marked by a stable loss of effector, cytotoxicity, and memory programs, along with mitochondrial stress and impaired protein translation. Importantly, transcriptomic and epigenetic analyses verified the development of terminal exhaustion-specific signatures in TDysf cells. Adoptive transfer of TDysf cells revealed their inability to recall effector functions or proliferate after acute lymphocytic choriomeningitis virus rechallenge. This tractable model system enables investigation of molecular pathways driving T cell terminal dysfunction and discovery of therapeutic targets for cancer or chronic infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cc4dbe9ec01dc079f493706a4c9a1123f839c591" target='_blank'>
              Faithful modeling of terminal CD8+T cell dysfunction and epigenetic stabilization in vitro
              </a>
            </td>
          <td>
            Amira Yousif, Abbey A. Saadey, Ava Lowin, Asmaa M. Yousif, Ankita Saini, Madeline R. Allison, Kelley Ptak, Eugene M Oltz, Hazem E. Ghoneim
          </td>
          <td>2025-10-08</td>
          <td>JCI Insight</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="A Proliferation-Inducing Ligand (APRIL) is a tumour necrosis factor superfamily member with multiple effector roles in the peripheral and central nervous system (CNS). In the CNS, APRIL helps maintain immune homeostasis and supports neuronal survival, yet whether it can therapeutically modulate acute neuro-inflammatory and neurodegenerative processes is unclear. To investigate this in a severe neuro-inflammatory context, we tested whether local APRIL delivery can influence microglial/astrocytic responses and demyelination in the cuprizone (CPZ) mouse model of neuro-inflammation and demyelination. We applied adeno-associated virus (AAV)–mediated gene transfer to drive APRIL expression by cortical neurons positioned directly above the splenium of the corpus callosum. Following CPZ intoxication, we evaluated microglial and astrocytic activation and myelin content by in vivo T2 and diffusion magnetic resonance imaging (MRI), and validated them by post-mortem quantitative immunohistochemistry (IHC) and bulk transcriptomic and proteomic profiling. T2 and diffusion MRI, corroborated by quantitative IHC, demonstrated that secretion of APRIL by cortical neurons attenuated CPZ-induced microglial recruitment and demyelination in the splenium, but not in the cortex. Integrated transcriptome-proteome analysis of splenium and cortex, further supported by IHC, highlighted astroglial lipid-metabolic circuitry - marked by the astrocytic fatty-acid-binding protein 7 (Fabp7) - as a candidate axis underlying APRIL’s effects to reduce inflammatory cell recruitment and myelin preservation. AAV-mediated expression of APRIL by cortical neuron counteracted microglial recruitment and demyelination in the splenium of CPZ-treated mice. Our multi-omics integration analysis nominated several pathways, including Fabp7-linked astrocytic lipid metabolism, to elucidate APRIL’s mechanism of action. Together, these findings provide a framework for the mechanistic dissection of APRIL’s therapeutic potential and further translational evaluation in CNS pathologies characterised by acute neuro-inflammatory responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b73ba8336580ec9e7f5e7539d0fbcc48e4944d3b" target='_blank'>
              AAV-mediated delivery of a proliferation inducing ligand (APRIL) to cortical neurons limits inflammation and demyelination in the corpus callosum of the cuprizone mouse model
              </a>
            </td>
          <td>
            Leonardo Ricciardi, Federica Di Marco, Marion Decrop, Julia Di Stefano, Tejaswini Kakunuri, Joëlle van Rijswijk, N. Vidas-Guscic, Yousra El Ouaamari, Alexandro A. Bufi, Ignace Van Spilbeeck, Johan Van Audekerke, Carole Faghel, Esther Bartholomeus, Eva Lion, Nathalie Cools, Steven Van Laere, I. Cicalini, Vincenzo de Laurenzi, Una Fitzgerald, D. Pieragostino, B. Huard, P. Del Boccio, Peter Ponsaerts, M. Verhoye
          </td>
          <td>2025-10-27</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="Alzheimer's disease (AD) leads to a progressive loss of cognitive abilities and memory. A critical factor now recognized as driving AD pathology is neuroinflammation—inflammation occurring in the nervous system, which contributes to neuronal harm and communication breakdowns. our research investigated the specific effects of neuroinflammation on neuronal signaling pathways. In this study, we primarily employed the SH-SY5Y neuroblastoma cell line as an in vitro neuronal model to investigate inflammatory responses relevant to AD etiology, alongside supplementary observations in primary neurons and 3D spheroids for comparative analysis. Our analysis focused on modifications of key molecules, including the neuroprotective protein Brain-Derived Neurotrophic Factor (BDNF), pro-inflammatory cytokines such as IL-6 and TNF-α, and crucial regulatory kinases. Our results demonstrated that LPS treatment dramatically lowered the vitality and decreased BDNF levels in the SH-SY5Y cells. Furthermore, we observed a considerable elevation in the pro-inflammatory cytokines IL-6 and TNF-α, coupled with elevated levels of COX-2 and iNOS. Gene expression data validated that LPS treatment altered the expression of essential signaling kinases (Protein Kinase A (PKA), Protein Kinase B (AKT), and Mitogen-Activated Protein Kinase (MAPK)). Our first comparative analysis revealed that 3D spheroid cultures may elicit more pronounced inflammatory responses than standard 2D cultures; nevertheless, our detailed investigation primarily focused on the SH-SY5Y model. This study revealed that LPS-induced neuroinflammation affects neuronal signaling in vitro, thereby revealing a relationship between inflammation and neuronal dysfunction in cellular models of neuroinflammation. These findings highlight pathways that may be relevant to AD pathophysiology; however, further in vivo studies are necessary to demonstrate their translational relevance to humans. This graphical abstract illustrates how LPS-induced neuroinflammation disrupts neurotrophic signaling and kinase activity in Alzheimer's models. It highlights the involvement of SH-SY5Y cells, primary neurons, and 3D spheroids in inflammatory cascades that lead to oxidative stress, BDNF suppression, and synaptic dysfunction, offering insights into potential therapeutic targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/eebe271151bdd650644870bff659a9f67f45a47b" target='_blank'>
              LPS-Induced Neuroinflammation Disrupts Brain-Derived Neurotrophic Factor and Kinase Pathways in Alzheimer's Disease Cell Models
              </a>
            </td>
          <td>
            B. Shademan, Hadi Yousefi, Rahim Sharafkhani, Alireza Nourazarian
          </td>
          <td>2025-11-10</td>
          <td>Cellular and Molecular Neurobiology</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="Melanoma plasticity drives immune evasion and therapy resistance through dynamic cell-state transitions beyond genetic alterations. Epigenetic remodeling critically influences such processes, yet its role in reshaping the tumor ecosystem under therapeutic pressure remains unresolved. Here, we profiled longitudinal biopsies from melanoma patients treated in the phase Ib NIBIT-M4 epi-immunotherapy clinical trial (NCT02608437), testing the combination of a DNMT1 inhibitor with anti-CTLA4 using single-cell multiome and high-resolution spatial transcriptomics. Integrated analyses resolved seven malignant meta-programs, including a rare Wnt/β-catenin–driven melanocytic state and a de-differentiated neural crest–like state enriched in non-responders. Spatial modeling revealed that homotypic clustering stabilizes resistant programs, with neural crest–like cells forming compact, centrally localized niches, whereas Wnt/β-catenin subpopulations displayed a bimodal architecture, either cohesive clusters sustained by adhesion or dispersed, transcriptionally plastic cells. Responders exhibited progressive enrichment of an antigen presentation/interferon program and coordinated remodeling of the tumor microenvironment with T and B cell expansion, whereas tumors from non-responder patients maintained stable composition of neural crest–like clusters. Epigenetic therapy reactivated transposable elements, providing both regulatory signals that prime innate immunity within microenvironment and generating antigens that drive immunoediting and immunogenicity of Antigen presentation/interferon cell states in responders. Finally, NFATC2 emerged as a master regulator of neural crests–like transcriptional phenotypes and promoter of resistance to therapeutic interventions in melanoma patients. NFATC2 perturbation was able to shift tumor cells towards more differentiated and immunogenic states. These findings reveal how epigenetic-based immunotherapy reshapes melanoma ecosystems, provide mechanistic insights into how multiple transcriptional programs promote tumor plasticity and resistance to both combinatorial therapies and immune checkpoint blockade, identify spatial clustering as a principle stabilizing resistant niches, and highlight β-catenin and NFATC2 as actionable vulnerabilities to overcome resistance.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dc9320984fb7ca80afa8b2d49d724dd86390a378" target='_blank'>
              Transposable Elements and Homotypic Niches Drive Immune Dynamics and Resistance in Melanoma Epigenetic-based immunotherapy
              </a>
            </td>
          <td>
            Erika Ciervo, Francesco Ceccarelli, A. D. Di Giacomo, Piera Grisolia, A. Covre, Z. M. Besharat, Antonio De Falco, F. Caruso, Luigi Laezza, Luigi Ferraro, Gloria Mas Martin, M. F. Lofiego, Tommaso Sani, E. Ferretti, Yan Guo, Sean B. Holden, R. Mortarini, A. Anichini, M. Maio, T. Noviello, M. Ceccarelli
          </td>
          <td>2025-10-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>60</td>
        </tr>

        <tr id="Ferroptosis plays a key role in neuronal death and functional outcomes following traumatic brain injury (TBI). While TBI affects diverse cell types in injured brain regions, the sex- and cell type-specific responses to ferroptosis during the acute phase in the immature brain remain poorly understood. Dexmedetomidine (DEX), a selective alpha-2 adrenergic receptor agonist, has been shown to reduce inflammation and improve survival outcomes in TBI patients, but its sex- and cell type-specific effects on ferroptosis are unclear. This study investigated whether TBI induces sex- and cell type-specific ferroptotic responses and examined the effects of DEX during the acute post-injury phase in a juvenile mouse model. By concurrently isolating neurons and microglia from the same animals, we demonstrate that TBI prompts distinct sex- and cell type-specific ferroptosis responses, including differential regulation of genes involved in iron and lipid metabolism, oxidative stress, and proinflammatory pathways in neurons and microglia. DEX treatment significantly improved behavioral outcomes and reduced iron overload, lipid peroxidation, and neuroinflammation, thereby decreasing ferroptosis in both neurons and microglia. However, its effects were less prominent in neurons from female mice. Further analysis indicated that these sex- and cell type-specific responses to DEX may be partially due to differences in alpha-2 adrenergic receptor expression in neurons and microglia following TBI. Overall, our findings offer new insights into the mechanisms underlying sex- and cell type-specific responses to ferroptosis and DEX treatment, highlighting the broader implications for lipid metabolism, oxidative stress, and inflammation in the immature brain during the acute phase after TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a73bf058969e84b7af62fcf495bc38cca54174d0" target='_blank'>
              Sex- and cell type-specific effects of dexmedetomidine on ferroptosis in neurons and microglia following traumatic brain injury in juvenile mice
              </a>
            </td>
          <td>
            Jie Fan, Stefanie Tasevski, Yara Mashal, Tia Atoui, Zahrah Naseer, Zhi Zhang
          </td>
          <td>2025-11-06</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Zika virus (ZIKV) is a neurotropic flavivirus capable of infecting the adult brain, however its impact on hypothalamic function and metabolic regulation remains unclear. Here, we show that ZIKV invades the hypothalamus of immunocompetent adult mice, where it replicates and persists, leading to sustained insulin resistance. Following infection, ZIKV RNA and negative strand were detected in the hypothalamus of mice and immunostaining confirmed viral proteins in neurons, especially POMC-positive cells. At 6 dpi, ZIKV induced hypothalamic neuroinflammation, as shown by the upregulation of TNF-α, IL-6, IFN-β, and ISG-15, as well as microglial activation. These inflammatory responses were associated with impaired insulin signaling, characterized by reduced phosphorylation of IRS-1 and S6K, downregulation of insulin receptor mRNA, and decreased anorexigenic response following intracerebral insulin administration. Our data also showed that, despite viral clearance and resolution of hypothalamic inflammation at 30 dpi, reduction in insulin receptor protein levels and hypothalamic insulin resistance persisted. These findings demonstrate that ZIKV replicates in the hypothalamus of immunocompetent adult mice, leading to long-lasting disruption of central insulin signaling. Our study identifies hypothalamic insulin resistance as a novel consequence of ZIKV central nervous system invasion and suggests that viral infections may contribute to long-term metabolic dysfunction, highlighting the need to investigate persistent hypothalamic and metabolic alterations in ZIKV infection-recovered individuals.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/deff0518eb16d110cb9b78adc5fc218285716fcf" target='_blank'>
              Central Zika virus infection causes hypothalamic inflammation and persistent insulin resistance in adult mice
              </a>
            </td>
          <td>
            E. V. de Lima, Clara O. Nogueira, R. R. Christoff, Emylle Costa-Bartuli, Tathiany Igreja-Silva, M. D. da Silva, Daniel Gavino-Leopoldino, Maria Luiza Móra Santos, F. S. Lemos, Jaderson C. da Costa, G. Venturin, I. Assunção-Miranda, João M. N. Duarte, Claudia P. Figueiredo, G. F. Passos, Julia R. Clarke
          </td>
          <td>2025-10-13</td>
          <td>Cell Death & Disease</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1381579458dad0f9eaa04f54a5f62506afb46bc5" target='_blank'>
              Neuroimmune crosstalk in Parkinson’s disease: the pivotal role of microglia and infiltrating T cells
              </a>
            </td>
          <td>
            Xinze Li, Wangjie Sun, Wenmo Chen, Naixuan Wang, Shaoxia Wang
          </td>
          <td>2025-09-26</td>
          <td>Molecular Biology Reports</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Degeneration of myelinating oligodendrocytes and the resulting breakdown of the myelin sheath are key drivers of neurodegeneration and disability across numerous central nervous system pathologies. Thus, a compelling strategy to preserve neuronal function is to promote endogenous myelin repair by oligodendrocyte precursor cells (OPCs). Extracellular vesicles (EVs) secreted by pro-regenerative microglia have been shown to enhance OPC maturation and remyelination across different experimental models. Yet, the mechanisms by which microglia-derived EVs exert their beneficial effects on OPCs are not fully understood. In this study, we performed transcriptomic profiling of primary murine OPCs treated during differentiation with EVs obtained from donor microglia following stimulation with pro-inflammatory cytokines (i-EVs), interleukin-4 (IL4-EVs), or mesenchymal stem cells in the presence of the inflammatory cocktail (MSC-EVs; GEO accession number: GSE304130). Compared to controls, IL4-EVs and MSC-EVs induced robust changes in gene expression, whereas i-EVs elicited far fewer alterations. Using bioinformatic analyses, we identified the molecular pathways significantly modulated by microglial EVs, revealing a large overlap between IL4-EV and MSC-EV targets. Notably, many of these shared pathways centered on mitochondrial function and bioenergetic metabolism. Upstream regulatory network inference further pinpointed candidate transcription factors and kinases that may drive EV-induced transcriptional reprogramming in OPCs. Hence, our findings indicate that rewiring mitochondria-associated pathways is a core mechanism underlying the pro-differentiation effects of microglial EVs on OPCs. Elucidating these intracellular circuits will open new avenues for developing EV-based or mitochondria-targeted remyelinating therapies. Transcriptional effects of microglia-derived extracellular vesicles on oligodendrocyte maturation. Transcriptomics profiling revealed that extracellular vesicles derived from pro-regenerative microglia (IL4-EVs and MSC-EVs) reprogram oligodendrocyte precursor cells (OPCs) by modulating mitochondrial and bioenergetic pathways, promoting their maturation. In contrast, pro-inflammatory i-EVs induce minimal transcriptional changes and have a limited impact on OPC differentiation Transcriptional effects of microglia-derived extracellular vesicles on oligodendrocyte maturation. Transcriptomics profiling revealed that extracellular vesicles derived from pro-regenerative microglia (IL4-EVs and MSC-EVs) reprogram oligodendrocyte precursor cells (OPCs) by modulating mitochondrial and bioenergetic pathways, promoting their maturation. In contrast, pro-inflammatory i-EVs induce minimal transcriptional changes and have a limited impact on OPC differentiation">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1b95243ad26d133386a4eadb6ee422c452782bc0" target='_blank'>
              Microglia-Derived Extracellular Vesicles Enhance Oligodendrocyte Maturation by Transcriptionally Regulating Mitochondrial Molecular Pathways
              </a>
            </td>
          <td>
            S. Raffaele, Marta Lombardi, Davide Marangon, M. Abbracchio, D. Lecca, C. Verderio, Marta Fumagalli
          </td>
          <td>2025-10-21</td>
          <td>Cellular and Molecular Neurobiology</td>
          <td>0</td>
          <td>66</td>
        </tr>

        <tr id="BACKGROUND
The COVID-19 pandemic, caused by SARS-CoV-2, has led to the first approval of mRNA vaccines in humans. By producing the full-length SARS-CoV-2 Spike protein, they induce protective antiviral immunity. Acute myopericarditis (AMP) development after vaccination has repeatedly been reported; however, the pathogenesis of this complication remains elusive.


METHODS
In-depth phenotyping of peripheral blood T cells was undertaken in cohorts of patients who developed AMP after mRNA vaccination, patients hospitalized for severe COVID-19, and healthy subjects with no cardiac side effects after mRNA vaccine. Validation studies were carried out using an experimental model of cardiac inflammation, in which a shared epitope elicits functional responses in patients and mice and induces AMP.


RESULTS
We show that T cells from patients with AMP recognize vaccine-encoded Spike epitopes homologous to those of cardiac self-proteins. One of these epitopes, mimicking an amino acid sequence from a cardiomyocyte-expressed K+ channel, induced AMP in mice. When functional responses to the Kv2 were analyzed, patients with AMP after mRNA vaccination, but not patients with COVID-19, displayed an expanded pattern of cytokine production similar to that observed in AMP mice and in autoimmune myocarditis. Crucially, T-cell autoimmunity segregates to cardiotropic cMet (c-mesenchymal epithelial transition factor)-expressing T cells and is prevented by cMet inhibition, suggesting that heart homing imprinting, permitted by the unique mRNA vaccine biodistribution, is required for AMP development.


CONCLUSIONS
AMP development after mRNA vaccines is mediated by distinct immune components, including molecular mimicry, T-cell receptor affinity, and, importantly, homing imprinting.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7a2c7768da7a26c5948ed8c2a53768a7ad48ff71" target='_blank'>
              Combined Adaptive Immune Mechanisms Mediate Cardiac Injury After COVID-19 Vaccination.
              </a>
            </td>
          <td>
            Silvia Fanti, Carlene Dyer, I. J. Ingimarsdóttir, Daniel Harding, Guosu Wang, Antonio d'Amati, Eriomina Shahaj, Aðalbjörg Ýr Sigurbergsdóttir, Helga Thorsdottir, Oddný Brattberg Gunnarsdóttir, S. Kanoni, Paul Wright, John Martin, J. Chorlton, Zoe Hollowood, S. F. Brynjólfsson, Bjorn Rúnar Lúdvíksson, Egle Solito, Serena Bert, Jack M. Keane, S. Mohiddin, M. Longhi, F. Marelli-Berg
          </td>
          <td>2025-10-30</td>
          <td>Circulation</td>
          <td>0</td>
          <td>69</td>
        </tr>

        <tr id="Long COVID has emerged as a major global health concern, yet the long-term trajectory of immune recovery and its contribution to persistent symptoms remain to be elucidated. Here, we conducted a three-year longitudinal follow-up of the 47 COVID-19 patients and applied single-cell RNA sequencing (scRNA-seq) and multiplex cytokine profiling to comprehensively characterize the peripheral immune landscape during convalescence. We observed persistent immune dysregulation up to three years post-infection, characterized by chronic inflammation and impaired restoration of naïve CD4⁺ T cells, naïve CD8⁺ T cells, and SLC4A10⁺ MAIT cells—features reminiscent of immunosenescence. Notably, Th17 cells, rather than monocytes, emerged as key drivers of chronic inflammation beyond one year. We identified two distinct Th17 subsets: RORC⁺ Th17 cells and LTB⁺ Th17 cells. While RORC⁺ Th17 cells were negatively correlated with inflammatory cytokine levels, LTB⁺ Th17 cells showed proinflammatory features and were positively associated with long COVID symptoms. Sustained elevation of S100A8 and IL-16 in follow-up patients may contribute to the persistent presence of LTB⁺ Th17 cells. Together, our study provides an in-depth longitudinal map of immune remodeling in COVID-19 convalescents, revealing key cellular and molecular drivers of sustained inflammation up to three years post-infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f682ef5df5972e318b0093c3cf2459508e92d089" target='_blank'>
              T cell-driven sustained inflammation and immune dysregulation mimicking immunosenescence for up to three years post-COVID-19
              </a>
            </td>
          <td>
            Tian Zheng, Ru Gao, Yiwei Liu, Ye-ming Wang, Chao Wu, Li Guo, Lan Chen, Xinming Wang, Yan Xiao, Jingchuan Zhong, Rongling Zhang, Ying Wang, Xianwen Ren, Bin Cao, Lili Ren, Jianwei Wang
          </td>
          <td>2025-11-20</td>
          <td>Immunity & Inflammation</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Long- and post-COVID-19 syndromes have emerged as a significant global health challenge, with millions of individuals experiencing persistent or the development of new symptoms after a long period of an initial SARS-CoV-2 infection. These symptoms are multisystemic and may indicate changes in the respiratory, neurological, cardiovascular and gastrointestinal systems, in addition to prolonged fatigue. Vaccination has played a crucial role in reducing severe disease and mortality, but the impact of the different vaccine combinations on the development and resolution of Long COVID remains a topic of debate. This review synthesizes current evidence on how different vaccine platforms, dosing strategies and booster doses influence the immunological response, protection, incidence, severity, and persistence of Long COVID symptoms. We discuss key immunological mechanisms by which vaccination may modulate and protect post-COVID syndrome outcomes, including its effects on viral clearance, immune response reprogramming, inflammation, and autoimmunity, seeking to combat misinformation and concepts spread by fake news. The review also highlights controversies and research gaps, such as variability in vaccine response among different populations and the role in the selection of more transmissible and virulent SARS-CoV-2 variants, as well as the potential differences between vaccine-induced and infection-induced immunity, and the role of pre-existing immune conditions in this scenario.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c1877f162e92139adf77d3156392d030444bf043" target='_blank'>
              Vaccination and COVID-19: impact on long-COVID
              </a>
            </td>
          <td>
            Gustavo N. Guimarães, N. S. Brunetti, D. G. de Lima, J. Proença-Módena, Alessandro S Farias
          </td>
          <td>2025-11-19</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="As the pediatric COVID-19 landscape evolves, it is essential to evaluate whether SARS-CoV-2 infection predisposes children to allergic disorders. This narrative review synthesizes current epidemiological and immunological evidence linking pediatric COVID-19 with new-onset atopy. Epidemiological data remain heterogeneous: large Korean and multinational cohorts report increased risks of asthma and allergic rhinitis following COVID-19, whereas U.S. cohorts show neutral or protective associations, highlighting geographic and methodological variability. Mechanistic insights provide biological plausibility: epithelial injury and the release of alarmin cytokines (IL-33, IL-25, TSLP) promote Th2 polarization and ILC2 expansion, while epigenetic “scars” (e.g., LMAN2 methylation changes) and hematopoietic stem cell reprogramming may sustain long-term Th2 bias. Cytokine memory involving IL-7 and IL-15 contributes to altered T- and B-cell homeostasis, whereas disrupted regulatory T-cell function may reduce tolerance thresholds. Paradoxical trade-offs exist, such as ACE2 downregulation in allergic airways, which may lower viral entry but simultaneously amplify type-2 inflammation. Together, these processes suggest that SARS-CoV-2 infection could foster a pro-allergic milieu in susceptible children. Although current evidence is inconclusive, integrating epidemiological surveillance with mechanistic studies is crucial for predicting and alleviating post-COVID allergic outcomes. Longitudinal pediatric cohorts and interventions targeting epithelial alarmins or microbiome restoration may hold promise for prevention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/915e70de93eed337c1055b8bcb1c32ceec3aa48b" target='_blank'>
              Immunological Mechanisms Underlying Allergy Predisposition After SARS-CoV-2 Infection in Children
              </a>
            </td>
          <td>
            Filippos Filippatos, Dimitra-Ifigeneia Matara, Athanasios Michos, K. Kakleas
          </td>
          <td>2025-09-28</td>
          <td>Cells</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Coronavirus disease 2019 (COVID-19) patients have a 1.7-fold higher arrhythmia risk with rates of cardiac complications ranging from 2% non-ICU patients to 59% in non-survivors. Atrial fibrillation (AF), the most common arrhythmia, is a frequent complication of acute and long COVID-19. The high expression of ACE2 in the heart suggested that infectious virus may underlie cardiac complications. However, we recently reported in human cardiac tissue from fatal COVID-19 cases perivascular spike protein, elevated pro-inflammatory cytokines, vascular damage, and cardiac remodeling without evidence for direct infection of cardiac cells by SARS-CoV2. Mislocalization of intercalated disc (ID) components, connexin-43 (Cx43) gap junctions and NaV1.5 sodium channels, was also evident in patients’ hearts, recapitulating structural remodeling we previously identified as providing a substrate for atrial arrhythmias following an acute inflammatory insult. Therefore, we hypothesized that the inflammatory response elicited by SARS-CoV2 spike protein is sufficient to provoke atrial arrhythmias. Structural and functional assessments of WT murine hearts were performed five days following a single bolus intravenous injection of the viral spike protein. In vivo ECGs demonstrated increased atrial arrhythmia burden in spike-injected mice vs. control. Immunohistochemistry studies revealed elevated expression of inflammatory markers and evidence of vascular damage in these mice. Additionally, we observed disruption of ID ultrastructure and mislocalization of Cx43 and NaV1.5 in the atria of spike protein-injected mice. Our results suggest that vascular-leak inducing inflammatory insult from viral spike protein, and not direct infection by SARS-CoV2 results in the pathophysiology of cardiac dysfunction in fatal COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c153f00606118d9f8c8e5f0644e86dd859e1dd6c" target='_blank'>
              SARS-CoV-2 spike protein-induced inflammation underlies proarrhythmia in COVID-19
              </a>
            </td>
          <td>
            Louisa Mezache, Andrew M. Soltisz, Esmerina Tili, Gerard J. Nuovo, R. Veeraraghavan
          </td>
          <td>2025-09-30</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Background. Asthma is a chronic progressive heterogeneous respiratory disease accompanied by the development of a systemic inflammatory response. Due to the widespread prevalence of the novel coronavirus infection, there is concern about the impact of COVID-19 on patients with asthma. Current evidence suggests that SARS-CoV-2 activates the inflammasome response, triggering a hyperinflammatory reaction in patients with asthma, but the long-term consequences are still insufficiently studied. 
Purpose. To study the features of the systemic inflammatory process over six months after SARS-COV-2 infection in individuals with asthma. 
Materials and methods. In patients with mild, partially controlled asthma after mild COVID-19 infection (n = 52) and individuals with asthma (n = 34) who did not contract COVID-19, an assessment of inflammatory markers in peripheral blood was performed. Patients were examined immediately after recovery and confirmation of a negative SARS-COV-2 test result; one month, three months, and six months after the infection. The control group included conditionally healthy volunteers (n=15) who did not contract COVID-19. The cellular composition of peripheral blood, ESR, CRP, D-dimer levels were determined by classical methods; interleukin concentrations: (IL)-1β, IL-6, IL-18, NOD-like receptor protein 3 (NLRP3) inflammasome, gasdermin D (GSDMD) were measured by ELISA methods. 
Results. It was revealed that for all studied parameters, there is a slow decrease in the level of indicators by six months. The levels of GSDMD, platelets, IL-1β, D-dimer, ESR, IL-6, NLRP3 after six months do not reach the values of the control group, which indicates a persistent hyperinflammatory response of the immune system. 
Conclusion. Activation of NLRP3 and gasdermin D by the SARS-CoV-2 virus directly or indirectly can lead to dysregulation of inflammasome-mediated mechanisms, triggering and maintaining a hyperinflammatory reaction for six months, prolonging the recovery process in patients with asthma. The study of these processes will expand the understanding of the pathological mechanism. This will allow the development of new therapeutic strategies for asthma patients who have suffered from the novel coronavirus infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4989330952617c30321fd95e1d3a822ad386e019" target='_blank'>
              Dynamics of inflammatory markers over six months in patients with asthma who underwent COVID‑19
              </a>
            </td>
          <td>
            T. G. Lobova, T. Vitkina
          </td>
          <td>2025-10-31</td>
          <td>Siberian Journal of Life Sciences and Agriculture</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Since its emergence, the coronavirus (SARS-CoV-2) outbreak has been a pandemic responsible for about 7 million deaths worldwide. Numerous studies have been conducted to determine the virus’s multiorgan system involvement, particularly its relation to cancer biology. Spontaneous regression of cancer has been observed in some patients with the coronavirus, which may be attributed to the virus’s ability to trigger specific immune responses that can be oncolytic and help reduce and eliminate oncogenic cells. This study aims to explore the paradoxical effects of COVID-19 in inducing cancer regression. The paradoxical effect of SARS-CoV-2 infection has been attributed to the possibility of a heightened immune activation possibly triggered by the virus, and some of these include increased levels of cytokines such as interferon and tumor necrosis factor-alpha (TNF-α), as well as the activation of T cells and natural killer (NK) cells. COVID-19-induced cancer regression presents new perspectives on the relationship between viral infections and the immune system’s antitumor capabilities. This would help foster future research investigating specific immune pathways activated during SARS-CoV-2 and discover how these can be therapeutically harnessed to aid cancer regression. Not applicable.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2b70234ee10e35d21e82680c57b0003d8503d4e0" target='_blank'>
              COVID-19 infection and cancer regression: a review of current evidence, potential mechanisms, and clinical perspectives on a Paradoxical phenomenon
              </a>
            </td>
          <td>
            I. Ogieuhi, V. Ajekiigbe, C. Agbo, Chidera Stanley Anthony, Adegbesan Abiodun Christopher, Jennifer Chinaecherem Onyehalu, M. C. Agu, Sylvia Mmesomachi Mbaji, Adewunmi Akingbola, Bisharat Ahmed, Owa Ogieuhi, O. Akinmeji
          </td>
          <td>2025-10-23</td>
          <td>Infectious Agents and Cancer</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Tuberculosis (TB) remains a major global health challenge. Peripheral blood immune cell composition provides valuable insights into TB progression and management. In this study, we analyzed cellular dynamics across the TB disease spectrum using 43 global transcriptomic datasets encompassing 5,902 blood samples. Distinct immune changes were identified during the early stages of TB progression. Transition from latent infection to incipient TB was associated with reduced proportions of natural killer (NK) cells. In subclinical TB, monocyte proportions increased further, accompanied by additional reductions in NK cells and B cells. These early immune shifts preceded the pronounced alterations observed in active TB, characterized by elevated monocytes and neutrophils alongside markedly decreased lymphocyte populations. During successful anti-TB treatment, immune profiles gradually normalized. Cellular dynamics were also influenced by TB burden, age, and HIV coinfection, with stronger immune responses observed in adults and in regions with lower TB burdens. Overall, this study highlights early-stage peripheral blood biomarkers, particularly NK cell changes, as potential indicators of TB progression and targets for preventive interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f8574e17dda1b09d6c703a7d3ef93ad3a9f3cdff" target='_blank'>
              Peripheral blood cellular dynamics during the progression of human tuberculosis
              </a>
            </td>
          <td>
            Shanshan Zhu, Qiuchen Dai, Kai Wang, Hanlin Yan, Yuexuan Ma, Yayan Niu, Cheng Chen, Meiying Wu, Xueying Xie, Wanjun Gu
          </td>
          <td>2025-10-27</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="ABSTRACT Background: The mortality of COVID-19 is largely the result of cellular injury and inflammation of pulmonary and nonpulmonary vital tissue after severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infection. Evidence has accumulated that this inflammation is associated with multiple cytokine overexpression, named Cytokine Storm Syndrome (CSS) or Cytokine Release Syndrome (CRS). The commonly used techniques to predict CSS/CRS and thereby severe COVID-19 are dependent on costly instrumentation and consumables, and frequent calibration and costly controls on a regular basis. Methods: We determined the specific cytokine gene (IL-1β, IL-6, IL-2, TGFβ, and IFN-γ) expression levels as a biomarker early in the disease process (Day-5) for severe disease using multiplex qRTPCR technique using real-time thermo-cyclers which are now available in all peripheral centers. Day-5 quantitative biomarker (C-Reactive Protein, IL-6, Ferritin, and D-Dimer) and day-7 IgG anti-SARS-CoV-2 levels were determined through the routine autoanalyzers and immune assays. We evaluated whether each of these specific biomarkers with age, gender, comorbidities, and severity can aid early detection of severity. Results: The present research identifies age > 65 years, presence of diabetes mellitus, hypertension or multimorbidity and lack of COVID-19 vaccination, and D-Dimer levels at Day-5 to be associated significantly (P value < 0.05) with severe COVID-19 infection. Crucially, Day-5 gene expression levels of IL-2, IL-6, and IFN-γ were inversely associated with COVID-19 severity and significantly lower (P < 0.05) in those with severe COVID-19 vis. healthy controls. Conclusion: We propose IL-2, IL-6, and IFN-γ gene expression study through a multiplex qRTPCR assay and the D-dimer test as rapid tools to triage COVID-19 patients during management and identify need for escalating therapy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7f5886606e5602e6e19694b99d3ff1ed2cbe4e18" target='_blank'>
              Early detection of cytokine storm and IgG levels to predict and prevent severe COVID-19 infection
              </a>
            </td>
          <td>
            Pramathadhip Paul, T. K. Mandal, Purba Mukherjee, Indranil Thakur, Rajsekhar Maiti, Sujit Kumar Bhattacharyya, Piyali Haldar, Subhenjit Ray, R. R. Ghosh, Ramaprasad Roy, Utpal Dan, S. Chatterjee
          </td>
          <td>2025-10-01</td>
          <td>Journal of Family Medicine and Primary Care</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Ending of COVID-19 pandemic does not exclude subsequent breakthrough infections caused by SARS-CoV-2 mutant strains. The rate of SARS-CoV-2 mutations increased with emerging omicron strain and exceeds those of the influenza virus. It remains unclear what IgG antibody levels are able to protect against new mutant SARS-CoV-2 strains, and how long the immune protection will last. The objective of this study was to monitor the maintenance of humoral and cellular immunity to SARS-CoV-2 viral antigens over 4 years after the infection. Thirty-two adult reconvalescents after COVID-19 were annually examined for humoral and cellular immunity markers to the SARS-CoV-2 S protein. Humoral immunity was assessed by ELISA; cellular immunity was evaluated by expression of CD107a on CD8hi lymphocytes after recognition of S protein antigens. A four-year observation of a group of patients who recovered from COVID-19 in 2020 (SARS-CoV-2, Wuhan strain) and were in contact with a novel, freely circulating mutant VoCs showed that, 1 year later, all subjects retained the IgG antibodies to S protein, mainly the IgG1 subclass, but the antibody avidity index barely exceeded 50%. After a breakthrough infection caused by the omicron strain, the level of IgG antibodies to S protein increased significantly, along with sufficient increase of antibody avidity. The IgG2, IgG3, and IgG4 antibodies to S protein occured in the spectrum of subclasses. The level of specific IgA decreased 1 year after the disease against their level after the primary disease. However, it was significantly increased to 4-5 PR after breakthrough infections. Cellular immunity to the SARS-CoV-2 S protein was detected in all subjects at 1 year after the primary disease. After repeated infection with the omicron strain, it increased significantly and remained at this level for the next year. By 4 years, it decreased to the level that was a year after the disease. Hence, humoral and cellular immunity to S protein does not fade away, but continues to persist, maturate, being maintained at a sufficient level. Upon exposure to a new VoC, it allows to endure such a meeting either asymptomatically, or as a mild clinical infection. In view of frequent mutations in the S protein, the role of T-cell responses in anti-infectious protection seems to increase significantly. When developing new vaccines, one should rely on development of cellular immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e639b1e50968635421ab873cef8a370649bdc963" target='_blank'>
              Immunological memory to SARS-CoV-2 S protein persists 4 years after the disease
              </a>
            </td>
          <td>
            Z. Afridonova, A. Toptygina, E. Semikina
          </td>
          <td>2025-09-28</td>
          <td>Russian Journal of Immunology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6f8533b56cfd6745039054451557c794b2fe28b8" target='_blank'>
              Neutrophil Transcriptomics in SLE: Exploring Intrinsic, Ex Vivo Adaptation, and CAR T-Cell Therapy-Induced Changes
              </a>
            </td>
          <td>
            Ehsan Dehdashtian, Guangnan Hu, Leah Whiteman, Md Tanimul Islam, Stefania Gallucci, Manuel Garber, Dominic Borie, G. Schett, Roberto Caricchio
          </td>
          <td>2025-11-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="Abstract The ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has highlighted the virus's remarkable ability to evolve and adapt in diverse hosts. Despite the observation of recurrent mutations and convergent evolution in the viral genome, the mechanisms driving these processes remain poorly understood, particularly in the context of diverse host environments and limited genomic surveillance. We established a rigorously controlled in vitro cellular system within a Biosafety Level 3 Laboratory, ensuring strict adherence to biosafety protocols while passaging the virus in seven cell lines derived from four tissues across five mammalian species. High-throughput sequencing revealed consistent positive selection on the Spike (S) protein, highlighting its adaptability in the absence of adaptive immune responses or therapeutic pressures. Type I interferons (IFN-I) and APOBEC-mediated editing may emerge as key modulators of viral evolution. Notably, IFN-I activation is inversely correlated with the accumulation of S protein mutations (E484D, P812R/L, L1186R). Our findings uncover host-specific selective forces in shaping SARS-CoV-2 evolution and highlight the need for systematic approaches to mitigate viral transmission and emerging variants.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/461722f90e682345662c6276a91b4383ad6356c7" target='_blank'>
              Convergent Evolution and Host-Limiting Impacts of SARS-CoV-2 Revealed by Cellular Experiments
              </a>
            </td>
          <td>
            Ting Zhang, Ren-Rong Tian, Fengyi Li, Xiaolu Tang, Wenbin He, Zhen-Ping Hao, Lin Zhuo, Jian Lu, Xuemei Lu, Yong-Tang Zheng
          </td>
          <td>2025-10-28</td>
          <td>Molecular Biology and Evolution</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Macrophage senescence is increasingly recognized as a key contributor to immune dysfunction during aging and chronic inflammation. Here, we developed a reproducible long-term in vitro culture model to investigate the senescence’s phenotypic and functional consequences in human macrophages. Monocyte-derived macrophages (MDMs) were cultured for 7, 14, or 21 days and assessed for canonical senescence markers and immune function. While macrophages at day 7 exhibited minimal expression of β-galactosidase, H2AXpS139, and CDKN2A (p16INK4a), these markers were significantly upregulated at days 14 and 21, indicating progressive acquisition of a senescent phenotype. Cell viability remained above 95% across all time points, confirming the system’s stability. High-dimensional flow cytometry and unsupervised clustering revealed marked phenotypic remodeling over time, shifting from anti-inflammatory CD163+/CD206+ profiles to proinflammatory CD14+/CD64+/TLR2+ populations. Five distinct macrophage subpopulations were identified, each with dynamic temporal distribution and unique marker expression, highlighting a loss of plasticity and emergence of senescence-associated states. Functionally, day 7 macrophages produced a diverse cytokine panel responding to lipopolysaccharide (LPS), including IL-2, IL-12p70, IL-4, IL-5, TNF-α, GM-CSF, IFN-γ, and IL-10. In contrast, macrophages at days 14 and 21 displayed a markedly restricted cytokine profile, retaining the secretion of cytokines but significantly downregulating the secretion of Th1-type cytokines. This long-term culture model constitutes a robust, physiologically relevant tool to study immune aging, senescence-driven immune reprogramming, and inflammation in macrophages with the potential for the preclinical evaluation of therapeutic strategies to ameliorate inflammaging and restore immune competence.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ab95a8839ef87268195895ca58ab1a30d34a0c3f" target='_blank'>
              A long-term culture model for investigating senescence-associated dysregulation in macrophages
              </a>
            </td>
          <td>
            Andy Ruiz, María Guadalupe Lucero-Gil, Martha Torres, Esmeralda Juárez
          </td>
          <td>2025-10-02</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Macrophages are crucial for neuroinflammatory responses following traumatic brain injury (TBI), encompassing various subtypes, such as border-associated macrophages (BAMs) that contribute to both brain damage and repair. However, the pathophysiological relevance of subtype-specific molecular markers is poorly understood. This study investigated the role of the BAM marker mannose receptor C-type 1 (MRC1, also known as CD206) during the early phase of TBI using controlled cortical impact (CCI). MRC1 gene expression was up-regulated, peaking between 3 to 7 days post-injury (dpi), and MRC1 protein expression predominantly localized to BAMs. To assess pathophysiological relevance, MRC1-deficient (MRC1-KO) and wild-type littermates (MRC1-WT) were examined following CCI for early neurological deficits, brain structural damage, intracerebral hematoma, and neuroinflammatory marker expression. At 5 dpi, MRC1-KO mice showed increased brain lesion volume and hippocampal neuron loss, with minor differences in neurological deficits compared to MRC1-WT mice. Intracerebral hematoma size increased in male but remained unchanged in female MRC1-KO mice. Immunostaining revealed no genotype-specific effects on GFAP+ astrocytes, while the number of perilesional CD68+ macrophages/microglia were reduced in MRC1-KO mice. Analysis of neuroinflammatory gene markers revealed an overall reduction in MRC1-KO mice. Sex-specific regulation was observed for the M2-like macrophage/microglia marker Arg1, with decreased expression in male and increased expression in female MRC1-KO compared to MRC1-WT mice. In conclusion, lack of MRC1 exacerbated brain tissue damage following experimental TBI. Reduced CD68+ macrophages/microglia and neuroinflammatory marker expression suggests impaired neuroinflammatory response in MRC1-KO, indicating MRC1 expression on BAMs contributes to beneficial early neuroinflammatory response following TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1ac5ec2bb9a4f897f1ee154ba78ff99b4c7b8daa" target='_blank'>
              The border-associated macrophage marker MRC1 contributes to an early neuroprotective inflammatory response to traumatic brain injury in mice
              </a>
            </td>
          <td>
            Jenny Strehle, Pawit Somnuke, Shuailong Li, Sudena Wang, Tobias Hirnet, Yong Wang, Michael K. E. Schäfer
          </td>
          <td>2025-10-30</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Abstract Background Survivors of COVID-19 frequently report psychiatric and cognitive sequelae. The origin of such sequelae has not been determined, as it has been a challenge to resolve whether these symptoms have a viral origin or are related to the contextual stressors associated with the pandemic. Using a mouse model of post-acute sequelae of SARS-CoV-2 infection (PASC), we examined neurobiological mechanisms underlying these effects without the confounding influence of contextual factors. Results SARS-CoV-2 infection induced cognitive, but not anxiety- or depression-like, behavioral deficits. Cognitive impairments correlated with severity of the acute disease. Infected mice showed significant alterations in brain cytokine levels, as well as in kynurenine pathway (KP) metabolites, both of which were associated with acute disease severity. Microbiome taxonomic profiling revealed group-specific differences, indicating that certain bacterial species may contribute to PASC development. Conclusions Our findings suggest that SARS-CoV-2 infection causes cognitive deficits in PASC, modulated by acute disease severity, while anxiety- and depression-like behaviors appear unrelated to the viral infection itself. This supports the idea that such psychiatric symptoms may stem from pandemic-related stressors rather than infection. Altered cytokine signaling and KP metabolism may play key roles in the pathophysiology of PASC, identifying potential biomarkers and therapeutic targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0fb3ed4fe779a93447277b5e14c32a1a056c5b57" target='_blank'>
              Neuropsychiatric- and cognitive post-acute sequelae of SARS-CoV-2 infection – evidence from K18-hACE C57BL/6 J mice
              </a>
            </td>
          <td>
            Marco Maria Santi, Eleonora Genovese, T. Schou, Matheus da Silva, Sophie Erhardt, L. Schwieler, Jacob Ahlberg Weidenfors, Giorgia Marino, S. R. Paludan, Sâmia Joca, G. Wegener, L. Reinert, C. Bay-Richter
          </td>
          <td>2025-09-30</td>
          <td>International Journal of Neuropsychopharmacology</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="Abstract Multiple sclerosis (MS) is a chronic, autoimmune, demyelinating disease of the central nervous system (CNS) in which macrophages play a pivotal and multifaceted role. These highly plastic immune cells are key effectors in the immunopathology of MS, contributing to both inflammatory-driven demyelination and subsequent tissue repair. Historically, macrophage function was viewed through the binary lens of pro-inflammatory M1 and anti-inflammatory M2 polarization. However, recent research reveals a far more complex spectrum of activation states within the dynamic microenvironment of MS lesions. Understanding the intricate signals and molecular pathways that govern macrophage polarization in the CNS represents a critical frontier for therapeutic innovation. Interventions aimed at rebalancing macrophage phenotypes have yielded encouraging results in preclinical models, and some therapeutic agents are now advancing into clinical trials. Future investigations are focused on the diverse functions of macrophages in MS pathogenesis, including their involvement in oxidative stress, antigen presentation, and myelin debris clearance. A particularly innovative approach involves harnessing macrophages as cellular vehicles for targeted drug delivery across the blood-brain barrier, offering a potential solution to one of the most significant challenges in CNS therapeutics. The primary challenge now lies in the safe and effective clinical translation of these macrophage-centered therapies. Successfully navigating this transition from bench to bedside holds the potential to deliver transformative treatments that can halt disease progression and restore neurological function for individuals living with this debilitating disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/aad33ff0adee236c1c773c1750932b0d5634824d" target='_blank'>
              Emerging Insights into the Role of Macrophages in Multiple Sclerosis: Pathogenesis and Potential Therapeutic Strategies
              </a>
            </td>
          <td>
            Jundong Yang, Ziyue Fu, Qiyuan Zou, Zhaoyinqian Li, Yuhan Xing
          </td>
          <td>2025-10-01</td>
          <td>Journal of Inflammation Research</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Influenza virus infections vary widely in severity, with human challenge studies revealing substantial heterogeneity in viral shedding and immune responses. Yet, the mechanistic basis of this variability remains unresolved. Here, we applied a multivariate mechanistic modeling framework to determine how variation in viral replication and CD8+ T cell responses shapes infection kinetics and symptom dynamics in individuals experimentally challenged with H1N1 influenza virus. The analysis identified six distinct infection clusters arising from multivariate influences, including viral dose and individualized rates of viral infectivity. Baseline T cell levels contributed minimally, and model outputs suggested a tradeoff between CD8+ T cell efficacy and expansion. Two participants showed evidence of reinfection despite being antibody negative, and modeling their data indicated that host-pathogen interactions remained consistent with those from primary infections, though data were insufficient to distinguish between cytotoxic and IFN-{gamma}-mediated protection. Modeling of symptom trajectories further revealed potential subjectivity in symptom reporting, independent of viral strain. Collectively, these findings demonstrate how mechanistic modeling can improve the predictability of influenza outcomes and reveal that intrinsic human variation can converge on similar infection trajectories.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/aafe79bc1a3e7118116d1f3a06bf63a057763842" target='_blank'>
              Multivariate Host-Pathogen Interactions Driving Heterogeneous Viral Shedding and CD8 + T cell Control of Influenza Virus Infection
              </a>
            </td>
          <td>
            Nicole Bruce, J. J. Weaver, C. Jeynes-Smith, Fatemeh Beigmohammadi, Solene G. D. Hegarty-Cremer, Amanda P. Smith, Morgan Craig, Amber M. Smith
          </td>
          <td>2025-10-27</td>
          <td>medRxiv</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Neurotropic viruses, such as Japanese encephalitis virus (JEV), trigger central nervous system (CNS) inflammation primarily through disruption of the blood–brain barrier (BBB) and infiltration of peripheral immune cells. Although the gut microbiota is known to regulate diverse immunopathological processes, its contribution to CNS neuroinflammation and systemic immune responses during neurotropic viral infection remains poorly understood. Here, we show that depletion of gut microbiota by antibiotic cocktail treatment markedly increases susceptibility to CNS neuroinflammation following JEV infection. Loss of microbiota promoted viral dissemination into extraneural tissues, aggravated systemic inflammation and organ damage, and impaired tonic type I interferon (IFN-I) responses and hematopoietic differentiation during disease progression. Remarkably, fecal microbiota transplantation (FMT) restored resistance to CNS neuroinflammation, highlighting the protective role of the microbiota. Moreover, ampicillin-mediated depletion of specific gram-positive bacteria—including Bifidobacterium, Faecalibaculum, Ligilactobacillus, and Turicibacter—was associated with enhanced viral spread, systemic inflammation, and organ injury, accompanied by distinct shifts in fecal metabolites. Collectively, these findings demonstrate that gut microbiota–driven tonic IFN-I responses limit viral dissemination in extraneural tissues, thereby attenuating systemic inflammation and protecting against CNS neuroinflammation, particularly viral encephalitis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/05dc7ecb536c1f8f63866db104e2581d4fc3e266" target='_blank'>
              The gut microbiota limits systemic inflammation during neurotrophic viral CNS infection by priming tonic type I interferon signaling
              </a>
            </td>
          <td>
            Hye Won Cho, Hee Won Byeon, S. Park, Erdenebileg Uyangaa, Jin Young Choi, Koanhoi Kim, S. Eo
          </td>
          <td>2025-11-04</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="Microglia play a crucial role in brain homeostasis through phagocytosis of amyloid-β (Aβ) fibrils, a hallmark of Alzheimer disease (AD) pathology. The balance between Aβ production and clearance is critical for AD pathogenesis, with impaired clearance mechanisms potentially contributing to disease progression. G-protein coupled receptor 34 (GPR34), a microglia-enriched Gi/o-coupled receptor, is highly expressed in homeostatic microglia and may regulate phagocytic functions, yet its role in Aβ clearance remains poorly understood. Using flow cytometry-based assays, we investigated the effect of a selective GPR34 agonist (M1) on Aβ uptake in mouse primary microglia and human induced pluripotent stem cell-derived microglia. We evaluated uptake specificity across different Aβ species and phagocytic substrates, and measured intracellular cyclic adenosine monophosphate (cAMP) levels to determine the signaling mechanism. We performed in vivo studies using human amyloid precursor protein knock-in mice with intrahippocampal M1 injections. Additionally, we analyzed GPR34 expression in Japanese AD patient brain samples using single-nucleus RNA sequencing and examined age-dependent expression changes across multiple datasets. M1 specifically enhanced uptake of Aβ fibrils through reduction of intracellular cAMP levels, without affecting monomeric or oligomeric Aβ internalization. Gpr34 knockdown experiments confirmed GPR34 as the molecular target of M1. An intrahippocampal injection of M1 significantly increased microglial Aβ uptake in vivo, an effect that required functional TREM2 signaling. GPR34 expression was significantly reduced in microglia from AD patients and showed age-dependent decline in both humans and mice. Our findings identify GPR34 as a promising therapeutic target for enhancing microglial Aβ clearance and highlight the potential of GPR34 agonists for AD treatment. The age-dependent decline in GPR34 expression may contribute to reduced Aβ clearance efficiency in aging brains, exacerbating amyloid accumulation. Pharmacological activation of GPR34 represents a novel strategy to counteract impaired Aβ clearance in both aging and AD brains, potentially modifying disease progression through enhancement of microglial phagocytic function.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5afe020f12c5a714a786e93704c90a8b2e2aca05" target='_blank'>
              Selective agonism of GPR34 stimulates microglial uptake and clearance of amyloid β fibrils
              </a>
            </td>
          <td>
            Hayato Etani, Sho Takatori, Wenbo Wang, Jumpei Omi, Yusuke Amiya, Aika Akahori, Hirotaka Watanabe, Iki Sonn, Hideyuki Okano, N. Hara, Mai Hasegawa, A. Miyashita, Masataka Kikuchi, T. Ikeuchi, M. Morishima, Yuko Saito, Shigeo Murayama, Takashi Saito, T. Saido, Toshiyuki Takai, Tomohiko Ohwada, Jun Aoki, Taisuke Tomita
          </td>
          <td>2025-11-20</td>
          <td>Alzheimer's Research & Therapy</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="ABSTRACT The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in 2020 led to the immediate development of vaccines to combat SARS-CoV-2 infections and coronavirus disease 2019 (COVID-19). First-generation (2020–2021) COVID-19 vaccines demonstrated high immunogenicity and efficacy, successfully reducing hospitalization, disease severity and COVID-19 related deaths. However, the initial clinical trials for these vaccines focused on overall healthy individuals, and generally excluded high risk populations, such as people with cancer. The SARS-CoV-2 VaccinE Response, Immunological eFfects and safetY in patients with Cancer (VERIFY-C) study formed a unique cohort in early 2021, to capture the initial immune response to BNT162b2 mRNA (Pfizer) vaccination in people with cancer, with or without ongoing/recent exposure to systemic cancer treatment. Fifty-three participants diagnosed with cancer were enrolled. Majority were non-Hispanic, Caucasian females. Patients under cancer treatment had significantly lower antibody responses than those without treatment at pre-second dose and 1-month post-second dose. The levels at 6-months post-second dose were similar between both groups. Patients under treatment had a significantly lower immune response 1-month post-second dose, with an increased immune response at 6-months post-second dose, suggesting a delayed immune response. Further investigations are needed to understand antibody functionality post-vaccination in these individuals.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e45420f0ba45dea4c651f1e55f885e82dbe1ff7e" target='_blank'>
              Humoral immune responses to the second dose of a COVID-19 mRNA vaccine in cancer patients undergoing treatment
              </a>
            </td>
          <td>
            Christine M Dang, Troy J. Kemp, Nancy V. Roche, Katarzyna Haynesworth, Sarah A Loftus, Benjamin J Borski, Ziad El Bakouny, C. Labaki, Gwo-Shou Mary Lee, Rachel Trowbridge, Sarah Strauss, Melissa E Hughes, Nancy U Lin, T. Choueiri, Ligia A. Pinto
          </td>
          <td>2025-10-14</td>
          <td>Human Vaccines & Immunotherapeutics</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="Leprosy is a chronic infectious disease that targets the peripheral nervous system, leading to peripheral neuropathy. Mycobacterium leprae primarily infects Schwann cells, adipocytes, and macrophages, altering their metabolism and gene expression. This study investigates the metabolic interaction between M. leprae and Schwann cells, with a focus on indoleamine 2,3-dioxygenase (IDO), a key enzyme in tryptophan catabolism via the kynurenine pathway. We found that M. leprae induces IDO expression in Schwann cells, suggesting a role in immune modulation and neuropathy. Inhibition of IDO with 1-methyl-L-tryptophan (1-MT) reduced Schwann cell viability and metabolic activity in response to M. leprae. After 24 h of infection, M. leprae impaired mitochondrial membrane potential, although no significant changes in autophagy or mitochondrial ultrastructure were observed by electron microscopy. Interestingly, IDO1 inhibition upregulated the expression of antioxidant genes, including GPX4, NFE2L2, and HMOX1. In conclusion, these findings highlight a central role for IDO in shaping the metabolic and immunological response of Schwann cells to M. leprae infection. IDO induction contributes to immune regulation and cellular stress, while its inhibition disrupts cell viability and promotes antioxidant gene expression. These results position IDO as a potential therapeutic target for modulating host–pathogen interactions and mitigating nerve damage in leprosy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/abb3610626dbc037a9c11480f7a7205f2b79ea22" target='_blank'>
              IDO-Mediated Immune and Metabolic Dysregulation in Schwann Cells Exposed to Mycobacterium leprae
              </a>
            </td>
          <td>
            Atta Ur Rahman, Raíssa Couto Santana, Mylena Masseno de Pinho Pereira, Claudia Luciana dos Santos Moura, Débora Santos da Silva, Otto Castro Araujo, Thyago Leal-Calvo, Isabela Espasandin, Tatiana Pereira da Silva, E. Sarno, Bruno J. de Andrade Silva, R. Menna-Barreto, M. M. Jardim, C. S. de Macedo, F. A. Lara, Roberta Olmo Pinheiro
          </td>
          <td>2025-10-01</td>
          <td>Cells</td>
          <td>0</td>
          <td>53</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/96d3861c110e5ae3f35e700cedd4412c7f059c98" target='_blank'>
              T-cell Multiomic Analysis Identifies Subsets and Mechanisms of Interaction with Epithelial Cells in Idiopathic Pulmonary Fibrosis
              </a>
            </td>
          <td>
            A. Serezani, Julia M. R. Bazzano, B. Pascoalino, Ludmilla da Silva, Abigail J. Dietrich, Chase J. Taylor, T. Sherrill, C. Calvi, Paula I. Gonzalez-Ericsson, E. Wilfong, Matthew D Bacchetta, C. Shaver, Lorraine B. Ware, M.L. Salisbury, Luc Van Kaer, N. Banovich, JA Kropski, Timothy S. Blackwell
          </td>
          <td>2025-11-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="Neuronal injury is a major pathological issue that cannot be ignored during viral infections. Mitochondria, the energy factories of the cell, play a unique role in this scenario and are severely impacted when viruses infect host cells. Viruses invade and infect cells via specific mechanisms, causing changes in cellular structure and function. These changes not only directly affect mitochondria but also disrupt their normal function through indirect pathways. This paper reviews the mechanisms of mitochondrial damage induced by infections with SARS‐CoV‐2, herpesviruses, human immunodeficiency virus (HIV), and hepatitis C virus (HCV), providing new insights and strategies for preventing and treating neuronal injury.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b7d11a6515ce64c0aca63891acdc45f1bc68ba1f" target='_blank'>
              Mitochondrial Disruption in Viral‐Mediated Neuronal Injury: A Mechanistic Perspective
              </a>
            </td>
          <td>
            Shuqi Shi, Mingzhu Zhai, Benqing Wu, Wuping Sun
          </td>
          <td>2025-10-01</td>
          <td>Journal of Medical Virology</td>
          <td>1</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/01d23f6e4d0fadd94bb32dc65cae50f988969ac5" target='_blank'>
              Re-shaping the immune response to influenza vaccination in a host with immune memory from influenza
              </a>
            </td>
          <td>
            Chantelle L. White, Lara Mengu, Siva K. Gandhapudi, K. Richards, A. J. Sant
          </td>
          <td>2025-10-01</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ff36a4b1a6924bc75f6af8503f56e2c97056bea0" target='_blank'>
              Dormant viral pathways underlie space-induced neural senescence – a neuroprotective strategy for spaceflight and neurological diseases
              </a>
            </td>
          <td>
            A. M. Martins, Hideyuki Nakashima, Angela Macia, Taichi Umeyama, Satoshi Miyashita, Livia Luz de Souza Nascimento, Luisa Bulcao Vieira Coelho, Pinar Mesci, Erik Viirre, Nicole Suarez, Aurian Saleh, Alex Savchenko, Beatriz Freitas, Aline L. Leite, Diego M. Assis, Masataka Ishizu, Tomoo Owa, Mikio Hoshino, John R. Yates, Kinichi Nakashima, A. Muotri
          </td>
          <td>2025-11-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>68</td>
        </tr>

        <tr id="Abstract Microglia, the immune cells of the central nervous system (CNS), quickly respond to neurodegeneration by proliferating and migrating to areas of disease, phagocytosing debris, and releasing cytokines to initiate inflammation. Critically, the mechanisms underlying these microglial functions remain only partly understood. One molecular regulator of interest is complement protein C1q, the initiator molecule of the complement cascade that increases 300-fold in healthy aging and accumulates with neurodegeneration. We have previously reported that exogenous C1q treatment alters inflammatory gene expression and cell function in human induced pluripotent stem cell-derived microglia (iMG). Here, we test the hypothesis that C1q induced cell changes are modulated by novel C1q receptor, CD44. We first used validated expression of five recently identified C1q receptors at the RNA and protein levels, and then we used proximity ligation assay to validate C1q-receptor binding on the iMG cell surface. CD44 was selected as an initial target and thus CD44 knockout iMG were generated to test whether the C1q response is dependent on CD44. While the C1q-induced inflammatory response was not dependent on CD44, we demonstrate that C1q-CD44 interactions regulate changes in microglial phagocytosis, proliferation, and migration. These data suggest C1q interacts with CD44 on iMG to modulate microglial functions that are critical to health and disease. This data informs future work which will test how C1q-CD44 interactions are altered in neurodegenerative disease and if these interactions could be modulated as a therapeutic target.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8b289d13959c42994aa13fbceb63e5c128433ea8" target='_blank'>
              C1q-CD44 interactions regulate microglial phagocytosis, proliferation, and migration
              </a>
            </td>
          <td>
            Pooja S Sakthivel, Alyssa J. Villegas, Anita Lakatos, Meghana Kaipa, Julian M. Lopez, Ashley Ling, Zeina H. Elrachid, Josh Karam, 
          </td>
          <td>2025-10-23</td>
          <td>Research Square</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="A major health challenge resulting from the COVID-19 pandemic is the manifestation of post-acute sequelae of SARS-CoV-2 (PASC). PASC (or long COVID) is a collective term used for clinical symptoms, various pathologies, and life-quality-changing functional impairment that persist for months to years after the initial SARS-CoV-2 infection. The mechanisms underlying PASC are not understood, although advances have been made in identifying factors that may contribute to long-term pathology. Recent data have emerged, showing an association between SARS-CoV-2 viral persistence and non-SARS-CoV-2 infections (pre-existing, viral reactivation, or new infections) in facilitating or mediating PASC. However, the heterogeneous nature and timing of co-infections have made it challenging to understand, interpret, and contextualize their contribution to PASC. Here, we summarize the impact of potential viral, bacterial, and fungal infections on SARS-CoV-2 pathogenesis, with a focus on their possible roles in the development of PASC. We also provide a framework to understand the mechanisms of PASC and inform basic, translational, and clinical research initiatives, including RECOVER, a large and ongoing research initiative to understand, treat, and prevent long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/000f98d578723e631538234351febf6a80fd995b" target='_blank'>
              The role of co-infection in the pathogenesis of acute SARS-CoV-2 infection and development of post-acute sequelae: A perspective
              </a>
            </td>
          <td>
            T. Henrich, Christopher P Montgomery, Joerg Graf, Nahed Ismali, S. Mohandas, Mehul Suthar, Hassan Brim, John M Coffin, Aayush Pagaria, Jeisac Guzmán Rivera, Urmila Vudali, P.S. Keim, Guangming Zhong, Rebecca McGrath, Belinda Edwards, Adolfo García-Sastre, M. Gennaro
          </td>
          <td>2025-11-17</td>
          <td>eLife</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/07b6cbe0eda40224684c97bf0f52bc79694f2cd8" target='_blank'>
              Third dose COVID-19 vaccination elicits immune memory in patients with inborn errors of immunity even in absence of neutralizing antibodies
              </a>
            </td>
          <td>
            E. S. J. Edwards, R. Gugasyan, N. Varese, S. Sun, J. E. Canning, E. G. Blight, P. Aui, I. Boo, S. Turville, A. Aggarwal, S. Ojaimi, J. J. Bosco, S. Stojanovic, P. M. Hogarth, H. E. Drummer, S. Bornheimer, R. O’Hehir, M. V. van Zelm
          </td>
          <td>2025-11-13</td>
          <td>None</td>
          <td>0</td>
          <td>44</td>
        </tr>

        <tr id="ABSTRACT Torquetenovirus (TTV) is a prevalent virus whose clinical significance remains unclear, potentially linked to immunosenescence. This study examines TTV species in relation to immune impairment, inflammation, and cellular stress response in aging. A subset of recruited age‐stratified individuals (RASIG) from the MARK‐AGE study was divided into three groups: Cohort 1 A (healthy young adults), Cohort 1B (older adults with mild immune decline), and Cohort 1 C (older adults with marked immune impairment). Analyses included TTV load, species diversity, lymphocyte subpopulations, inflammatory markers, Poly‐(ADP‐ribose) polymerase (PARP‐1) expression/activity. Alpha‐ and beta‐diversity analyses showed the highest TTV species diversity in Cohort 1 C, with significant cohort‐dependent differences and partially cohort‐specific clustering patterns. Increased TTV species number correlated with higher TTV load, elevated CMV IgG levels, and greater immune impairment risk. Specific TTV species were associated with CD4/CD8, and reduced T‐cell receptor excision circles, suggesting impaired T‐cell homeostasis. TTV viremia positively correlated with C‐reactive protein (CRP) and α2‐macroglobulin. PARP‐1 expression and activity increased in individuals with higher TTV diversity, particularly in the presence of TTV9 and TTV20. TTV load and species diversity are associated with immunosenescence, inflammation, and PARP‐1 activation suggesting their potential as biomarkers of age‐related immune decline. Longitudinal studies are needed to clarify underlying mechanisms.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f80aaae8b6afb118dd4b1838c672bee68f10102b" target='_blank'>
              TTV Species Diversity as a Novel Biomarker of Immune Dysregulation in Aging
              </a>
            </td>
          <td>
            Federica Novazzi, P. G. Spezia, F. Ferrante, A. Genoni, P. A. Grossi, Nicasio Mancini, Marco Malavolta, Marta Ballietti, Francesco Piacenza, Serena Marcozzi, Carlo Fortunato, G. V. Badillo Pazmay, L. Cianfruglia, Alexander Bürkle, M. Moreno-Villanueva, M. Dollé, E. Jansen, Tilman Grune, E. Gonos, C. Franceschi, M. Capri, Michele Zampieri, P. Caiafa, F. Ciccarone, Anna Reale, Birgit Weinberger, E. Sikora, Florence Debacq-Chainiaux, W. Stuetz, Mikko Hurme, P. Slagboom, J. Bernhardt, Fabiola Olivieri, Fabio Filippini, F. Maggi, R. Giacconi
          </td>
          <td>2025-10-23</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>64</td>
        </tr>

        <tr id="Influenza A virus (IAV) is a prevalent pathogen that causes severe respiratory infections worldwide. Currently, the incidence of coinfections between IAV and Gram-negative bacteria has been steadily increasing, and the synergistic interaction between IAV infection and bacterial exposure represents a pivotal risk factor for disease exacerbation. Lipopolysaccharide (LPS), a major Gram-negative bacterial virulence factor, is hypothesized to regulate IAV-induced immune response intensity and disease severity by reshaping the pulmonary immune microenvironment. Here, we established an in vivo coadministration model via intratracheal instillation of low-dose LPS and H1N1 to dissect their synergistic pathogenesis. LPS exposure potentiated H1N1-induced severe lung injury, manifested as persistent neutrophil and monocyte infiltration, elevated levels of cytokines (e.g., CXCL1, CCL2, and IL-6), and alveolar damage without affecting viral replication. Mechanistically, LPS triggered immune hyperactivation through early neutrophil recruitment, neutrophil extracellular trap (NET) formation, and a self-sustaining positive feedback loop. Intervention experiments revealed that the degradation of NETs by DNase I or neutrophil inhibition significantly alleviated lung damage and systemic inflammatory responses. This study establishes NET-driven innate immune amplification as a key mechanism underlying LPS-enhanced H1N1 pathogenicity, offers an immunomodulatory approach for severe bacterial-viral coinfections, and underscores the parity of immunomodulatory therapy with anti-infective treatment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8a8204eba4e3f2c05f83c187d56985bc21d9c8f7" target='_blank'>
              Exposure to bacterial lipopolysaccharide aggravates H1N1-mediated lung immunopathology via neutrophil extracellular trap formation
              </a>
            </td>
          <td>
            Guiling Yan, Zhongwen Hu, Yuanyuan Peng, Yuqin Tu, Jingling Xie, Yuchao Zhong, Changchun Niu, Yang Luo
          </td>
          <td>2025-11-18</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Inflammasomes and interferons are two critical defense mechanisms of innate immunity, and their imbalance is a key strategy employed by viruses to evade host immune surveillance. During porcine reproductive and respiratory syndrome virus (PRRSV) infection, an arteritis virus, a characteristic “high inflammation, low interferon” immune imbalance is observed. This study identifies PRRSV non-structural protein NSP5 as a central mediator of this immune imbalance. We demonstrate that NSP5 recruits NLRP3 to the endoplasmic reticulum (ER)-mitochondrial interface, triggering ER stress and Ca2+ leakage, which subsequently activates the NLR family pyrin domain containing 3 (NLRP3) inflammasome. Notably, a specific NSP5 mutation (G30A) abolishes its ability to activate NLRP3. PRRSV carrying this mutation exhibits suppressed NLRP3 activation and IL-1β release. Concurrently, NSP5 retains STING in the ER, preventing its trafficking and inhibiting type I interferon induction. This dual mechanism ultimately drives the high inflammation and low interferon phenotype observed during PRRSV infection. Importantly, our findings reveal that a single viral protein can orchestrate immune imbalance, suggesting a potentially widespread strategy for viral evasion of host immune surveillance.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4e730d92266f5f6b0990407c8ac29dced1f7ed68" target='_blank'>
              PRRSV NSP5 orchestrates dual immune disruption by targeting NLRP3 and STING
              </a>
            </td>
          <td>
            Xiangyu Huang, Xuyan Xiang, Xiaohan Jiang, Weiyu Qu, Yufei Zhang, Zhenchao Zhao, Minjie Li, Haiwei Wang, Xin Li
          </td>
          <td>2025-10-16</td>
          <td>Veterinary Research</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Parrots, valued companion animals with a concerning conservation status, can act as reservoirs for zoonotic diseases. During various infections, systemic inflammation significantly impairs host health. However, the regulation of inflammatory responses in birds, particularly in cognitively advanced parrots, remains poorly understood. Here, we examine parrot systemic inflammation in response to virus-mimicking stimulation. In budgerigars (Melopsittacus undulatus), a novel model for neuroinflammation research, we induced sterile inflammation with synthetic poly(I:C) RNA and analysed dose-, time- and tissue-dependent gene expression patterns of key markers, including TLR3, NLRP3, CASP1, IL1B and IL6, during acute immune response. We report a significant relationship between cytokine expression (IL1B, IL6) in the intestine (local response) and brain (systemic response) that has not yet been described after viral stimulation in parrots. Peripheral IL6 expression was upregulated at 3–6 h after stimulation with poly(I:C). In the brain, multiple genes (TLR3, IL1B and IL6) showed activation early during the immune response. These findings highlight the susceptibility of parrots to neuroinflammation following viral infections, having specific relevance for basic research in neurobiology, immunology and behavioural science, and also veterinary research in psittacine birds. Our study provides a foundation for future comparative research on avian neuro-immune crosstalk and neuroinflammation-related behavioural disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b23dca0d96ff356c079d40ec7845a15398f0ccf4" target='_blank'>
              The neuro-immune crosstalk between periphery and central nervous system during acute immune response to virus-mimicking RNA in parrots
              </a>
            </td>
          <td>
            Balraj Melepat, Daniel Divín, Kateřina Marková, Tao Li, Nithya Kuttiyarthu Veetil, Eleni Voukali, Lucie Schmiedová, Martin Těšický, Michal Vinkler
          </td>
          <td>2025-10-01</td>
          <td>Royal Society Open Science</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="A quarter of the human population is infected with Mycobacterium tuberculosis, but less than 10% of those infected develop pulmonary TB. We developed a genetically defined sst1-susceptible mouse model that uniquely reproduces a defining feature of human TB: the development of necrotic lung granulomas and determined that the sst1-susceptible phenotype was driven by the aberrant macrophage activation. This study demonstrates that the aberrant response of the sst1-susceptible macrophages to prolonged stimulation with TNF is primarily driven by conflicting Myc and antioxidant response pathways leading to a coordinated failure (1) to properly sequester intracellular iron and (2) to activate ferroptosis inhibitor enzymes. Consequently, iron-mediated lipid peroxidation fueled superinduction of Ifnβ and sustained the type I interferon (IFN-I) pathway hyperactivity that locked the sst1-susceptible macrophages in a state of unresolving stress and compromised their resistance to Mtb. The accumulation of the aberrantly activated, stressed, macrophages within the granuloma microenvironment led to the local failure of anti-tuberculosis immunity and tissue necrosis. The upregulation of the Myc pathway in peripheral blood cells of human TB patients was significantly associated with poor outcomes of TB treatment. Thus, Myc dysregulation in activated macrophages results in an aberrant macrophage activation and represents a novel target for host-directed TB therapies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ccd2477b702b8cb23b46dd905bcdea499b17e34a" target='_blank'>
              Lipid peroxidation and type I interferon coupling fuels pathogenic macrophage activation causing tuberculosis susceptibility
              </a>
            </td>
          <td>
            Shivraj M. Yabaji, V. Zhernovkov, Prasanna Babu Araveti, Suruchi Lata, Oleksii S. Rukhlenko, Salam Al Abdullatif, Arthur Vanvalkenburg, Yuriy O Alekseyev, Qicheng Ma, Gargi Dayama, N. Lau, Evan Johnson, William R. Bishai, N. Crossland, Joshua D. Campbell, Boris N. Kholodenko, Alexander A. Gimelbrant, L. Kobzik, Igor Kramnik
          </td>
          <td>2025-10-02</td>
          <td>eLife</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="T-cell exhaustion is a terminal state of immune dysfunction characterized by impaired proliferation and effector functions, diminished cytokine secretion, and sustained expression of inhibitory receptors. In coronavirus disease 2019 (COVID-19), increasing evidence links exhausted T-cell phenotypes with poor clinical outcomes, including severe disease, delayed viral clearance, and persistent symptoms associated with Long COVID. Exhaustion results from prolonged antigenic stimulation and inflammatory signals and is marked by transcriptional reprogramming, metabolic and epigenetic dysregulation, and co-expression of inhibitory receptors such as programmed cell death protein-1 (PD-1), T-cell immunoglobulin and mucin-domain containing-3 (TIM-3), and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Notably, exhausted phenotypes in COVID-19 frequently coexist with hyperactivation, raising the unresolved question of whether inhibitory receptor expression reflects transient activation or irreversible dysfunction. Emerging therapeutic strategies to reverse these dysfunctional states include immune checkpoint inhibitors, cytokine modulation, metabolic interventions, and epigenetic therapies, although their clinical translation remains at an early stage. Critical research gaps include the scarcity of longitudinal data, incomplete profiling of T-cell subsets across disease stages during COVID-19 and Long COVID-19, and contradictory evidence of vaccine-induced exhaustion with limited understanding of its consequences. This non-systematic literature review synthesizes current advances in COVID-19 immunopathology and therapeutic strategies, underscoring that understanding T-cell exhaustion is crucial to improving outcomes and shaping next-generation immunotherapies and vaccines.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fcda848fedb31d45bcaf7a6be07292887c93eed0" target='_blank'>
              T-cell exhaustion in COVID-19: what do we know?
              </a>
            </td>
          <td>
            Roderick Chen-Camaño, Rodrigo DeAntonio, S. López-Vergès
          </td>
          <td>2025-10-29</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Age is a critical factor in immune responses to infection. In malaria, severe disease risk increases with age in non-immune individuals. Malaria severity is in part driven by inflammation, but mechanisms contributing to age-dependent disease risk are incompletely understood. We assessed inflammatory cytokines during malaria in non-immune children and adults, and innate cell responses in vitro to malaria parasites in naive children and adults. We show during malaria age is associated with increased inflammatory chemokines CCL2, CCL3, CXCL8, CXCL9, along with CRP, and IDO, which associate with symptoms. In naive individuals, classical monocyte and Vδ2+ γδ T cells from adults have higher inflammatory cytokine production, and transcriptional activation following stimulation with parasites. Classical monocyte responses in adults are dominated by CCL2, while in children increased IL10 and enrichment of IL10 signaling pathways is detected. Findings identify age-dependent cellular mechanisms that play crucial roles in driving inflammatory responses in malaria. How age affect the immune response to malaria is not fully understood. Here, the authors characterise the transcriptome and serum inflammatory cytokines in children and adults in response to malaria, showing that there is an increase of inflammatory chemokine and cellular responses in adults compared to children.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/08d5c0c81051d13694cfc33dd1cf3b4215156753" target='_blank'>
              Age is an intrinsic driver of inflammatory responses to malaria
              </a>
            </td>
          <td>
            Jessica R. Loughland, Nicholas L Dooley, Zuleima Pava, Arya SheelaNair, D. Andrew, Peta E. Tipping, Peter Bourke, C. Engwerda, J. A. Lopez, Kim A. Piera, Timothy William, Bridget E. Barber, M. Grigg, N. Anstey, Gabriela Minigo, Michelle J. Boyle
          </td>
          <td>2025-09-30</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="Emerging evidence suggests brain-resident myeloid cells, including perivascular macrophages and microglia, provide a reservoir for HIV infection in the central nervous system (CNS), and their inflammatory activation is a proposed pathogenic mechanism in HIV-associated neurocognitive disorders (HAND). We investigated whether cannabinoid receptor 2 (CB2), an immunomodulatory receptor expressed in myeloid cells, regulates viral replication and inflammation in HIV-infected macrophages and microglia. Using the synthetic CB2-specific agonist JWH-133, we found that CB2 activation reduced HIV replication in primary human monocyte-derived macrophages (MDMs) and human induced pluripotent stem cell-derived microglia (iMg) at differing doses, corresponding to the basal expression of CNR2, which encodes CB2, and related endocannabinoid transcripts in each cell type. JWH-133 broadly reduced release of cytokines from HIV-infected MDMs but not iMg. RNA-seq revealed that CB2 agonism primarily altered interferon and integrated stress response pathways in MDMs while altering homeostatic pathways, including synapse maintenance and phagocytosis, in iMg. Further analyses in iMg revealed that NLRP3 inflammasome activation, but not priming, was reduced by CB2 activation, which did not inhibit HIV-induced nuclear factor kB activation. This study identifies key differences in CB2 response between myeloid lineage cell types and implicates CB2-specific agonists as promising candidates for the regulation of HIV-associated neuroinflammation. Created in BioRender. Espinoza, C. (2025) https://BioRender.com/mxfla3i">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/71c568f55c0cf3f5f771b5d05ce139396b2d6389" target='_blank'>
              Differential Effects of Cannabinoid Receptor 2 Agonists on HIV Replication and Inflammatory Activation in Monocyte-Derived Macrophages and Induced Pluripotent Stem Cell-Derived Microglia
              </a>
            </td>
          <td>
            Alexander Starr, Sara Rathore, Marzieh Daniali, P. J. Gaskill, Ç. Akay-Espinoza, Kelly L Jordan-Sciutto
          </td>
          <td>2025-10-11</td>
          <td>Journal of Neuroimmune Pharmacology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="


 Recent advances in single-cell transcriptomics have revealed significant heterogeneity in microglia, brain-resident macrophages that monitor the brain microenvironment. Disease-associated microglia (DAM), a unique transcriptional state, have been implicated in neurodegeneration and aging. Despite their critical role, the signaling pathways regulating DAM development and their function remain unclear. By overexpressing α-synuclein in neurons, our lab established a mouse model of Parkinson’s Disease (PD) that recapitulates microglial activation, immune cell infiltration, and dopaminergic neuron loss. In our model, we observed an expansion of the DAM transcriptional state and successfully characterized DAM accumulation at the protein level throughout PD progression. This accumulation coincides with reduced immune cell infiltration, linking DAM to chronic neuroinflammation. Using scATAC-seq, we identified transcription factors enriched in distinct microglial states: RelA motifs in acutely activated microglia and Irf4 motifs in DAM. Conditional knockout (cKO) of RelA in microglia reduced immune cell infiltration, whereas IRF4 cKO reduced protein expression of Clec7a, a DAM marker. By blocking transitions between different microglial states, our research aims to elucidate the function and role of α-synuclein-mediated DAM in PD progression and potentially establish DAM as a therapeutic target in neurodegenerative disorders.



 Aligning Science Across Parkinson’s: ASAP



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4da3d370218c60ccf242a6e1d980c70ae41a4936" target='_blank'>
              The role of α-synuclein-mediated disease-associated microglia in Parkinson’s disease 3319
              </a>
            </td>
          <td>
            Ya-Ting Yang, David A. Figge, Jhodi M. Webster, , Asta Zane, A. Harms
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Abnormal lipid metabolism is observed in Alzheimer’s disease (AD), but its contribution to disease progression remains unclear. Genetic studies indicate that microglia, the brain’s resident immune cells, influence lipid processing during AD. Here, we show that microglia—the brain’s resident immune cells—selectively regulate lipid accumulation that associated with disease pathology in both AD mouse models and human postmortem brains. Using lipidomics and histological analysis, we identify a striking buildup of arachidonic acid–containing bis(monoacylglycero)phosphate in response to amyloid plaques, which depends on microglial activity and the AD risk gene GRN. In contrast, lysophosphatidylcholine and lysophosphatidylethanolamine accumulate independently of microglia, correlating instead with astrocyte activation and oxidative stress. These results connect dysregulated lipid metabolism in AD to distinct brain cell types and molecular pathways. Our findings highlight microglial lipid homeostasis as a potential therapeutic target for modifying disease progression in AD. Alzheimer’s disease disrupts brain lipid metabolism; while microglia are likely implicated, the relationship is unclear. Here, the authors show that microglia selectively regulate lysosomal and myelin lipids, but other lipid changes occur independently of microglia.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dcf1904c66d1a89b63b357f3807774f51ef30d3a" target='_blank'>
              Microglia-specific regulation of lipid metabolism in Alzheimer’s disease revealed by microglial depletion in 5xFAD Mice
              </a>
            </td>
          <td>
            Ziying Xu, Sepideh Kiani Shabestari, Savannah Barannikov, Kevin F. Bieniek, Mathew Blurton-Jones, J. Palavicini, Xianlin Han
          </td>
          <td>2025-10-15</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Highlights What are the main findings? COVID-19 patients show a unique DNA methylation profile in the upper airway, with over 510,000 differentially methylated CpGs affecting antiviral, interferon, and immune response genes. Some methylation changes are temporary, normalizing after 6 weeks, while key immune regulators (e.g., IL17A, ERK1/2, OAS1, MX1) remain significantly involved. What is the implication of the main finding? SARS-CoV-2 may reprogram immune and repair pathways in the airways, influencing recovery and susceptibility to future respiratory infections. These findings provide potential targets for biomarkers and therapeutic strategies to modulate post-COVID-19 airway health. Abstract SARS-CoV-2 infection remains a global health concern, with its impact on host immune responses not fully understood. In a case–control study, we examined how COVID-19 affects DNA methylation patterns in the upper respiratory airway of hospitalized individuals. DNA methylation arrays were performed on nasopharyngeal samples at inclusion/hospitalization and 6 weeks post-inclusion. We found a distinct DNA methylation pattern in COVID-19 patients compared to healthy controls, identifying 510,099 differentially methylated CpGs. Within the transcription start sites (TSSs) and gene body, COVID-19 patients displayed a higher number of genes/CpGs with elevated methylation levels. Enrichment analysis of TSS-methylated genes revealed effects of SARS-CoV-2 on genes associated with type I interferons, anti-viral and inflammatory responses, and immune functions. Some CpG methylations were transient, and normalized at group level by 6 weeks post-inclusion. Several IFN-regulated genes, including OAS1, OAS3, IFIT3, and MX1, were identified. Among the top regulators were IL17A and ERK1/2, both involved in inflammatory processes. Networks nodes included IGF1 and EGF, associated with processes including tissue repair and activation of immune responses. Overall, our data suggests that COVID-19 can impact the upper airway by modifying gene methylation patterns. This could have implications for conditioning of the airways, how individuals respond to future airway infections, and therapeutic interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c17feb2000b785e79540fe240ded0e083db9f8dc" target='_blank'>
              Altered DNA Methylation Pattern Contributes to Differential Epigenetic Immune Signaling in the Upper Respiratory Airway of Unvaccinated COVID-19 Patients
              </a>
            </td>
          <td>
            Melissa Govender, Jyotirmoy Das, Francis R. Hopkins, Cecilia Svanberg, Johan Nordgren, M. Hagbom, Jonas Klingström, Åsa Nilsdotter-Augustinsson, Y. Yong, V. Velu, S. Raju, Johanna Sjöwall, Esaki M. Shankar, Sofi A Nyström, Marie Larsson
          </td>
          <td>2025-10-27</td>
          <td>Cells</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="Emerging evidence underscores the critical role of Toll-like receptor 7 (TLR7)-mediated interferon (IFN) signaling in host defense against viral infections including SARS-CoV-2, through the modulation of both innate and adaptive immunity. However, the specific mechanisms by which TLR7 activation shapes SARS-CoV-2-specific immune responses, particularly via IRF-IFN pathways, remain incompletely elucidated. This review synthesizes current findings on how intrinsic TLR7-driven IFN signaling influences viral clearance, modulates adaptive immunity, and contributes to autoantibody production in COVID-19. A deeper understanding of these processes is essential for developing targeted therapeutic interventions and improved vaccines aimed at mitigating severe COVID-19 and preventing post-acute sequelae of SARS-CoV-2 infection (PASC).">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2bd6dead6a1a78751a4bbff0555654ffbab2b138" target='_blank'>
              Unraveled role of TLR7-mediated interferon signaling activation in COVID-19
              </a>
            </td>
          <td>
            Junjian Xue, Xiaoyin Wang, Hui Wang, Bin Qiao, Pengfei Gao, Bin Ren, Shushan Yan
          </td>
          <td>2025-10-08</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Abstract Cognitive impairment in people with HIV (PWH) remains prevalent despite viral suppression. To provide insights into the cellular mechanisms of pathogenesis, we carried out a multi-modal pan cell-type specific differential analysis of the frontal cortex of PWH. We show cell type-specific dysregulations of oxidative phosphorylation, glycolysis, ribosomes and translation, DNA damage, and neuroinflammation in PWH. Key genes and pathways identified showed a considerable overlap with transcriptional hallmarks of Alzheimer’s disease (AD) and involved AD vulnerable cell types, among others. We computed several differentially accessible chromatin sites in all major cell-types. Neuronal genes with perturbed chromatin accessibility regions were enriched in synaptic signaling genes supporting an epigenetic contribution to cognitive impairment in HIV. Convergent mechanisms of pathogenesis between HIV and AD support that broad therapeutic targets can be identified to ameliorate neurodegeneration and neuroinflammation in HIV and neurodegenerative conditions such as AD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/29d72128e541581bbb4ad72f6c22615a64b2a360" target='_blank'>
              Single-Cell Multi-Modal Differential Analysis of the Human Neo-Cortex in HIV Infection Reveals Similarities with Hallmarks of Alzheimer’s Disease
              </a>
            </td>
          <td>
            Arpita Joshi, Pietro Paolo Sanna
          </td>
          <td>2025-11-01</td>
          <td>Research Square</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Epstein-Barr virus (EBV) lytic infection contributes to virus-associated cancers and autoimmunity and depends on viral subversion of host DNA damage responses (DDR). Here, we use high-content screening (HCS) for morphologic and pseudotemporal profiling of single-cell EBV reactivation and DDR dynamics spanning seven lytic induction treatments in nine B cell lymphoma models. We generated an atlas (>750,000 cells) of spatiotemporally distinct phenotypes of immediate-early (IE) and late lytic proteins, viral and cellular DNA replication, and double-stranded break (DSB) DDR factors. Single-cell segmentation, feature extraction, and clustering identify treatment- and model-dependent cell responses and lytic induction. Notably, genotoxin-induced DDR profiles differ in lytic versus latent cells, and lytic protein localization varies across pharmacologic and physiologic stimuli. Pseudotime trajectories of physiologic reactivation reveal viral replication compartment (VRC) nucleation and expansion alongside concomitant host DDR localization. The early DDR marker γH2AX is depleted from VRCs but widespread across host chromatin throughout reactivation. Surprisingly, the lytic-essential late DDR protein 53BP1 is present in lytic cells prior to viral genome replication but subsequently absent from VRCs and host chromatin, indicating spatial and kinetic DDR dysregulation during EBV reactivation. Collectively, these data support a model wherein EBV transiently employs host DSB DDR mediators to initiate genome replication while a host-targeted DDR is initiated but impaired. We further demonstrate biological generalizability and utility of the method across confocal and epifluorescence systems. Thus, this work demonstrates a powerful technique to recover host-virus dynamics from static timepoints and will support future high-throughput single-cell virology applications.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8351d90d1e76d2976355d93ad064503b2904e7b0" target='_blank'>
              Reconstructing EBV reactivation and DNA damage response kinetics in morphologic pseudotime
              </a>
            </td>
          <td>
            Dina G. Tekle, Jonathan Z. Sexton, E. SoRelle
          </td>
          <td>2025-10-06</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Aged tissue is characterized by chronic inflammation known as “inflammaging”. While this aging immune phenotype supposedly drives some of the most common diseases affecting the elderly, little is known about the structural drivers of inflammaging. In this study, we demonstrate that age-dependent activation of NF-kB in tissue fibroblasts remodels the immune architecture, promoting the emergence of an exhausted T cell population (GZMK+/CD8+) recently identified in normal aging, as well as autoimmunity and cancer. Fibroblast-specific NF-kB activation triggered a fibroblast-macrophage-T cell circuit to form tertiary lymphoid structures in the lung and promoted the emergence of exhausted GZMK+ T cells. Fibroblastic activation of NF-kB increased host susceptibility to acute lung injury and mimics severe pneumonia commonly seen in elderly patients, which was alleviated by deletion of GZMK+ T cells. Our data provide a structural basis for inflammaging, where fibroblasts orchestrate the complex immune aging phenotype in non-immune tissues, increasing susceptibility to age-related diseases. Highlights - Bronchus-associated lymphoid tissue (BALT) enriched for GZMK+ T cells develop with age - Lung adventitial fibroblasts demonstrate increased NF-kB activation with age. - Fibroblast activation of NF-kB in young animals recapitulates multiple features of normal lung immune aging - Depletion of GZMK+ cells decreases lung inflammation in a mouse model of acute respiratory distress syndrome (ARDS)">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1d8a754f463ab7baffd2a9daeb1d70ff841b56ea" target='_blank'>
              Fibroblast orchestration of inflammaging via NF-kB activation
              </a>
            </td>
          <td>
            Nancy C. Allen, Christian Ringler, Jin Young Lee, Nabora S. Reyes, Ritusree Biswas, Sofia E Caryotakis, M. Magnen, Pedro Ruivo, V. Auyeung, M. Looney, Averil Ma, Ari B. Molofsky, Tien Peng
          </td>
          <td>2025-10-01</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disorder of the central nervous system (CNS). Age is the strongest predictor of disease phenotype, with the majority of older adults transitioning to a progressive form marked by irreversible neurological decline. This clinical progression is associated with smoldering, CNS-compartmentalized inflammation and neurodegeneration, for which there are currently no effective disease-modifying therapies. Cellular senescence, characterized by the secretion of pro-inflammatory mediators collectively known as the senescence-associated secretory phenotype (SASP), increases with age and contributes to tissue injury. In MS, neuroinflammation can further promote cellular senescence, creating a self-reinforcing cycle of damage. Senescent microglia have been identified within MS lesions, where their SASP may impair remyelination and exacerbate neurodegeneration. Senolytic agents selectively target and eliminate senescent cells by disrupting anti-apoptotic pathways. In experimental autoimmune encephalomyelitis (EAE), a widely used model of MS, senolytic treatment reduces senescent microglia burden and attenuates disease severity in an age- and drug-dependent manner. Specifically, here we show that middle-aged mice (40–44 weeks) with EAE exhibit improved clinical outcomes and survival following treatment with either dasatinib plus quercetin (D+Q) or navitoclax. Early-phase clinical trials of senolytics in age-related diseases have demonstrated functional benefits, including improved gait speed in idiopathic pulmonary fibrosis and CNS penetrance in Alzheimer’s disease. Translating senolytic therapy to MS will require careful selection of CNS-penetrant and well-tolerated agents, identification of appropriate patient populations, and deployment of responsive biomarkers. Senolytic therapy represents a promising geroscience-based strategy to meet the urgent therapeutic need in progressive MS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/833c0a2c74e7a7ab280e18c8d71dabfd9c454a2a" target='_blank'>
              Targeting senescent microglia in progressive multiple sclerosis: a geroscience-informed approach
              </a>
            </td>
          <td>
            Jeffrey Atkinson, Amy Dokiburra, Hayley Groover, Jonathan P. Godbout, B. Segal, Yinan Zhang
          </td>
          <td>2025-10-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Type 1 diabetes (T1D) risk has been associated with enteroviral infections, particularly coxsackieviruses B (CVB). Cellular host factors contributing to virus-induced islet autoimmunity remain unclear. We show that the Hippo pathway effector Yes-associated Protein (YAP) is markedly upregulated in the exocrine and endocrine pancreas of T1D and at-risk autoantibody-positive (AAb+) donors, along with its target CTGF. YAP expression correlates with CVB RNA presence, often in or near infected cells. YAP overexpression enhances CVB replication, islet inflammation, and β-cell apoptosis, whereas its inhibition halts viral replication in primary and immortalized pancreatic cells. In exocrine-islet co-cultures, CVB triggers YAP and target gene expression. In mice, chronic β-cell YAP expression impairs glucose tolerance, abolishes insulin secretion, and promotes β-cell dedifferentiation. Mechanistically, YAP, in complex with its transcription factor TEAD, induces its own negative regulator MST1. MST1 inhibition boosts viral replication and reduces β-cell apoptosis, constituting a negative feedback loop in which the reciprocal antagonism between YAP and MST1 balances viral replication and β-cell death during CVB infections. YAP is thus an important host factor for enteroviral amplification, offering a potential antiviral target in T1D. Viruses such as coxsackievirus B (CVB) have been associated with type I diabetes (T1D) and islet destruction. Here the authors show that Yes-associated protein (YAP) is upregulated in the whole pancreas in T1D and at-risk autoantibody (AAb + ) organ donors and that YAP over-expression enhances CVB replication, islet inflammation and β-cell apoptosis and suggest exocrine-islet-immune interactions as targeted interventions for T1D.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/46a8c22841dec45ad83eda3f4933a10a838e2d8e" target='_blank'>
              The Hippo terminal effector YAP boosts enterovirus replication in type 1 diabetes
              </a>
            </td>
          <td>
            Shirin Geravandi, Huan Liu, Heena Pahwa, Murali Krishna Madduri, Farah Atawneh, Adib Miraki Feriz, Sahar Rafizadeh, Annabelle Elisabeth Kruf, Mona Khazaei, Pouria Bahrami, David Gotti, Mohamed Elawour, R. Elgamal, Ausilia Maria Grasso, David Bund, Blaz Lupse, Zahra Azizi, Omar Zabad, Karim Bouzakri, Marc Horwitz, A. Pugliese, Kathrin Maedler, A. Ardestani
          </td>
          <td>2025-10-06</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Alphaherpesviruses such as Herpes Simplex Virus 1 (HSV-1) and Pseudorabies virus (PrV) invade the central nervous system (CNS) via peripheral nerves. While olfactory and trigeminal pathways are well-known, additional cranial routes remain underexplored. Using a PrV-∆UL21gfp/US3∆kin mutant in CD1 mice, we mapped early neuroinvasion (4–96 hpi) by immunofluorescence and RNA in situ hybridization. Viral antigen and lytic viral gene expression (UL19 RNA) were detected in the olfactory epithelium, vomeronasal organ, incisors, palate, olfactory bulb, and brainstem. These results indicate multineural CNS access involving olfactory (I), trigeminal (V), glossopharyngeal (IX), and hypoglossal (XII) nerves, highlighting this model’s value for studying early alphaherpesvirus spread.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/482b9038c7d6a92c4041e61d7cb34225fda421b3" target='_blank'>
              Spatial and temporal mapping of early alphaherpesvirus invasion routes into the mouse central nervous system
              </a>
            </td>
          <td>
            Viktoria Korff, Issam El-Debs, Julia Sehl-Ewert
          </td>
          <td>2025-09-28</td>
          <td>Journal of Neurovirology</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Sepsis induces profound immune dysregulation, often resulting in chronic critical illness characterized by persistent immunosuppression and poor outcomes. Myeloid-derived suppressor cells (MDSCs) are central mediators of this immunosuppressive phenotype, yet the influence of age and sex on their transcriptional and metabolic states remain poorly understood. Here, we employed single-cell RNA sequencing of splenic leukocytes from young (3-4 months) and older (18-24 months) adult male and female mice subjected to a clinically relevant murine sepsis model to define age- and sex-specific MDSC phenotypes. We identified significant differences regarding age and sex in MDSC expansion, transcriptome, canonical pathway activation, RNA velocity, mitochondrial metabolism, and predicted cell-cell communication after sepsis. Using drug2cell analysis of total leukocytes we also identified cohort-specific drug target profiles. These findings underscore the importance of age and sex in shaping sepsis-induced MDSC biology and suggest that personalized immunomodulatory strategies targeting MDSCs could improve sepsis outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0387bf223414d2cdfcd6b8258e94b4747d5384ae" target='_blank'>
              Age- and Sex- Driven Transcriptional and Metabolic Diversity in Myeloid-Derived Suppressor Cells After Mouse Sepsis
              </a>
            </td>
          <td>
            Christine Rodhouse, Dayuan Wang, Hongru Tang, Valerie E. Polcz, Miguel Hernandez-Rios, Xuanxuan Yu, Leandro Balzano-Nogueira, J. Rincon, Angel M. Charles, Seiichiro Fujishima, Quan Vo, M. Dirain, Ricardo F. Ungaro, Dina C. Nacionales, Leilani Zeumer-Spataro, Larissa Langhi Prata, Shawn D. Larson, Gemma Casadesus, Feifei Xiao, Shannon M. Wallet, Maigan A. Brusko, Tyler Loftus, Letitia E. Bible, Alicia M. Mohr, Paramita Chakrabarty, Michael P. Kladde, Clayton E. Mathews, L. Moldawer, Robert Maile, Guoshuai Cai, Philip A. Efron
          </td>
          <td>2025-10-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a0bf33bdd16f38189fb9b14d44624d7f3e4abc03" target='_blank'>
              Organotypic Airway Models Derived from Primary Human Nasal Epithelial Cells
              </a>
            </td>
          <td>
            Jing Liu, H. Ong, Kun Qu, De-Yun Wang
          </td>
          <td>2025-10-23</td>
          <td>Current Allergy and Asthma Reports</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="COVID-19 research now provides a coherent picture of the virus's immunological impacts, highlighting immune-evasion mechanisms, the particular vulnerabilities of patients with inborn errors of immunity (IEI), and evolving therapeutics for severe disease. SARS-CoV-2 exploits ACE2 for cell entry and can utilise CD147 to infect immune cells, undermining antiviral defences; recent work details cytokine storm biology, NLRP3 inflammasome activation, and suppression of type I interferon responses. IEI patients are disproportionately affected, often with severe, prolonged courses and persistent PCR positivity. Therapeutic approaches such as convalescent plasma, anti-cytokine agents interferon alpha-2b, and plasma exchange show variable effectiveness, while vaccine performance is challenged by ongoing viral evolution. Together, these insights underscore the need for tailored treatment strategies for IEI populations, vigilant monitoring for immune-escape variants, and continuous adaptation of therapeutic and preventive measures. The aim of this review is to synthesise these findings, evaluate their implications for clinical management, and highlight future directions for research and patient care.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1f582b3a29cce6c91c09a0b1c7c85ccffbfc52a0" target='_blank'>
              Lessons From COVID-19 on Inborn Errors of Immunity: A Five-Year Narrative Review.
              </a>
            </td>
          <td>
            Gamze Sonmez, Gizem Gunduz, S. Esenboğa, D. Çağdaş
          </td>
          <td>2025-10-28</td>
          <td>Scandinavian journal of immunology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/662c0a4546b496eb7b71aadd2e98cd82d2407b6f" target='_blank'>
              Endothelial activation and oxidative stress in pulmonary endothelial cells following sever COVID-19.
              </a>
            </td>
          <td>
            Zohreh Arab, S. Rezaee, Fatemeh Sadat Mohammadi, Amir-Hashem Asna-Ashari, Alireza Shariati, M. Mahmoudabady, S. Niazmand
          </td>
          <td>2025-10-05</td>
          <td>Journal of thrombosis and thrombolysis</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has led to a global health crisis by triggering extensive systemic and immune dysregulation. Granulocytes, including neutrophils, eosinophils, and basophils, are critical components of the innate immune system that play dual roles in protection and pathogenesis during infection. In this review, we examine the multifaceted roles of granulocytes in COVID-19 and their impact on disease severity through excessive inflammation, cytokine storm, and tissue damage. Neutrophil extracellular traps (NETs) and the overactivation of neutrophil subtypes contribute to the development of thrombosis and acute respiratory distress syndrome. In contrast, eosinophils and basophils modulate T helper 2-type and allergic responses that may influence recovery or disease progression. We further summarize the therapeutic strategies targeting granulocyte activation and signaling pathways, including IL-1, IL-6, IL-17, IL-5 receptor, granulocyte-macrophage colony-stimulating factor inhibitors, and antihistamines, emphasizing their clinical outcomes, approval status, and the global regions in which they are studied. Understanding the regulatory mechanisms of granulocyte activation and inhibition provides new insights into COVID-19 immunopathology and opens pathways for targeted immunomodulatory therapy. These findings underscore the importance of balancing protective immune functions with controlled anti-inflammatory interventions to mitigate the severe complications of SARS-CoV-2 infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c1949f61557e86e96575d6b1c878127a5eaa2ccc" target='_blank'>
              COVID-19: Understanding the Granulocyte Response and Exploring Their Therapeutic Interventions.
              </a>
            </td>
          <td>
            Zahra Farjami, Mina Moradi, Neshat Ebrahimi, Mohammad Mehdi Akbarin
          </td>
          <td>2025-10-31</td>
          <td>Viral immunology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Neuronal intranuclear inclusion disease (NIID) is a group of neurodegenerative diseases caused by GGC repeat expansion and is characterized by diverse clinical manifestations that may characterize a spectrum of underlying pathologies. Extensive inflammatory cell infiltration has been observed in multiple tissues obtained from NIID patients, including the temporal lobe, skin, lungs, colon, kidneys, and fallopian tubes. Intriguingly, eosinophilic intranuclear inclusions have been identified within the nuclei of these infiltrating inflammatory cells, underscoring the central role of inflammation in NIID. The infiltration of immune cells within the brain tissue of NIID patients highlights the critical role of neuroinflammation in disease pathogenesis. Moreover, in patients with NIID, not only is the neutrophil-to-lymphocyte ratio (NLR) markedly elevated but also the peripheral blood cytokine profile substantially altered. Despite the prominent involvement of central and peripheral inflammation in NIID and experimental evidence at the cellular level demonstrating that activation of the NF-κB‒NLRP3 pathway can reduce the burden of intranuclear inclusions and ameliorate phenotypic manifestations, therapeutic strategies targeting inflammation have yet to alter the disease course in human patients. This review presents the latest advancements in the study of inflammatory markers in NIID and the GGC100 cell model. Specifically, it explores the role of inflammatory molecular markers in disease pathogenesis and their correlation with clinical parameters. Furthermore, we summarize the potential applications of certain inflammatory biomarkers as novel therapeutic targets and strategies, which may pave the way for expanded therapeutic interventions in NIID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e267dc0ae394eef9b238314bb13858da22304633" target='_blank'>
              Inflammation in Neuronal Intranuclear Inclusion Disease (NIID): mechanisms, biomarkers, and therapeutic implications
              </a>
            </td>
          <td>
            Xiaoxiao Zheng, Ling Li, Hongyue Ma, Xiuli Li, Xinhong Feng
          </td>
          <td>2025-10-29</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="ABSTRACT Streptococcus pneumoniae (pneumococcus) is an opportunistic pathogen that remains the leading cause of bacterial meningitis worldwide. For meningitis to occur, pneumococcus must breach the blood-brain barrier (BBB), a highly specialized network of brain endothelial cells that comprise the microvasculature of the brain. Here, we report the use of human induced pluripotent stem cell-derived brain-like endothelial cells (iBECs) to model the BBB during pneumococcal infection. iBECs were infected with the S. pneumoniae strain TIGR4. Adherence assays showed that pneumococcal adherence to iBECs was a saturable process. Moreover, deletion of two pneumococcal adhesins resulted in an adherence defect, supporting a receptor-mediated interaction between pneumococcus and iBECs. Next, the integrity of several tight junction components was assessed via western blot and RT-qPCR, revealing the loss of abundance and expression in iBECs during infection with pneumococcus. Simultaneously, the expression of VEGFA and the tight junction repressor SNAI1 was upregulated. Semi-automated analysis of junction images also demonstrated a loss of ZO-1 and occludin continuity during pneumococcal infection. Consistent with these findings, the loss of TEER and the increase in barrier permeability were observed in pneumococcus-infected iBECs. The toxin pneumolysin (Ply) was important for this disruption, as the loss of Ply in pneumococcus partially arrested the reduction of TEER and the increase in permeability. Finally, RT-qPCR showed that pneumococcus was sufficient to upregulate a panel of inflammatory cytokines in iBECs. Taken together, these findings show that pneumococcus interacts with and disrupts iBECs during infection, supporting iBECs as an important model for studying pneumococcus-BBB interactions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7b4da273ff50172679dc524578b58f9068453a41" target='_blank'>
              Stem cell-derived brain-like endothelial cells to interrogate Streptococcus pneumoniae interaction with brain endothelium
              </a>
            </td>
          <td>
            Henry D Mauser, Taryn E. Keyzer, Jessica M Surma, Natalie G Alexander, William D Cutts, Sarah F. Hathcock, Kimberly H Lackey, Daryl W. Lam, Justin A Thornton, Nadine Vollmuth, Brandon J. Kim
          </td>
          <td>2025-10-03</td>
          <td>Virulence</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Introduction Chronic low-grade inflammation has been associated with the development and progression of depression. However, its impact on neuronal development and connectivity remains poorly understood. In this study, we investigated how chronic and acute inflammation may influence early neurite development in neuronal-like cells (monocyte-derived neuronal-like cells, MDNCs). Methods Circulating monocytes were obtained from healthy controls (HC, n = 5), patients with major depression (MD, n = 4), patients with depression and elevated peripheral inflammatory markers (MD-INF, n = 4) and patients with schizophrenia (SZ, n = 5). Monocytes were transdifferentiated into MDNCs and either left untreated (CTRL) or exposed to lipopolysaccharide (LPS, 100 ng/mL) to induce an acute inflammatory response. Neurite morphology was quantified using MAP2 immunofluorescence staining and microscopic analysis. Results Transdifferentiation rates were significantly higher in MD-INF cultures compared with HC, MD and SZ. Sholl analysis demonstrated that MD-INF MDNCs treated with LPS exhibited a significantly greater neurite ending radius than MD and SZ cells or MD-INF under control conditions. Similarly, MD-INF cells treated with LPS showed more Sholl intersections compared with SZ cells treated with LPS and MD-INF cells under control conditions. Furthermore, the average neurite length of MD-INF cells treated with LPS exceeded that of MD and SZ cells treated with LPS and MD-INF cells under control conditions. Discussion These findings suggest a hyperresponsive phenotype to inflammatory stimulation in vitro in early neurons from patients with depression and elevated peripheral inflammation. Our results may provide novel insights into how inflammation could influence neurodevelopmental processes relevant to depression and may serve as a model for further investigations regarding targeted interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9ea2384d3246c9273f9136338578d14f211881a8" target='_blank'>
              Hyperresponsiveness to inflammatory stimulation in human neuronal-like cells from patients with inflammation-associated depression
              </a>
            </td>
          <td>
            S. Schillo, C. Schiweck, M. Aichholzer, Anna Y. Yotova, Tsendmaa Tsengenbayar, S. Edwin Thanarajah, Andreas Reif, Florian Freudenberg
          </td>
          <td>2025-10-29</td>
          <td>Frontiers in Psychiatry</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="ABSTRACT Chronic antigen exposure drives CD4⁺ T cell senescence, yet how autoimmunity and persistent viral infections differentially shape T cell differentiation and function remains unclear. Using cytomegalovirus (CMV) and rheumatoid arthritis (RA) as models of chronic immune activation, we performed high‐dimensional mass cytometry and functional assays to define their impact on CD4⁺ T cells. In CMV‐seropositive individuals, CD27−CD28− CD4⁺ T cells were abundant and exhibited a predominantly cytotoxic, nonproliferative phenotype. Only a minor fraction was CMV‐reactive, suggesting that bystander‐driven differentiation contributes to this subset. In the absence of CMV, senescent CD4⁺ T cells were infrequent and phenotypically distinct, though they still exhibited low proliferative capacity. EBV and HSV did not independently increase CD27−CD28− CD4⁺ T cell frequency. Similarly, RA had little effect on their abundance but instead tuned the functional quality of senescent cells. In CMV‐seropositive RA patients, senescent CD4⁺ T cells produced less pro‐inflammatory cytokines and showed impaired cytotoxic degranulation. Central memory CD4⁺ and CD27−CD28− CD8⁺ T cell functions were preserved, with no evidence for CMV reactivation, suggesting maintained viral control by unaffected T cell responses. These findings highlight distinct, nonredundant effects of CMV and RA on CD4⁺ T cell senescence and reveal RA‐specific functional defects in senescent CD4⁺ T cells.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3441dc9dbc45e96d9b0a98bad7c5d0ce97797b4d" target='_blank'>
              Divergent Effects of Cytomegalovirus and Rheumatoid Arthritis on Senescent CD4+ T Cells
              </a>
            </td>
          <td>
            Lea Williams, Ali O Saber, Silina Awad, Xi Su, Asgar Ansari, Ruozhang Xu, Hannah Jung, Anupama Shahane, Joshua F. Baker, Laura F. Su
          </td>
          <td>2025-11-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Traumatic brain injury (TBI) initiates a prolonged and complex immune response that critically shapes both secondary injury and long-term recovery. Among adaptive immune cells, CD4⁺ T cells have emerged as central regulators of neuroinflammatory processes, acting as a double-edged sword that can be either neuroprotective or neurotoxic. This review focuses on the roles of major CD4⁺ T cell subsets-Th1, Th2, Th17, and Tregs-in modulating the immune landscape following TBI, with an emphasis on their temporal dynamics, phenotypic plasticity, and therapeutic potential. We examine how blood-brain barrier disruption and innate immune activation facilitate T cell infiltration into the central nervous system, and outline the cytokine networks and signaling pathways that orchestrate CD4⁺ T cell differentiation and functional polarization. Advances in single-cell RNA sequencing (scRNA-seq) have provided new insights into the transcriptional heterogeneity of CD4⁺ T cells post-TBI, offering novel angles for therapeutic targeting. In addition, we assess current strategies for targeting CD4⁺ T cells therapeutically and examine translational challenges, particularly the translational gap between animal models and human disease. To provide a focused synthesis, this review does not delve into all immune cell types or other aspects of neuroinflammation that may also play significant roles in TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5bb08683dbcd2c252e04f0b54a89e13ce83a8999" target='_blank'>
              The immunological paradox of CD4⁺ T cells in traumatic brain injury (Review Article).
              </a>
            </td>
          <td>
            Qian Zhao, Bo-Ao Chen, Wen-Qing Ai, Nadezhda Brazhe, Dan Liu, Ling-Qiang Zhu, Ming Wen
          </td>
          <td>2025-10-15</td>
          <td>International journal of surgery</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/75adc2fc401fe68e4fecfbc1d302e045b6cba87f" target='_blank'>
              Inflammatory reprogramming of human brain endothelial cells compromises blood–brain barrier integrity in Alzheimer’s disease
              </a>
            </td>
          <td>
            R. Pinals, Md Rezaul Islam, Oisín King, Aaron Choi, Eulim Kang, Masayuki Nakano, Anjanet Tuyéras, Maeesha Tasnim Naomi, Arthur Ngo, Al Jiang, Nhat Truong, Emre Agbas, Claudia F Lozano Cruz, Colin Staab, Tak Ko, David A. Bennett, Alice E. Stanton, Robert Langer, Li-Huei Tsai
          </td>
          <td>2025-09-27</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="Dengue virus (DENV) is a major arthropod‐borne pathogen, endemic in over 100 countries and posing global health challenges. While innate immune responses and viral evasion mechanisms have been extensively studied in animal models and mononuclear cells, severe dengue can affect multiple tissues, including the central nervous system (CNS), leading to neurological manifestations. However, the CNS immune response remains poorly understood. This study analyzed molecules linked to innate immunity in CNS lesions from fatal dengue cases. Histopathological examination of the cerebral cortex revealed marked neuronal damage—chromatolysis, pyknotic nuclei—accompanied by microglial hyperplasia, white matter demyelination, perivascular inflammation, vascular congestion, vasogenic edema, and occasional hemorrhage or meningitis. DENV antigen was detected in endothelial cells of cortical and leptomeningeal vessels and in glial cells or macrophages. Immunohistochemistry revealed altered expression of innate immune markers: RIG‐I was sparsely expressed, STING was absent, and IFN‐α/β levels were reduced compared to controls. Notably, IRF2 expression was markedly elevated, with strong labeling in neurons, glial, and endothelial cells. These findings suggest an atypical pattern of immune activation in the CNS during severe dengue and highlight a potential role for IRF2 in modulating cerebral immune responses, offering new insights into the neuropathogenesis of dengue.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b8f7f91bd3195b66fc9031dd8d09c37a3bc65daf" target='_blank'>
              Histopathological Alterations and Dysregulation of Type I Interferon Signaling in the Human Cerebral Cortex During Severe Dengue
              </a>
            </td>
          <td>
            Leandro Mantovani de Castro, E. R. Fernandes, J. Quaresma, Carmen Lucia Penteado Lancelotti, Maria Irma Seixas Duarte, L.V. Carvalho, R. Penny, P.F.C. Vasconcelos, Evandro Sobroza de Mello, M. Sotto, C. Pagliari
          </td>
          <td>2025-10-01</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/618bcfb789463c1d6cd34f9be203229ced80b89b" target='_blank'>
              Multi-omic profiling reveals age-related immune dynamics in healthy adults.
              </a>
            </td>
          <td>
            Qiuyu Gong, Mehul Sharma, Marla C. Glass, Emma L. Kuan, Aishwarya Chander, Mansi Singh, Lucas T. Graybuck, Z. Thomson, Christian M. LaFrance, S. Rachid Zaim, Tao Peng, L. Okada, Palak C. Genge, Kathy Henderson, Elisabeth M. Dornisch, Erik D Layton, Peter J. Wittig, A. Heubeck, Nelson M. Mukuka, Julian Reading, Garrett Strawn, Teminijesu Titus-Adewunmi, Kathleen Abadie, Charles R. Roll, Veronica Hernandez, Vaishnavi Parthasarathy, Tyanna J. Stuckey, B. Musgrove, Elliott G. Swanson, Cara Lord, M. Weiss, C. Phalen, Regina R Mettey, Kevin J. Lee, John B. Johanneson, Erin K. Kawelo, Jessica Garber, Upaasana Krishnan, Megan E. Smithmyer, E. Wherry, L. Vella, S. E. Henrickson, Mackenzie S. Kopp, Adam K. Savage, Lynne A. Becker, Paul Meijer, E. Coffey, Jörg J. Goronzy, Mikael Sigvardsson, Cate Speake, Thomas F. Bumol, Ananda W. Goldrath, Troy R. Torgerson, Xiao-jun Li, Peter J. Skene, J. Buckner, Claire E. Gustafson
          </td>
          <td>2025-10-29</td>
          <td>Nature</td>
          <td>0</td>
          <td>64</td>
        </tr>

        <tr id="Chlamydia invades multiple mucosal tissues in humans and animals. The body’s first line of defense against chlamydial infection is provided by innate immunity, whereas adaptive immunity plays a crucial role in managing the infection’s progression and preparing the immune system to combat reinfection. Host resistance to chlamydial infection necessitates a coordinated effort between innate and adaptive immune cells. Numerous cell types are capable of producing interferon gamma (IFN-γ) as a defense mechanism against chlamydial infection, thereby effectively mediating the clearance of infection. However, the distinct roles of various immune cell populations in responding to chlamydial infection, as well as their functions during infection progression, remain poorly understood. Therefore, we will discuss the various roles of IFN-γ released by different immune cells in chlamydial infection, focusing primarily on experimental animal models and a review of available data from in vivo cellular immunological studies in humans.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7c375743e3715f5e17dc641ecdc55eebdf06385f" target='_blank'>
              Role of IFN-γ from Different Immune Cells in Chlamydia Infection
              </a>
            </td>
          <td>
            Xuan Chen, Wenjing Yang, Yuchen Hu, Yang Zhou, Zhou Zhou
          </td>
          <td>2025-10-01</td>
          <td>Microorganisms</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="People living with HIV-1 (PWH) and chronically using opioids have elevated risks of developing HIV-associated neurological disorders (HAND) that are often correlated with persistent inflammation. Microglia, innate immune cells in the brain, are the principal HIV-1 reservoir in the central nervous system and regulate neuroinflammation. Our group previously showed that HIV-1 infection of induced pluripotent stem cell (iPSC)-derived microglia and viral intron-containing RNA (icRNA) expression triggers inflammatory responses. Microglia express μ opioid receptor, MOR, yet the immunomodulatory effects of opioids on HIV-1 infection in microglia are unclear. Here, we report that MOR activation impacts HIV-1 infection establishment and HIV-1-induced innate responses in microglia. Morphine pretreatment enhanced reverse transcription (RT), integration, viral transcription, and p24Gag secretion in HIV-1-infected iPSC-derived microglia, which was blocked by treatment with naloxone, a MOR antagonist. In contrast, morphine treatment did not impact HIV-1 infection in MOR-deficient monocyte-derived macrophages, although, induced exogenous expression of MOR in macrophages conferred morphine-mediated enhancement of HIV-1 infection. Interestingly, viral transcriptome analysis by digital-drop PCR revealed selective enhancement of HIV-1 icRNA expression in morphine-exposed iPSC-derived microglia, which correlated with enhanced HIV-1 icRNA-induced secretion of IP-10 in MOR+ cells. Further, PI3K inhibitor, wortmannin, blocked morphine-mediated enhancement of HIV-1 replication and HIV-1 icRNA-induced IP-10 secretion, suggesting that MOR signaling and HIV-1 icRNA expression synergistically activate the PI3K-Akt signaling pathway in microglia to exacerbate virus-induced inflammatory responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/33120b856a2b6c63c61e9bfd1c234edbc64bb007" target='_blank'>
              Mu opioid receptor activation in microglia enhances HIV-1 infection and HIV-infection-induced inflammatory responses
              </a>
            </td>
          <td>
            Chelsey A. Skeete, Gabriel M. Sgambettera, Aldana D. Gojanovich, Xianbao He, Daniel Bryant, Mengwei Yang, Shreya Banerjee, Andrés A Quiñones-Molina, H. Akiyama, Gustavo Mostoslavsky, Andrew J. Henderson, S. Gummuluru
          </td>
          <td>2025-10-06</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Type 1 interferons (T1IFNs) are typically expressed in low concentrations under homeostatic conditions, but upon pathogenic insult or perturbation of the pathway, these critical immune signaling molecules can become either protectors from or drivers of pathology. While essential for initiating antiviral defense and modulating inflammation, dysregulation of T1IFN signaling can contribute to immunopathology, making it and its associated pathways prime targets for immune evasion and disruption by pathogens. This review focuses on the changes in T1IFN signaling across the lifespan, with particular emphasis on the role of the Stimulator of Interferon Genes (STING) pathway in autoimmune and infectious disease susceptibility, especially in the context of viral infections. Aging is associated with diminished T1IFN responsiveness, partially resulting from chronic stimulation of the STING pathway, which contributes to increased susceptibility and impaired viral clearance. Conversely, neonates and young children also show increased vulnerability to certain viral infections, but whether this is driven by T1IFN differences or another mechanism remains incompletely understood. Despite growing interest in T1IFN-based immunotherapies, pediatric and elderly populations remain underrepresented in clinical trials. Here, we advocate for a deeper molecular and systems understanding of how the interferon response evolves across the human lifespan, to inform age-tailored therapeutic approaches and more inclusive study designs, thereby improving outcomes in both the youngest and oldest patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/92fe0ce0558850fa46898881223207341f832632" target='_blank'>
              What goes up must come down: dynamics of type 1 interferon signaling across the lifespan
              </a>
            </td>
          <td>
            Lucy Hartnell, P. Agudelo-Romero, S. Montgomery, R. Ben-Othman, Valerie Verhasselt, Stephen M. Stick, Tobias R. Kollmann
          </td>
          <td>2025-10-16</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Understanding and enhancing vaccine-induced immune responses in the elderly population is critical, as they face elevated risks of severe COVID-19. This work systematically delineates age-associated alterations in innate and adaptive immunity and their impact on responses to SARS-CoV-2 inactivated vaccination. Compared to young mice, aged mice exhibited polarized bystander Th1 CD4+T cell populations (31.68 ± 5.62% versus 3.31 ± 0.48%) with distinct transcriptomic signatures, which augmented humoral immunity in aged mice. In human cohorts, post-vaccination antigen-specific antibody titers are comparable across different age groups. Stratified analysis based on antibody concentration reveals that high-responder individuals possess elevated pre-existing Th1 cells at baseline, which exhibit a modest positive correlation with post-vaccination antibody titers (r = 0.423, p = 0.001). Therefore, compared to age-based stratification, baseline Th1 cells serve as a superior predictive biomarker for antibody generation following SARS-CoV-2 inactivated vaccination. Collectively, these findings unveil novel mechanisms underlying Th1-mediated vaccine immunogenicity, offering pivotal insights for developing next-generation vaccines with optimized protective efficacy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/94a9d36618b10b6d7d7b319e4caa280465ee9310" target='_blank'>
              Pre-Existing Th1 Immunity Outperforms Age in Predicting Antibody Responses to SARS-CoV-2 Inactivated Vaccines.
              </a>
            </td>
          <td>
            C. Ye, Xiaoli Zhang, Lingfeng Qiu, Jia Ji, Jueqing Gu, Hongyu Jia, Yingfeng Lu, Jiyang Chen, Zelu Meng, Jiangshan Lian, Hangping Yao, Xun Zeng, Yida Yang
          </td>
          <td>2025-11-16</td>
          <td>Advanced science</td>
          <td>0</td>
          <td>13</td>
        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

</body>

<script>

  function create_author_list(author_list) {
    let td_author_element = document.getElementById();
    for (let i = 0; i < author_list.length; i++) {
          // tdElements[i].innerHTML = greet(tdElements[i].innerHTML);
          alert (author_list[i]);
      }
  }

  var trace1 = {
    x: ['2024', '2025'],
    y: [2, 6],
    name: 'Num of citations',
    yaxis: 'y1',
    type: 'scatter'
  };

  var data = [trace1];

  var layout = {
    yaxis: {
      title: 'Num of citations',
      }
  };
  Plotly.newPlot('myDiv1', data, layout);
</script>
<script>
var dataTableOptions = {
        initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;

                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);

                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';

                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    scrollX: true,
    scrollCollapse: true,
    paging: true,
    fixedColumns: true,
    columnDefs: [
        {"className": "dt-center", "targets": "_all"},
        // set width for both columns 0 and 1 as 25%
        { width: '7%', targets: 0 },
        { width: '30%', targets: 1 },
        { width: '25%', targets: 2 },
        { width: '15%', targets: 4 }

      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  }
  new DataTable('#table1', dataTableOptions);
  new DataTable('#table2', dataTableOptions);

  var table1 = $('#table1').DataTable();
  $('#table1 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table1.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
    }
  });
  var table2 = $('#table2').DataTable();
  $('#table2 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table2.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
    }
  });
</script>
<style>
  .child-row-content {
    text-align: justify;
    text-justify: inter-word;
    word-wrap: break-word; /* Ensure long words are broken */
    white-space: normal; /* Ensure text wraps to the next line */
    max-width: 100%; /* Ensure content does not exceed the table width */
    padding: 10px; /* Optional: add some padding for better readability */
    /* font size */
    font-size: small;
  }
</style>
</html>







  
  




  



                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8v12Z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "..", "features": ["navigation.top", "navigation.tabs"], "search": "../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    

      <script src="../assets/javascripts/bundle.c8d2eff1.min.js"></script>
      
    
<script>
  // Execute intro.js when a button with id 'intro' is clicked
  function startIntro(){
      introJs().setOptions({
          tooltipClass: 'customTooltip'
      }).start();
  }
</script>
<script>
  

  // new DataTable('#table1', {
  //   order: [[5, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });

  // new DataTable('#table2', {
  //   order: [[3, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });
  new DataTable('#table3', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
  new DataTable('#table4', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
</script>


  </body>
</html>